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Abstract
The titin molecule has a length of over 1 µm and functions as a colossal protein
scaffold in the muscle sarcomere. Up to 90% of its total mass is composed of repetitive
immunoglobulin (Ig) and fibronectin (FnIII) domains that form linear tandems
interspersed by unique sequences, among them a Ser/Thr kinase domain located at its
C-terminus. The distinct pattern of Ig and FnIII motifs N-terminal to the kinase domain
is conserved in other „giant kinases“ and invertebrate titin homologues. In vertebrate
titin, it is involved in the specific recruitment of the ubiquitin ligase MuRF-1 to the
filament. MuRF-1 is involved in the pathological atrophy of skeletal and cardiac
muscle.
We have determined the crystal structure of titin A168-A170 comprising two Ig
and one FnIII domains and established its binding to MuRF-1 in solution. We analysed
the structure with the aim to understand the interdomain relationships between
repetitive Ig and FnIII subunits in titin as well as to shed light into the molecular
determinants that confer specificity to ligand binding on the scaffold and in particular in
the M-line interface to MuRF-1. A168-A170 shows an extended, rigid architecture. Its
surface displays a shallow groove along its full length as well as a unique loop
protrusion, both features conceivably mediating MuRF-1 binding. Moreover, our ITC
data show that binding occurs with high affinity between residues 166-315 of MuRF-1.
These data suggest that A168-A170 is of interest to attempt therapeutic inhibition of
MuRF-1-mediated muscle turnover.
In addition we have elucidated the structure of the B-box domain of MuRF-1 to
further investigate the role of MuRF-1 in homo- and hetero-oligomeric interactions at
the M-line region. We found that MuRF-1 B-box adopts a RING-finger-like fold and
exists in a dimeric state in solution. The domain possesses characteristic surface
properties that are likely to mediate interactions of MuRF-1 with other sarcomeric
components that are important in MuRF-1 function at the M-line.
Finally, we have also carried out the biophysical characterization of the nuclear
adaptor protein LAP2! that interacts with the nuclear lamina scaffold. Conceptually,
LAP2! and the nuclear lamina are closely related systems to MuRF-1 and titin. This
characterization, whose ultimate finality is to understand the interaction of LAP2! with
lamin A/C establishes now the basis for a future structure elucidation.
vThis work illustrates how scaffold protein systems, which are structural skeletons
composed of multiple repetitive units, can become functionalized by the recruitment of
specific shuttle proteins to their surface. Specific binding in such systems involves
steric factors as well as the evolution of unique sequence inserts at defined locations.
Recruited proteins often act as adaptors that, in turn, attract other cellular components.
They often result in large, heterogeneous molecular assemblies that amplify the
physiological response. In the case of titin, the potential formation of a signalosome
assembly at its M-line, surrounding a kinase domain, is thought to mediate mechano-
transduction pathways involved in the regulation of myofibril turn-over and, thereby, in
the adaptative remodelling of muscle to mechanical load.
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1 Introduction
1.1 Protein-protein interactions
1.1.1 Network modules
The cell as the basic unit of life is able to move, communicate, metabolise, grow,
reproduce and dynamically remodel its shape in response to external and developmental
stimuli. For these processes to occur, a precise spatiotemporal order is absolutely
essential. This is reflected by the concept of hierarchical organization of the cellular
machinery from atoms to macromolecular assemblies to organelles and beyond to
tissues, organs and organisms. A constant interplay across all organization levels
extends from events that happen on the timescale of the whole cell, e.g. cell motility,
reproduction and development to the most rapid events operating at the timescale of
macromolecules, e.g. protein synthesis or catalysis. As a result, life is inevitably
orchestrated by chemical reactions between all cellular components, which thus form
metabolic, protein-protein or protein-DNA networks.
Current post-genomic projects aim at unravelling the relationships between
cellular protein components (Alloy and Russell, 2006; Joyce and Palsson, 2006). The
study of protein-protein interactions in pathways, complexes or even complete
organisms has become a new paradigm in protein biology (Butland et al., 2005; Stelzl et
al., 2005; Uetz, P. et al., 2000). These studies revealed that most cellular proteins are
tightly embedded into biological networks and function often within the context of
multimeric or supramolecular assemblies. Prominent, due to their stability well
characterized examples are the spliceosome (Neubauer et al., 1998), the proteasome
(Verma et al., 2000) or the nuclear pore complex (Rout et al., 2000). Other examples
include more transient interactions between proteins and protein complexes like
tyrosine kinase signalling cascades that are composed of scaffold protein complexes and
various regulators and effectors (Csiszar 2006).
According to the network modularity principle introduced by Hartwell et al.
(Hartwell et al., 1999) these molecular assemblies contain so-called “functional
modules” as critical level of their biological organization. These modules are discrete
entities whose functions are separable from other modules. The underlying molecular
components (small molecules, protein, RNA, DNA) and their interactions collectively
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contribute to the function of the module (Figure 1.1). Nevertheless, the function of the
module cannot be predicted from the isolated underlying components. By
computational analysis it has become clear that most relevant functional modules in
biological networks are found in the meso-scale format, that is, they consist of 5-25
genes/proteins per module (Spirin et al., 2003).
Figure 1.1: Concept of hierarchical modularity in biology.
a) Modularity on the protein level: Uridylate kinase (1ukz; Mueller-Diekckman & Schulz, 1995) contains
a single NTP-hydrolase domain. In the multi-domain transcription factor protein EF-TU (1exm;
Hilgenfeld et al., 2000) a domain from the same superfamily is present (in red).
b) Modularity at the cellular level as exemplified by three distinct types of functional modules:
i)  a metabolic pathway - the mevalonate pathway.
ii) a signalling pathway - mating response MAPK pathway in yeast (Schwartz and Madhani, 2004).
iii) a protein complex - ATP synthase (1e79; Gibbons et al., 2000) Six chains (red and orange) that all
contain an NTP-hydrolase domain are assembled into a ring together with additional domains (Figure
modified from: Pereira-Leal et al., 2004).
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Two types of modules have been classified: i.) stable protein complexes such as
the splicing machinery, protein export-, protein transport-complexes, transcription
factors; and ii.) dynamic functional units like signalling and metabolic cascades, cell
cycle regulation modules (Spirin and Mirny, 2003). The latter ones do not require
physical contact of all components at all times or physical contact at all. Rather they are
connected by a succession of interactions in the case of an information-processing
signalling cascade or by the product of one enzyme being the substrate of the next in a
metabolic cascade (Pereia-Leal et al., 2004). By definition, the module is a discrete
entity whose function is distinct from other modules. The underlying isolation principle
can either be in the case of complexes spatial location or in the case of dynamic
functional modules their chemical specificity and temporal existence.
The modular organization of protein-protein interaction networks facilitates the
combinatorial generation of complexity as well as functional diversity, both of which
are important factors in the context of evolution biology (Kirschner and Gerhart, 1998).
Evolution re-wires modules instead of altering individual modules, following the
concept of hierarchical modularity applicable also to many other scientific disciplines
including computer science and organization theory (Cohen and Tong, 2001). Also in
protein structure, the concept of modularity is also an established principle (Figure 1.1).
Proteins are formed by autonomously folding units called domains that display strong
connections within, but weaker connections outside the domain, a defining feature that
is also shared with modules in cellular networks (Pereia-Leal et al., 2004).
1.1.2 Protein complexes
Protein complexes act as well-defined functional modules in cellular networks.
They are formed by cohesive and strong interactions and often can be reconstituted in a
functional form independently of the rest of the protein interactions network. Two types
of complexes can be distinguished: i) Obligate protein complexes, in which the
individual protomers in isolation do not form stable structures; ii) non-obligate
complexes, where the protomers exist and function also as individual units
independently of complex formation (Nooren and Thornton, 2003)
The stability of the complex depends strongly on the physiological environment
and cannot be predicted a priori. Nevertheless, the transient or stable nature of the
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complex can often be inferred from the biological context, i.e. temporary interaction in
signalling (weak linkage) or stable constitutive interaction in structural function (strong
linkage). An advantage of protein-protein interactions via weak linkage is an increased
“evolvability” of the system (Kirschner and Gerhart, 1998). Together with
compartmentation and redundancy it leads to a reduction of the interdependence of each
components and facilitates the accommodation to novelty through accumulation of non-
lethal mutations. This principle is reflected by the fact that proteins interacting with
many other proteins in strong, structural interactions like for example active sites in
enzymes, histones, actin and tubulin monomers have changed little during evolution.
Within a complex, protein-protein interactions can be established between
identical or non-identical chains, thus forming homo- or hetero-oligomeric
arrangements. Frequently observed motifs of homo-oligomeric interactions are coiled-
coil motifs (Burkhard et al., 2001). In an isologous association both partners interact via
the same surface on both monomers, whereas in an heterologous association assemblies
use different interfaces, which potentially can lead to higher order aggregation. This is
exemplified by the pathogenetic amyloid formation leading to Alzheimers disease
(Sunde et al., 1997).
Homo-oligomeric complexes are highly abundant (Figure 1.2). For example
calculations utilizing the typical macromolecular composition of the E.!coli cytosol
revealed that the average oligomeric state of soluble proteins is four, with 15% forming
higher order assemblies (Goodsell et al., 1991). Analysis of the Protein Quaternary
Structure (PQS) database (Henrick and Thornton, 1998) has revealed that over 70!% in
a non-redundant set of protein complexes contained interactions between identical
proteins (Pereia-Leal et al., 2004), i.e. homo-oligomerisation contributes to a large
extent to protein complex formation.
Given its frequent occurrence, homo- and hetero-complex formation must stand
under substantial evolutionary pressure and have a number of structural and functional
advantages.
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Figure 1.2: Homo-oligomeric protein-protein interactions are highly abundant.
Shown is the result of an analysis of the protein quarternary structure database (PGS) (Henrick and
Thornton 1998). Structures on the top represent examples of the complex type: homotrimer of carbonic
anhydrase (1qrf; Iverson et al., 2000), 2-oxoisovalerate dehydrogenase heterotetramer (1ps0; Valencia et
al., 2004) and hetero-dimer of the cap-binding protein (1n52; Calero et al., 2002). Interactions are show
as red (homomeric) and green (heteromeric) lines between the nodes of a two-dimensional representation
of each complex (Figure taken from: Pereira-Leal et al., 2004).
1.1.3 Advantages of complex formation
Protein complex formation leads to synergistic effects. Clustering of molecules in
signalling complexes for example ensures a rapid information exchange and eliminates
delays that would occur as a result of cytosolic crowding and diffusion limitation.
Complex formation can also provide a unique, local physicochemical environment that
leads to an increase in specificity, affinity and, at times, potentiated activity through
cooperativity; a prominent example are the ubiquitin ligases that frequently self-
assembly into higher order structural assemblies with compartment character (Kentsis et
al., 2002; Reymond et al., 2001; see chapter 1.3). Furthermore DNA binding proteins
are frequently components of large functional modules and bind DNA as homo-dimers
like the type II restriction enzyme (Pingoud and Jeltsch, 2001) or transcription factors
like the glucocorticoid response element (Cairns et al., 1991).
In addition, formation of higher-order assemblies provides an increase in
mechanical and chemical stability, an advantage most clearly envisioned in the homo-
oligomeric filamentous assemblies of the cytoskeleton. Intermediate filaments (IFs), for
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example, are resistant against treatments with high concentrations of urea or detergents
and constitute stress-bearing fibres. Yet cytoskeletal filaments are dynamic structures
that can be assembled and disassembled rapidly. In this case, the process of self-
assembly can reduce the genome size and prevents problems emerging from the folding
of large single-chain proteins (Marianayagam et al., 2004).
1.1.4 Scaffolding complexes enforce proximity
One method to influence components, subcellular localization and activity of
protein ensembles involves scaffold proteins. These proteins influence protein-protein
interactions without modifying their targets and can recruit two or more molecules
simultaneously into a global complex (Vondriska et al., 2004), a concept known as
“forced proximity” (Ferrell and Cimprich, 2003). Accordingly, scaffold proteins have
been described as signal transduction “catalysts”: they mediate the pre-localization of
all participants in a pathway, so that immediate and rapid access to the up and
downstream substrates in the cascade can be achieved. The regulation of scaffolders is
crucial for the coordinated function of the cell. Hence, scaffold proteins can themselves
be subjected to post-translational modification. Additional regulatory mechanisms are
their oligomerization state, their ability to undergo conformational changes and their
susceptibility to irreversible protease cleavage or degradation by ubiquitin pathways
(Csizar, 2006).
1.1.5 Functions of Scaffold proteins
Scaffold proteins constitute structural formations in distinct cellular locations with
a number of specific advantages. Through combinatorial control, components of a
complex might be displaced or added, deactivated or activated depending on
competitive/non-competitive interactions with other elements of the complex (Burack et
al., 2002). Conformational changes, alterations in the interaction surface or post-
translational modifications trigger these processes. A varying combination of a discrete
set of molecules also increases the number of distinct signalling modules for distinct
phenotypes.
Scaffolding can also increase the specificity of the processes by preventing
interactions with components of other pathways, hence conferring insulation to the
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signalling module. Depending on sub-cellular location with its local environment and
together with the sequential assembly process on the scaffold, different kinetic
activation thresholds can regulate signal propagation downstream of the signalling
complex. In contrast to diffusion controlled signalling events, tethering of transducers to
protein scaffolds can lead to attenuation rather than amplification of responses, a fact
that might help the cell to prevent undesirable amplification of signals in the absence of
appropriate stimuli. On the other hand, scaffolding can clearly potentiate activity by
increasing the local concentration of the effector molecule and the close proximity of
the signal processing machinery (Burack et al., 2002). Taken together, anchoring,
targeting and isolation are the major regulatory features of scaffold proteins.
To fulfil these functions, the “scaffolder” needs to provide a rigid folding unit that
is capable of minimizing the conformational entropy loss of both interaction partners
during the complexation event. Thus, a well-defined protein core that substantially
contributes to the energy of domain folding is critical (Skerra, 2000). A structurally
well-characterized example involved in protein modification can be found in the
ubiquitin ligases of cullin type (Zheng et al., 2002). Scaffolding building blocks include
for example phospho-tyrosine binding (PTB), Src homology (SH2, SH3) or pleckstrin
homology (PH) domains in the case of tyrosine kinase signalling complexes (Csizar,
2006)) or the zinc binding RING finger domain (Borden, 2000; chapter 1.2 and 1.3).
Scaffolding subunits can be grouped according to their secondary structure
content into !-helical proteins, into small structures with few secondary structure
elements and irregular ! /" architecture and finally into predominantly "-sheet
containing scaffolding motifs (Hosse et al., 2006. Among the all-"-motifs, clearly the Ig
as well as the related fibronectin type III (FnIII) domain are highly abundant protein-
protein scaffolding platforms (Holt et al., 2003; Koide et al., 1998).
1.1.6 The Immunoglobulin superfamily (IgSF)
The Immunoglobulin (Ig) fold is probably the most widespread architectural motif
in multidomain proteins, among them matrix proteins, receptors, chaperones and
enzymes. This is reflected in the wealth of functional, structural and sequence diversity
among the Ig domains (Barclay, 2003). Nevertheless, a common function of all Ig–like
domains is their involvement in diverse binding interactions. To date, no single Ig
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domain has been reported to contain enzymatic activity (Bork et al., 1994). Structurally,
the Ig domain consists of seven to nine anti-parallel "-strands forming a "-sandwich
with a Greek key.
The available structural information lead to a topological sub-classification of the
Ig fold into four distinct sub-classes based on number of the strands and their
connectivity (Figure 1.3a). Most conserved are the strands termed B, C, E, F, which
define a two-by-two structural core. Nevertheless, the edges of the sheets are
conformationally flexible (strands A, G, C’, C’’) and the location of the strands C’/D
defines the four subtypes. The C-type (Constant) represents the classical seven-stranded
topology, whereas the S-type (Switched) also contains seven strands, with strand D and
C’ switched. The H-type (Hybrid) of Igs can be envisioned as hybrid between C- and S-
type with eight strands and finally the nine-stranded V-type (Variable) is observed in
the variable domain of immunoglobulins (Bork et al., 1994). Two additional topologies
are realized in the Ig domains of human lamin A/C (Dhe-Paganon et al., 2002; Krimm
et al., 2002) and the Ig domain of Telokin (Harpaz and Chotia, 1994), which both form
deviations of the canonical topologies through the presence of extra strands at the edges
of the sheets (Figure 1.3b).
Binding of Ig ligands is not restricted to the loop regions like in the
complementary determining region (CDR) of the immunoglobulins variable domain,
but can also be mediated by interactions within the sheets. Often consecutive regions in
more than one domain constitute the binding interface (Huber et. al., 1994).
The fibronectin type III fold (FnIII) found in numerous extracellular matrix
(ECM) proteins resembles the S-type Ig fold (Figure 1.3b). Fibronectins’s function
depends on its ability to bind ECM components including adhesion molecules, cytokine
receptors, collagens and integrins. Its extended domain arrangement of independently
folded units leads to a “beads on a string” appearance in electron micrographs (Erickson
et al., 1981). Three different kinds of Fn modules are realized in the subypes I, II and III
(Ruoslahti 1988), which are all structurally characterized (Type I: Williams et al, 1994;
Type II: Constantine et al., 1992; Type III: Leahy et al., 1992). The Type III module is
the biggest module and characterized by a consensus sequence of approximately 90
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Figure 1.3: Sub-classification of the Ig-fold according to connectivity and strand topology.
a) The two sheets of the domains are displayed as if they are in an open book lying face down. Closing of
the book can reproduce the fold. Four distinct subtypes are classified. "-strands A, B, C, E, F and G are
common to all Ig-like domains (Bork et al., 1994). The strand connectivity and presence of accessory
strands (grey) distinguishes between Ig domain subtypes. The fibronectin type III (FnIII) fold possesses
similar topology like the S-type Ig. b) Two different types of Ig domains relevant for the work in hand are
the lamin (L-type; Dhe-Phaganon et al., 2002) and the titin subtype (I-type; Harpaz & Chotia, 1994), both
characterized by extra strands. The L-type represents a variation from the S-type Ig fold, whereas the I-
type represents a variation from the V-type Ig. The 3D structure of Ig I1 from titin I-band (Mayans et al.,
2001) and of FnIII A-71 (Muhle-Goll et al., 1996) is included for illustration. In the lamin fold the extra
strands are not named.
residues (Patthy, 1991) and contains unique features that are necessary for cell
adhesion activity. These features include the Arg-Gly-Asp (RGD) loop between strand
F and G and an additional region on an adjacent FNIII modules termed synergy region.
Compared to the Igs it shows a distinct hydrophobic core and only low sequence
homology (Main et al., 1992).
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1.2 Titin´s M-line: a structural scaffold and signal transduction
“module”
1.2.1 Structure of the sarcomere
The sarcomere or contractile unit of striated vertebrate muscle is considered to be
the most highly ordered and functionally coordinated supra-molecular structure known
to date. Its remarkable paracrystalline arrangement of myofilaments is directed to
generate force in a rapid and directed way.
The striated pattern that is visible in the light microscope lead to a division of the
2-3!µm long sarcomere into several zones (Figure 1.4a). It is bordered at each end by a
dark, narrow line known as the Z-disc, that bisects a lighter region, the so-called I-band
(isotropic in polarized light), which is shared by two adjacent sarcomeres. At the center
of the sarcomere, a dark zone called the A-band (anisotropic in polarized light) is again
divided by a less dense region called the H-zone. Within the H-zone, a narrow band of
higher density called the M-line defines the geometrical middle of the sarcomere. The
M-line also contains a fine-structure of up to five dense and less-dense lines that varies
in number among different muscle types (review Squire et al., 2005).
The striation pattern results from the precisely ordered arrangement of the two
contractile filaments actin and myosin as deduced from ultrathin sections of muscle
investigated by electron microscopy (Hanson and Huxley, 1953). These two
cytoskeletal filaments are the basic active-force generating proteins forming the thin
(actin-based) filament of the I-band and the thick (myosin-based) filament of the A-
band. Capping and cross-linking proteins are necessary for the correct polymerization of
both filaments and construction of a registered, three dimensional lattice. Intermediate
filaments at the Z and M-line reinforce sarcomere structure through the sarcolemma
providing a scaffold of force transduction, maintain sarcomeric registry and connect
adjacent sarcomeres.
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Figure 1.4: EM micrograph of striated muscle and schematic representation of sarcomere.
a) Individual myofibrils are aligned and consist of alternating dark and light stripes. The dark bands are
called A bands (labelled A), while the light regions are termed I bands (labelled I). The A bands are
themselves striped, consisting of a lighter central band called the H zone (labelled H) flanked by two
darker regions. At the centre of the H zone is a thin dark line, the M line (labelled M). A similar line, the
Z line (labelled Z) is visible in the centre of the I band. The sarcomere is defined as the region between
two Z lines (picture taken from Engel & Franzini-Armstrong, Myology, 3rd edition).
b) Principle components of the sarcomere are the I-band, the A-band, Z-disc and M-line. Four distinct
filament systems (titin, nebulin, actin and myosin) contribute to sarcomere integrity. At the Z-disc the N-
terminus of titin is bound to telethonin (T-cap). Each of the four filaments has a distinct domain
composition. Titin contains several unique regions among them an unstructured region (PEVK) and a
Ser/Thr kinase domain. In the A-band a super-repeat pattern of alternating immunoglobulin and
fibronectin type III domains is believed to mediate interaction myosin binding protein C (labelled C-
protein). (Figure taken from Gregorio et al., 1999).
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1.2.2 Overall structure of the third filament of the sarcomere: titin
The giant protein titin (formerly known as connectin; (Maruyama, 1976) is the
third muscle specific filament system and has essential structural, contractile and
regulatory functions in the sarcomere. It spans half of the sarcomere from the Z-disc to
the M-line (Figure 1.4b).
The titin gene contains 363 exons coding for 38138 residues (4200 kDa) and
multiple splice isoforms have been identified. The expressed protein exists as a single
polypeptide chain with an isoform-dependent molecular composition between 27000
and 33000 residues corresponding to a molecular weigth of 2970 kDa in the cardiac and
3700 kDa in the soleus skeletal muscle isoform (Bang et al., 2001). With its length of
over 1!µm it is the largest protein known to date (Swiss-Prot/TrEMBL accesion
numbers Q10465, Q10466, and Q8WZ42, Labeit and Kolmerer, 1995).
Its N-terminus resides in the Z-disc interacting with a protein called T-cap or
telethonin. Telethonin gets phosphorylated by the kinase domain of titin (Mayans et
1998) and is essential for sarcomere formation in the differentiated myocyte (Gregorio
et al., 1998). After the Z-line titin runs parallel to the actin filament the I-band region.
This region of titin contains tissue-specific isoforms with distinct mechanical properties
as well as intrinsically unstructured regions functioning as entropic springs (Labeit and
Kolmerer, 1995; Freiburg et al., 2000).
In the A-band region titin binds to meromyosin and MyBP-C, serving as a
template or “blueprint” during fibrillogenesis (Trinick, 1994). Due to this strong
interactions the A-band of titin is stiff under physiological conditions. By contrast, the
I-band region is an elastic spring that creates the passive and restoring force during
sarcomere stretch and compression, key aspects of mechanical behaviour of the
myofibrill (Linke et al., 1994).
Titin’s C-terminus overlaps with an adjacent titin molecule at the M-line creating a
continuous system throughout the sarcomere. Through embedding into transversal
cytoskeletal networks at the M-line, it ensures that equal forces are developed in the two
halves of the A band (Agarkova et al., 2003).
Several titin-related molecules have also been found in invertebrate muscles
(Bullard et al., 2002). The conservation of Fn-Ig modules and the kinase domain in
twitchin and two insect projectins suggest an important function for this part of the
molecule. Stretchin-MLCK (stretchin myosin light chain kinase) is a protein present in
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Drosophila, which is predicted to have a tandem Ig composition as well as unique
proline, glutamate valine and lysine rich sequences termed PEVK and a C-terminal
kinase domain. By contrast, the tandem-Ig containing protein kettin, which is found in
insects, C.elegans and crayfish, contains no FnIII modules and no kinase domain. It
shows high similarity to the titin I-band region.
1.2.3 Domain composition and interactions of the giant scaffold titin
Similar to cell adhesion and extracellular matrix proteins (fibronectin, L1-CAM,
N-CAM; Gerrow and El-Husseini, 2006) titin consists of a modular array of up to 166
copies of immunoglobulin (Ig) and 132 copies of fibronectin type III (FnIII) domains in
soleus skeletal muscle (Figure 1.5). As a result, it appears as a string-of-beads in
electron micrographs (Trinick et al., 1984).
The filament utilizes the nature of the Ig fold as a protein-protein interaction
domain to interact with a majority of sarcomeric proteins, other filaments and cytosolic
signalling molecules of highly diverse functions and cellular location (Lange et
al.,!2006). Currently, the amount of titin-associated proteins identified by yeast two
hybrid techniques (Piehler 2005) is constantly growing (Miller et al., 2004; Lange et al.,
2006).
Structural interactions that contribute to sarcomere integrity are found in the Z-
disc, A-band and M-line. Proteins with proposed signalling or regulatory function
cluster at three “signalling hot spots” with extensive cross-talk between them: the Z-
disc, the beginning of the I-Band (N2-PEVK region; next chapter) and the M-line
(Granzier and Labeit, 2004).
1.2.4 I-Band titin
The I-band region of titin contains tandem Ig domains and unique sequences. The
Ig domains are arranged in two sections, proximal and distal I-band to the Z-disk which
are intervened by a unique PEVK region of variable length. Passive tension and
sarcomeric slack length are largely determined by I-band titin through tissue-specific
and developmental expression of proximal Ig and PEVK splice isoforms (Bang et al.,
2001). Cardiac spliceoforms include the stiff N2B (short spring) isoform and the more
compliant N2BA isoform (long spring). A variation of I-band molecular mass of 0.7
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MDa in cardiac and 1.5 MDa in soleus muscle was observed (Labeit and Kolmerer,
1995). Accordingly, Wu et al. have shown that upon exposure to elevated heart pacing
levels leading to pace-induced cardiac failure, the sarcomere changes its titin
composition on the timescale of weeks in favour of the more stiffer N2B isoform (Wu
et al., 2002). Hence via alternative splicing of titin and together with likewise isoform-
dependent calcium and actin binding properties of titin the sarcomere can rapidly adjust
its mechanical properties and modulate a broad range of elasticity (Granzier and Labeit,
2004). Furthermore, titin phosphorylation in the cardiac N2B and N2BA region was
found to reduce passive force. The reduction of passive force was found independent of
the association between titin and the thin filament, as thin filament-extracted
preparations showed comparable, solely titin-based decrease in stiffness.
Figure 1.5: Domain structure of human cardiac titin and characterized titin ligands.
Titin consists to > 90% of its mass of tandem Ig (dark grey) and FnIII (light grey) modules. 19 unique
sequences including a PEVK (blue) and kinase (orange) region have been identified. Shown are cardiac
N2B (yellow) and N2A (red) spliceoforms). Various titin ligands have been identified by Y2H screens.
They cluster in three distinct positions: i) Z-disc, ii) I-band N2A region and iii) M-line. Shown are T-cap
(red), !-actinin (orange), DRAL/FHL2 (light blue), cariac ankyrin protein (CARP; yellow), myopalladin
(blue), p94 (calpain, green ), Muscle specific RING-finger protein (MURF; brown) and myomesin (pink).
The A-band shows a super-repeat pattern of alternating Ig and FnIII domains (Figure taken from: Miller
et al., 2004).
A potential alteration of native structures within the N2B region resulting in slack
length gain was proposed, but the exact mechanism is currently unknown.
Despite its mechanical involvement in muscle passive tension, both I-band
regions N2B and N2A have been shown to constitute targets for signalling molecules.
N2B was found to interact with the zinc-binding LIM family member DRAL/FHL-2,
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which in turn binds to the metabolic enzymes creatinine-, adenylate- and
phosphofructo-kinase (Lange et al., 2002). Hence a function in compartmentalisation of
metabolic functions was proposed for the central I-band region to assure the ATP
supply needed for muscle contraction. For the N2A element present in both cardiac and
skeletal muscle several ligands have been identified. Two of its Ig domains (Ig82/83)
interact with the calpain protease p94 (Ono et al., 2004). Its binding to titin is thought to
regulate p94 protease activity.
Additional ligands include the two homologous ankyrin repeat proteins cardiac
ankyrin repeat protein (CARP) and diabetes ankyrin repeat protein (DARP). CARP in
turn interacts with myopalladin, an actin associated scaffold found also in the nucleus
(Otey et al., 2005). All ankyrin repeat protein were found up-regulated after cardiac
injury, muscle denervation or during recovery after metabolic efforts suggesting their
involvement in stress response pathways (Kuo et al. 1999; Kemp et al., 2000; Ikeda et
al., 2003). This is further corroborated by their presence in the nucleus and interaction
with transcriptional regulators (Miller et al., 2003).
1.2.5 A-band titin
The A-band section of titin is an integral part of the myosin filament. The latter
can be subdivided based on visual appearance in electron micrographs into three regions
termed D-, C- and P-zone (Sjöström and Squire, 1977).
Strikingly, titin FnIII domains are exclusively found in the A-band region forming
two defined super-repeat patterns. A seven domain superrepeat (Ig-Fn-Fn-Ig-Fn-Fn-Fn)
is found at the beginning (D-zone), which is repeated six times and a 11 domain super-
repeat (Ig-Fn-Fn-Ig-Fn-Fn-Fn-Ig-Fn-Fn-Fn) repeated 11 times in the region of the A-
band (Figure 1.5). Near the M-line, the unique Ig-Ig-Fn-Fn-Ig-Ig-Fn motif directly
precedes the kinase domain (P-zone). Corresponding positions of Igs and FNIIIs in the
super-repeats were found to have substantially higher sequence homology (Amodeo et
al., 2001). With a length of 4-4.5 nm per domain this super-repeat pattern is roughly
43!nm long, a distance found also in the intrinsic helical repeat of the myosin filament
with a pitch of 42.9 nm made up of three 14.3 nm-spaced crowns (Squire et al., 1998).
Freiburg & Gautel have shown in vitro via dot blot assays that recombinantly expressed
fragments of titin’s C-zone, in particular the first Ig domain of the long superrepeat, are
involved in binding to the last three C-terminal domains of myosin-binding protein C
Introduction: The M-line of Titin                                                                                  16
(MyBp-C) (Freiburg and Gautel, 1996). These are currently the only data on a direct
titin interaction with MyBp-C, suggesting a direct correlation between super-repeat
pattern and MyBp-C binding.
Labeit et al. further suggested an interaction of the FnIII domains of the titin A-
band with myosin (Labeit et al., 1992). Muhle-Goll demonstrated via co-sedimentation
and solid state binding assays that the poly-domain constructs A77-A78, A80-A82 and
A84-A86 from the titin A-band are able to bind to myosin, light meromyosin portion
and subfragment S1 (Muhle-Goll et al., 2001). This stands in contrast to previous
electron microscopic studies, in which binding of titin only to the light meromyosin
region of myosin was detected (Houmeida et al., 1995). Further analysis is needed to
elucidate the interaction between the two filaments.
In summary, it is speculated that the titin A-band performs a template function
regulating the thick filament assembly (Okagaki et al., 1993; Freiburg et al., 1996).
Moreover, it is thought to keep thick filaments in register in the relaxed and activated
state of the sarcomere and creates restoring forces to unequal contraction through its
integration into the M-band lattice (Horowits and Podolski, 1987).
1.2.6 M-line titin
Towards the C-terminus of titin, a unique region of titin harbours a catalytic
Ser/Thr kinase domain between the A-band and the M-line (TK; Labeit et al., 1992;
Mayans et al., 1998). The arrangement and sequence of kinase and adjacent Ig/FnIII
domains is homologous to other so-called giant kinases like Myosin-Light-Chain
Kinase (MyLCK) and the invertebrate titin homologues projectin and twitchin (Bullard
et al., 2002).
TK consists of a catalytic and a regulatory domain. From the crystal structure
(Mayans et al., 1998; Figure 1.7) it became clear that the active site is blocked by the
regulatory domain and gets activated upon phosphorylation by a to date unknown
kinase and through Ca2+/Calmodulin binding. As a substrate of TK, telethonin (T-cap)
was identified (Mayans et al., 1998; Gregorio 1998; Mues et al., 1998), which is located
remotely at the N-terminus of titin in the differentiated sarcomere. Hence, the authors
suggested a role of TK in the early stages of myofibrillogenesis. The exact function of
TK in existing or yet unknown myofibrillar signalling pathways remains to be
determined. Interestingly, TK has been detected as a critical component of a signalling
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module at the M-line potentially involved in a mechanotransduction pathway (Lange et
al., 2005; chapter 1.2.14).
Following the kinase in C-terminal direction a set of ten Ig modules (M1-M10)
extends towards the very C-terminus of titin. These Ig domains are interconnected by
unique insertions of various lengths and unknown function (Obermann et al., 1997).
Titin is embedded into the M-line matrix consisting of the poly-Ig/poly-FnIII
proteins myosin, myomesin and M-protein (Luther and Squire, 1978). They are
involved in transversal and longitudinal organization and connection of overlapping
filament ends providing a continuous filament that is necessary for rapid and efficient
contraction of the sarcomere (Fürst et al., 1999).
The carboxy-terminal Ig M4 of titin interacts with a region of Ig/FnIII repeat
protein myomesin (domains My4-My6) in a phosphorylation dependent manner. This
was proven using recombinantly expressed, purified myomesin poly-domain constructs
that were tested in a solid state overlay assay against individual titin M-line Igs (M1-
M10). A minimum of three Fn domains were necessary for binding suggesting a
cooperative binding through a large number of weak interactions (Obermann et al.,
1997). A similar observation was found for the interaction of A-band titin with MyBP-C
(Freiburg and Gautel, 1996). The interaction cross-links titin with the myosin filaments
and has implications during sarcomere formation, regeneration and turnover. It was
suggested that M-band proteins are responsible for lateral alignment of the thick
filament, while titin provides the centring of the A-band during relaxation (Agarkova et
al., 2003). Furthermore, recent studies by Weinert et al. show that complete knockout of
titin’s M-line (A169-M7) through a germline recombination approach does not
influence sarcomere assembly, but severely interferes with sarcomere strength and
lateral growth, which  eventually leads to sarcomere disassembly. As a result of the
knockout titin’s C-terminal region was found not integrated into the A-band structure
and early embryonic lethality was observed (Weinert et al., 2006). These experiments
clearly further corroborate the role of M-line titin in the structural integrity of the
sarcomere.
Additional to the mentioned structural proteins a set of soluble metabolic,
signalling and regulatory factors was found to target the M-line components and titin
(Figure 1.6). Often they are not exclusively present at the M-line, but can also be found
at the Z-disc, the nucleus or in a cytoplasmatic pool (Lange et al. 2006). Among them
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are enzymes involved in energy metabolism like muscle creatinin kinase (M-CK, Stolz
et al., 1998) and LIM domain proteins DRAL/FHL-2, which were found in various
locations of the sarcomere including I-band, M-band and nucleus (McLaughlin et al.,
2002).
Recently, also members of the muscle specific Ring finger family of proteins
(MuRF-1 and MuRF-2) have been identified as M-line components (Centner et al.,
2001) and moreover act as dynamic shuttles between M-line, Z-disc and the nucleus
(McElhinny et al., 2002). The muscle specific cysteine protease calpain (p94) was
found to bind to titin’s M-line Ig domain M9 and the adjacent unique insertion Is-7
(Sorimachi et al., 1995). Since the C-termini of two titin molecules overlap at the M-
line, the binding sites for calpain and MuRF-1 could come close in space and a
functional interaction between the E3-ligase MuRF-1 and calpain (p94) was speculated.
Potentially MuRF-1 is a substrate for the proteolytic activity of p94 (Gregorio et al.,
1999).
Figure 1.6: M-line titin, a complex, modular protein-protein interaction network.
Titin is embedded within structural components of the M-line (myomesin, M-protein) and linked to non-
structural factors like metabolic enzymes and signalling molecules. Via its interactions with the MuRF
proteins it is linked to the protein ubiquitin-dependent degradation machinery as well as to transcriptional
pathways involving GMEB and SRF. (Figure modified from: Lange et al., 2006).
a) b)
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1.2.7 Overview of existing structures of titin
Extensive structural studies have been carried out on the titin filament using
diverse microscopy techniques (Kellermeyer and Grama, 2002; Squire 1997). In
contrast to the wealth of microscopic data, the analysis of the filamentous molecule titin
by methods providing higher resolution like e.g. NMR-spectroscopy or X-ray
crystallography is severely hampered by its large size, structural complexity and elastic
nature. Hence, high-resolution structural studies are restricted only to small poly-
domain segments or single individual molecular building blocks due to experimental
constraints (chapter 1.5). In principle, the overall organization of the filament can be
reconstituted from its building blocks in a “divide and conquer approach” using
complementary information provided for example by small angular X-ray scattering
((SAXS); Vazina et al., 2006; Marino et al., 2005; Improta et al., 1998), electron
microscopy or by in silico modelling approaches (Amodeo et al., 2001; Muhle-Goll,
2001). The latter approach needs a reliable ensemble of representative structures of high
sequence similarity comprising both individual building blocks as well as transitions
between filament subunits that are necessary to exactly model long-range effects on a
larger scale. In the case of titin with only a handful high-resolution structures of
individual domains this prerequisite does not exist yet. Figure 1.7 summarizes the
currently available structural data.
The molecular structures of several individual domains from titin have been
determined by NMR spectroscopy and X-ray crystallography (for references see
Figure!1.7b). These structures are representatives for different regions of titin, i.e. the
Z-disc (Z1Z2), the proximal (I1) and distal I-band (I91), the A-Band (A71), titin kinase
and the M-line (M1, 5). Currently, the study on the very N-terminus of titin, the Z1Z1
Ig tandem, remains the only poly-domain high-resolution structure of titin (Zou et al.,
2006; Marino et al., 2005).
The titin Ig domains all posses a characteristic "-sandwich-fold of the
intermediate set of the immunoglobulin superfamily (Harpaz and Clothia, 1994). The
only fibronectin domain structure (Muhle-Goll et al., 1997) shows high homology to the
fibronectin archetype (Leahy et al., Science 1992).
Homology modelling identified surface features that are distinct for the titin
regions. Z-disc Ig have the lowest polarity among all titin Igs, most of which are
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generally more polar than charged. A-band Ig modules have larger non-polar surfaces
potentially resulting from filament interactions.
The analysis of structural data by various authors has identified characteristic
features of representatives of constitutively and differentially expressed I-band Ig
domains (Fraternali et al., 1999; Witt et al. 1998; Marino et al., 2005).
The first class comprises the constitutively expressed Ig-domains with shortened
BC and FG elements and a minimal number of prolines at the N-terminal loop cluster.
As a result, the shape of the molecule is slightly less elongated and the expected inter-
domain flexibility is higher.
An N-terminal loop cluster of the differentially expressed group is strictly
conserved, while these region appears more variable in the constitutionally expressed I-
band. The second class, N-conserved, differentially expressed type of I-band Igs are
characterized by a long BC "-hairpin harbouring a PP motif and long FG turns
harbouring a NxxG motif as well as the prevalence for a PP motif at the N-terminus
within strand A (for strand nomenclature see Figure 1.3 and Figure 1.7a). These two
proline residues are expected to be inserted into the groove formed by the BC and FG
loops, conferring rigidity to the N-conserved, differentially expressed isoforms.
Studies aiming at elucidation of the relative domain arrangements in the
constitutive I-band by a combined approach of NMR and SAXS on a four-domain
construct (Improta et al., 1998) and six-domain construct (Marino et al., 2005) have
confirmed the string-of-beads model determined by electron microscopy suggesting a
bending of 155° and twisting of 90° degrees with low interdomain mobility between
successive domains. As a result a shortening of 10-17% compared to fully extended
conformation was found. For the skeletal I-band Igs, this conformational rigidity and
extended domain arrangement was proposed to be linker-independent. This is important
since titin’s Ig-based elasticity is mainly governed by inter-domain mobility, which in
turn depends on linker length and interface residues. The differentially expressed I-band
region as well as titin’s A-band are predicted to be even stiffer due to a conserved
super-repeat pattern (Tskhovrebova and Trinick, 2004). Concerning titin’s A-band FnIII
domains homology modelling approaches utilizing the representative structure of A71
(Muhle Goll et al., 1998) as well as homologous structures from related proteins have
identified potential hydrophobic residues in linker regions and on the surface (Muhle-
Goll et al., 2001; Amodeo et al., 2001).
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a)
b)
Figure 1.7: Available high-resolution structures of titin domains.
a) Representative molecular structures of individual domains have been obtained for several regions of
titin. The schematic layout shows all domains of titin including cardiac spliceoforms of the I-band.
Strands are assigned for Ig I1 according to Mayans et al., 2001 and for FnIII A71 according to Leahy et
al., 1994 (Figure modified from: Lange et al., 2006) b) References and additional data to a).
Together with the fact that the second position of the long super-repeat was
considerably more conserved than the rest (values range from 42 to 64!% of total
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surface area) a potential myosin-binding model was proposed and subsequently tested
in in vitro binding experiments (see previous chapter). Generally, the D-zone shows a
lower degree of surface conservation (between 29 to 41!% of total surface area).
Recently, the structure of the N-terminal tandem Ig domains Z1Z1 in complex
with telethonin was determined (Zou et al., 2006) (Figure 1.7). The structure reveals a
unique, palindromic arrangement of the two overlapping titin N-termini, that is tightly
hold together by telethonin. From the structure it became evident that the N-terminus of
titin provides a rigid anchoring scaffold linking together two giant titin molecules form
the same sarcomere (Lee et al., 2006). The arrangement might be required to avoid
uncontrolled disassembly during muscle-contraction. Furthermore additional, mobile
molecules might target the Telethonin/Z1Z2 complex (Kontrogianni-Konstantopoulos
and Bloch, 2003) and integrate it into the Z-disk stretch sensor machinery (Knoll et al.,
2002).
Finally, also the PEVK region has been investigated by CD-spectroscopy in
combination with NMR (Ma et al. 2004.) A 28-mer corresponding to human fetal titin
contained distinct features of poly-proline II helices interrupted by flexible spacer
regions. These regions could therefore act as entropic spring elements.
1.2.8 Hereditary titin diseases
The immense size of titin makes it a prominent target for disease causing
mutations. Most prominent are mutations leading to dilated cardiomyopathy (DCM).
They are localized in titin exon 18 and 326. Mutation in exon 326 is causing a
frameshift leading to a 2000!kDa truncated version of titin, which is additionally
sensitive to proteolysis. Mutation in exon 18 encodes an Ig domain and the mutation
was thought to disrupt the Ig structure (Gerull et al., 2002).
In the case of skeletal muscular dystrophy (TMD) a mutation in exon 365 was
found to destabilize the fold of the corresponding Ig domain. Mutations in exon two and
14 (Z-disc) and exon 49 (N2B) element lowered the affinity for telethonin and !-actinin
(Zou et al., 2006). In addition, a DCM causing mutation of TK was found to interfere
with a potential signalling complex at titin’s M-line (Lange et al. 2005; chapter 1.2.14).
In summary, disease-causing mutations in titin are so far either involved in perturbing
individual domains or interfere with protein-protein interactions.
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1.2.9 MuRFs
The MuRF family of proteins consists of three, highly conserved isoforms coded
by three distinct genes. MuRFs were first described as Striated Muscle RING Zinc
finger (SMRZ, Dai & Liew 2001) and sequentially identified by yeast to hybrid screens
(Y2H-screens). To date, they are only reported in vertebrates (Centner et al, 2001).
MuRF-1 and MuRF-2 share 62!%, MuRF-1 and MuRF-3 share 77!%, MuRF-2 and
MuRF-3 share 65!% sequence identity. All three posses a highly conserved N-terminal
region (up to 85!% within the first 140 residues) containing a zinc binding RING-finger
domain (RING), a MuRF Conserved region (MFC) and a zinc binding B-box type two
(B2) domain (Figure 1.8). The B-box domain is directly followed by a predicted coiled-
coil (CC) region (Centner et al., 2001). A C-terminal acidic tail with high glutamic acid
content is the region of strongest divergence within the family. Three additional
spliceoforms of MuRF-2 and one of MuRF-3 were identified and are characterized
mostly by the presence of C-terminal extensions of unrelated structural nature. The
small, cardiac specific isoform of MuRF-2, MuRF-2p27 lacks the coiled-coil regions in
its C-terminus (Pizon et al., 2002).
According to domain arrangement and composition, MuRFs are members of the
growing family of RBCC (RING, B-box, coiled-coil) or tripartite motif family of
proteins (Reddy et al., 1992; Freemont 2000; and chapter 1.3). Further names for
MuRF-1,!2,!3 are RING finger protein (RNf28, 29, 30) or Tripartite Motif protein
TRIM63, 54, and 55 (http://www.gene.ucl.ac.uk/cgi-bin/nomenclature/search-genes.pl).
As a characteristic to TRIM-fold containing proteins, all three MuRFs have the
potential to homo- and hetero-oligomerize via their CC regions (Spencer et al., 2000;
Centner et al., 2001; McElhinny et al., 2002). However, like for many TRIM proteins,
the exact oligomeric state of the MuRFs is not known to date, since in addition to the
CC domain, also the N-terminal RING domain has the propensity to form homo-
oligomeric interactions. This oligomerization propensity of TRIM proteins can
eventually lead to macromolecular, meso-scale assemblies (Borden, 2000; Kentsis and
Borden, 2004). Higher order oligomers are necessary for the correct cellular functioning
of the TRIM proteins (Reymond et al., 2001). Furthermore, many TRIM proteins
contain canonical features of ubiquitin-ligases (Freemont, 2000; Joaeiro et al. 2000).
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1.2.10 Functions of MuRF proteins
MuRF-1 was found constitutively expressed throughout development in three
distinct locations in myocytes: in the Z-disc, in the M-line and in a cytoplasmatic pool.
Among the best-characterized functions of MuRF-1 is its involvement in muscular
atrophy. Atrophy is characterized by muscle protein degradation upon a variety of
stimuli including denervation, immobilization, glucocorticoid treatment, space flight
and aging (Bodine et al., 2001). Several lines of evidence point towards a role of
MuRF-1 in these pathologic conditions:
MuRF-1 possesses intrinsic ubiquitin ligase activity (Bodine et al., 2001). In
addition, MuRF-1 null mice are resistant to atrophy and MuRF-1 levels are upregulated
in skeletal muscle during the atrophic state. Hence, MuRF-1 is thought to be involved in
ubiquitin-depended degradation of muscle protein (Bodine et al., 2001). Accordingly, in
neonatal rat cardiomyocytes MuRF-1 targets troponin I for degradation via its E3-
ubiquitin ligase activity (Kedar et al., 2004). Finally, the binding of MuRF-1 to nuclear
glucocorticoid modulatory element binding protein-1 (GMEB-1) involved in
transcription and up-regulation in response to glucocorticoid exposure, might link
MuRF-1 function in atrophy to gene expression profiles in response to external stimuli
(McElhinny et al., 2002).
A second function common to all three MuRFs is connected to their association
with the cytoskeletal microtubule system. Short and Cox (Short and Cox, 2006) have
identified a sequence motif with in the TRIM proteins (MID-1, MID-2, TRIM9, TNL,
TRIM36, TRIFIC and the MuRFs) termed COS (C-terminal subgroup One Signature)
Box. It is located C-terminally to the CC of the TRIM fold (residues 267 to 326 in
MuRF-1), right before the C-terminal acidic tail region and is predicted to contain two
!-helical coiled-coils. The authors demonstrate with the help of transfection studies and
mutational analysis that members of this distinct TRIM subfamily associate with
microtubules in a COS-box dependent manner.
To date, microtubule association has been demonstrated for MuRF-2 and MuRF-3
(Table 1.1), which show different expression pattern and subcellular localization than
MuRF-1. MuRF-2 was found to be down-regulated during development, being only
present in fetal heart (Centner et al., 2001). It also co-localizes transiently with
glutaminated microtubules, is present as essential component of the M-line and was
found enriched in nuclei after mechanical inactivity (Pizon et al., 2002; Lange et al.
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2005, see chapter 1.2.14). MuRF-2-labelled microtubules transiently associate with
myosin and A-band titin in the nascent myofibril. After maturation, labelled
microtubules disappear from the sarcomere suggesting an active, microtubule-mediated
transport of myosin. The temporal order of MuRF-2 localization (Z-disc, I-band and A-
band) furthermore suggests an involvement of MuRF-2/microtubule associations in the
stretching and straightening of titin during myofibrillogenesis (Pizon et al., 2002).
According to the authors MuRF-2 might function as transient adaptor between the
sarcomeric proteins titin and myosin and the microtubular system. MuRF-3 was found
to be up-regulated during development and necessary for microtubule stability. It was
detected both at the Z-disc and M-line (Spencer et al., 2000).
Figure 1.8: Overview of the titin binding site for MuRF-1 and MuRF-1 domains.
The central region of MuRF-1 was found to interact with titin’s A-band Ig domains A168-A169 in close
proximity the kinase domain of titin. MuRF-1 belongs to the RBCC (RING, B-box, coiled-coil) or tri-
partite motif (TRIM) family of proteins. Three distinct genes have been observed. Alternative splicing
creates isoforms of MuRF-2 and MuRF-3 with differences mostly in the C-terminal tail region (Figure
taken from Gregorio et al., 2005). A small cardiac specific isoform of MuRF-2p27 (not shown) is missing
the coiled-coil regions and terminates after the B-box.
Co-localization of myofibrillar-based MuRF-1 and MuRF-2 might link together
myofibrillar and microtubular pathways since MuRF-2 co-localizes both with MuRF-1
and microtubular-based MuRF-3. This suggests an interdependence of both systems.
Critical to these processes is the hetero-oligomerization potential among the MuRFs
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(Centner et al., 2001), an ability that is rarely seen across different TRIM containing
proteins (Reymond et al., 2001).
In summary, the binding partners of MuRF-1 are either nuclear factors or
myofibrillar proteins (Witt et al., 2005; Gregorio et al. 2005; Table 1.1; Figure 1.9). An
additional class of proteins interacting with MuRF-1 are metabolic enzymes involved in
energy production Witt et al., 2005).
Table 1.1: MuRF proteins and there interaction partners (modified from Gregorio et al., 2005).
1.2.11 The titin-interface with MuRF-1
Inspired by the strong homology of the titin kinase region with other “giant
kinases” like myosin-light chain kinase or invertebrate titin homologues, Centner et al.
have carried out Y2H-screens using the titin A167-kinase-M2 region (P-zone,
Figure!1.8) as bait (Centner et al., 2001). MuRF-1 was found to interact with titin at the
two Ig domains A168 and A169, which are located N-terminally to the kinase domain,
~100!nm away from the centre of the M-line in the M-line periphery (Figure 1.6).
On the MuRF-1 side, 144 amino acids of the central region (residues 74-218)
including the B-box and parts of the adjacent coiled-coil have been identified by Y2H
screens as necessary and sufficient for binding. The studies were also complemented by
pull-down assays (Centner et al. 2001). Whereas MuRF-1 was found to be the only
Protein Expression Localization Interactions Proposed function
MuRF-1 constitutive
during development
up-regulated
in response to atrophy
Myofibril (Z-disc, M-line)
Nucleus
titin A168-A169
MuRF-1,2,3
SUMO-3, GMEB-1
Ubc-9, ISOT-3
ATP Synthase, creatinine kinase
Rack1
Nebulin
N-RAP
TnT
MLC-2
Myotilin
Telethonin (T-cap)
cardiac troponin I (cTpI)
Ubiquitin ligase activity
Degradation of muscle proteins
during atrophy
Thick filament assembly
M-line integrity
myofibril maintenance/turnover
Regulator of energy metabolism
MuRF-2 down-regulated
during development
Stable microtubules (Glu-MTs)
Myofibril (M-line)
Nucleus (upon mechanical inactivity)
titin A164-A169
MuRF-1,2,3
p62/SQSTM1
Nebulin
N-RA
TnT
MLC-2
Myotilin
Telethonin (T-cap)
Stability of stable microtubules and
intermediate filaments
adaptor between titin and microtubules
critical for myoblast fusion and
myofibrillogenesis
M-line integrity
Component of M-line stretch sensor
MuRF-3 up-regulated
during development
Stable microtubules (Glu-MTs)
Myofibril (Z-disc, M-line)
MuRF-1,2,3
Microtubules
establish/maintain stable Glu-MT array
required for myoblast fusion and myogenesis,
gene expression and differentiation
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MuRF that interacts with titin, Pizon et al. (Pizon et al. 2002) have also demonstrated a
direct interaction of MuRF-2 with titin domains A164-A169. Further studies will be
needed to clarify this discrepancy.
More recently, after the initiation of the study in hand, Witt et al. (Witt et al.,
2005) have further characterized the titin binding region on MuRF-1 by SPOTS blots
using a set of overlapping peptides of MuRF-1 and a titin A168-A170 construct. They
identified a C-terminal region at the coiled-coil periphery as primary binding site
(residues 284-315). Notably, this region overlaps with the COS-Box motif that was
found to mediate microtubule association of certain TRIMs (Short and Cox, 2006).
1.2.12 Function of MuRF-1 in M-line integrity and sarcomeric protein turover
MuRF-1 was found in Z-disc, M-line location was well as in a cytosolic pool and
nuclei of myocytes and a dynamic, controlled translocation between the locations was
suggested (Centner et al., 2001; McElhinny et al., 2002). Overexpression of full MuRF-
1, its central region (comprising the B-box and adjacent coiled-coil regions) or its
complementary titin binding site A168-A170, resulted in a severe disruption of the M-
line region and the organization of the thick filament. MuRF-1 was found in aggregates
of varying size and intensity. However, other regions of titin like the Z-disc or the thin
filaments are not affected as verified by site-specific immunofluorescence studies and
might be stabilized by Z-disc and thin filament specific components (McElhinny et al.,
2002). A dominant-negative phenotype caused by the truncation MuRF-1 was excluded
by the fact that overexpression of full-length MuRF-1 also lead to the same phenotype
furthermore suggesting a tight regulation of MuRF-1. Hence, the constitutive expression
of MuRF-1 seems to be essential for myofibril stability throughout development.
Nevertheless, reducing the levels of MuRF-2 by anti-sense oligonucleotides results in
similar impairment of myofibrillogenesis with disrupted M-line, perturbation of
microtubule populations and the intermediate filaments desmin and vimentin
(McElhinny et al. 2004).
Studies by Weinert et al. (Weinert et al., 2006) show that complete knockout of
the M-line region of titin ($A169-M7) including the kinase domain and M-line
interfaces to MuRF-1, myomesin and calpain does not influence sarcomere assembly.
However, it severely interferes with sarcomere strength and lateral growth at later
stages eventually leading to sarcomere disassembly. A similar observation was made
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upon deletion of the kinase and MuRF-1 binding region (Gotthardt et al., 2003).
Surprisingly, knockout of MuRF-1 in mice showed no primary effect in myofibril
integrity, but animals were resistant to muscle atrophy (Bodine et al., 2001).
The E3 ubiquitin-ligase activity of the MuRF-1 furthermore suggests a role in
sarcomeric protein turnover. Witt et al. have detected ubiquitination of titin, nebulin,
myosin light chain-2 (MLC-2) and troponin cTnI in skeletal and cardiac muscle by
staining of Western Blots with anti-ubiquitin antibodies (Witt et. al., 2005). This
suggests that besides titin, the myofibril itself could be a target of MuRF-1 dependent
ubiquitin transfer. The authors localized the ubiquitination epitope on titin to the A-
band region. However, in a MuRF-1 knockout, the target proteins were still
ubiquitinated suggesting that other ubiquitin-ligases are involved in the ubiquitination
process or that ubiquitination may not be an exclusive property of MuRF-1. Possibly
they could also be carried out by MuRF-2 and3, which where not affected by the
knockout.
1.2.13 Multiple localisation of MuRF proteins and the SUMO pathway
Y2H-screens revealed that all MuRF's interact via their RING domain with small
ubiquitin like modifier SMT3b/SUMO-3 (Dai and Liew, 2001) and isopeptidase T-3
(ISOT-3). Ubiquitination and SUMOylation are related, but distinct mechanism of post-
translational modification of target proteins (Lange et al., 2006).
Nuclear and cytoplasmatic localisation is characteristic for sumoylated proteins
(Melchior, 2001, Melchior et al., 2003). Accordingly, binding of MuRF-1 to ubiquitin-
modifying enzyme-9 (Ubc-9), which acts as a SUMO E2 transferase (Tong et al., 1998;
McElhinny et al. 2002) was detected. Nuclear import, influence on gene expression and
subcellular localisation of MuRF family members might be controlled by
SUMOylation. However, to date it is not clear if MuRF-1 is indeed SUMOylated or
merely interacts with sumoylated proteins.
Furthermore, SUMO-proteins are components of cellular response pathways
(Saitoh and Hichey 2000). Hence MuRF-1 SUMOylation may also be a response to the
atrophic state of muscle. SUMOylation does not lead to degradation, but instead
regulates protein-protein interactions, intracellular localization and protects modified
targets from ubiquitin-dependent degradation (Pichler and Melchior, 2002). Its
interaction with the nuclear transcription factor GMEB-1, which is involved in
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transcriptional control in response to altered glucocorticoid levels, probably represents
the nuclear part of a signalling module involved in stress detection and muscular
atrophy. It clearly highlights the link between gene expression and myofibrillar
signalling.
1.2.14 Titin as a sarcomeric stretch sensor: the kinase signalosome
Titin might regulate MuRF activity in a stretch-dependent fashion. Recently, a
signalling module at the titin M-line was detected potentially involved in mechano-
transduction (Lange et al. 2005; Figure 1.9). It links the titin kinase domain via two
multi-compartment zinc finger proteins, Nbr1 and p62 to MuRF-2 and furthermore to
the nuclear transcription factor serum response factor (SRF).
Figure 1.9: The M-line signal transduction module of titin.
A functional module that is proposed to act as a sarcomeric stretch sensor. Mechanically induced
formation of a signalling cascade consisting of titin kinase, the scaffolding components NBR1, p62,
MuRF-2 and the nuclear transcriptional regulator SRF translates mechanical into transcriptional stimuli.
(Figure modified from Lange et al., 2005).
Key prerequisite for formation of this signalling cascade is the presence of a
kinase lacking parts of the C-terminal autoinhibitory segment. Based on modelling by
force-probe molecular dynamics (Gräter et al., 2005), the authors refer to this
conformation as a conformation that resembles a mechanically activated titin kinase.
However, currently both in vivo and in vitro data do not exist that proof the existence of
a) b)
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such a conformation. Several constructs designed based on these in silico data were
screened for potential interaction partners in Y2H-screens.
A scaffolding protein called next to breast cancer gene-1 (NbR1) was found to
interact with the truncated TK via its N-terminal PB1 domain. On the contrary, wildtype
TK did not lead to any interaction. Structurally, the PB-1 domain (~85 residues)
resembles the ubiquitin-like "-grasp fold (Müller et al., 2006). It mediates polar
heterodimeric interactions by two types of PB1 domain termed A and B, which are of
opposite charge on their surface (Noda et al., 2003).
Subsequent Y2H-screening lead to the identification of p62, which together with
the PB domain of NBR1 is a prominent scaffolding unit of large signalling complexes
(Pawson and Scott, 1997). MuRF-2 was identified as ligand of p62 and consistently, all
three proteins, NBR1, p62 and MuRF-2 were detectable at the M-band by
immunofluorescence microscopy. Both NBR1 and p62 contain a zinc binding ZZ
domain that possess strong similarities to the RING-finger like domain of MuRF-1
(Legge et al., 2004). Moreover, both proteins are involved in homo-oligomeric
interactions.
Upon mechanical arrest by chemical agents or denervation, a substantial
accumulation of MuRF-2 was detectable in the nucleus. Nuclear MuRF-2 was found to
interact via its RING/B-box domain to the trans-activation domain (TA) of serum
response factor (SRF) (Lange et al., 2005), a protein involved in myogenic transcription
events (Li et al., 2004). SRF belongs to the MADS box family of transcription factors.
The N-terminal half of the MADS motif determines DNA binding specificity, while the
C-terminal part is involved in dimerization. SRF controls expression of immediate early
genes (IEG), for example the prototypic IEG c-fos (Murphy et al, 2002), most of which
are by themselves transcription factors or DNA binding proteins and represent a rapid
response mechanism to various cellular stimuli (Davis et al., 2003). It acts as a nuclear
target of kinases and Rho signalling networks directing cell activities as diverse as cell-
cycle progression, neuronal synaptic transmission and muscle cell differentiation
(Mercado et al., 2003).
Upon overexpression of the small cardiac isoforms of MuRF-2 (missing the C-
terminal CC region), a substantial suppression of c-fos activity was detectable, which is
indicative of a strong influence of mechanically induced nuclear localization of MuRF-
2 on transcription events controlled by SRF. Conversely, overexpression of TK could
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rescue the mechanically arrest-dependent low transcription levels of c-fos. Thus, the
presence of the NBR1-p62-MuRF-2 protein complex clearly reduced the nuclear pool
of MuRF-2 leading to unhindered SRF activity.
Finally, a mutation in titin kinase regulatory domain (R279W) that leads to
hereditary myopathy with early respiratory failure (HMERF) was found to inhibit
binding of TK to NBR-1. As a result, the structural organization of the sarcomere was
impaired (Edstrom et al., 1990) highlighting the importance of TK-NBR1 interaction
for correct sarcomere function.
Taken together, the mechanically induced formation of the TK-NBR1-p62-
MuRF-2-SRF module might form a sarcomeric stretch-sensor that could translate
mechanical stimuli into biological response, i.e. affecting muscle gene expression.
The above signalling cascade represents an alternative pathway to the MuRF-
1/SUMO-3/GMEB-1 centred signalling network mentioned by McElhinny et al.
(McElhinny et al. 2002). Clearly, further studies are needed to elucidate the role of titin
and associated proteins in sarcomeric signalling events to unravel the molecular basis of
myofibrillogenesis, mechanical properties of the sarcomere and pathological situations
leading for example to muscle atrophy.
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1.3 The B-box, protein-protein interaction domain of the titin-
associated protein MuRF-1
1.3.1 MuRF-1 is a member of a protein family with the characteristic TRIM fold
TRIM or RBCC proteins are eukaryotic multidomain proteins that share a
common tripartite domain architecture at their N-terminus. The TRIM fold is
characterized by the presence of a Really Interesting New Gene (RING or A-box;
Reddy et al. 1992), one or two B-box domains and an associated coiled-coil domain
(Freemont et al., 1993). Hence proteins containing this motif are named TRIM for
Tripartite Motif or RBCC proteins standing for RING, B-box, Coiled-Coil. Currently,
65 members of the TRIM family are known in man and less than 20 members in flies
and worms (Short and Cox, 2006; Meroni & Diez-Roux 2005). An overview can be
found in Figure 1.10a and in the web at
(http://www.informatics.jax.org/mgihome/nomen/genefamilies/trim.shtml).
In contrast to the RING domain, which is found in many other proteins, the B-box
is the critical determinant of the TRIM motif and some proteins have been termed
TRIM despite the absence of the RING domain (Reddy et al., 1992). Following the CC
domain, the C-terminus of TRIM proteins shows strong divergence in domain
composition and sequence length (Figure 1.10c).
Throughout the genome, TRIM/RBCC proteins are highly dispersed, which
suggests their independent evolution (Reymond et al., 2001). The RING domain is not
found in prokaryotes consistent with the lack of the ubiquitination system in these
organisms (see below). B-box domains are absent in prokaryotes, viruses and fungi
(Meroni and Diez-Roux, 2005). RING and B-boxes are characterized through unique
sequence consensi (Figure 1.10c).
1.3.2 TRIM components
The best-characterized domain of the TRIM fold is the RING domain. Currently
over 17 structures of RING domains have become available in the RCSB protein
database (for overview see prosite entry PS00518).
The first determined RING structure was the one of the immediate early gene of
herpes simplex virus (IEEV) determined by Barlow et al. (Barlow et al., 1994). The
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RING domain binds two zinc atoms by means of eight conserved cysteine or histidine
ligands thereby adopting a characteristic topology known as „cross-brace“
(Figure!1.11a). In this motif the first and third metal ligation pair bind the first zinc
atom, while the second and fourth metal ligation pair bind the second zinc atom
(Freemont, 1993). Two main types of RING fingers have been described: The H2- and
C2-subtypes depend on the nature (cystidine or histidine) of the metal ligand at position
five (Freemont, 2000). Notably, only C2-type RINGs are found in the TRIM/RBCC
family.
Specific functions of the RING domain include a critical role in ubiquitination
events (Joazeiro et al., 2000). Ubiquitin ligases like MuRF-1 (known as E3s) are
involved in the last step of a three-enzyme cascade involving so-called ubiquitin
activating (E1) and ubiquitin conjugating enzymes (E2) (Pickart et al., 2001). The E3
mediates the transfer of ubiquitin from the E2 to the substrate by formation of an
isopeptide bond between ubiquitin carboxy-terminus and specific lysine chains on the
substrate. The interface forms a shallow groove on the domain surface. Apart from
binding of the E2 moiety, it additionally confers specificity to the reaction. Borden and
co-workers refer to a second function of the RING domain in the RING-dependent self-
assembly of large macromolecular assemblies through homo-oligomeric protein-protein
interactions (Borden, 2000; Kentsis and Borden, 2002).
Like the RING, the B-box is also a zinc-binding domain with a similar yet distinct
pattern of metal binding residues. The B-box motif has been sub-classified by Freemont
and others (Freemont, 1993) into a B-Box 1 (B1) and a B-box 2 (B2) subtype. The two
variants mainly differ in the nature of the second metal ligand, which is a cysteine in B1
and a histidine in B2, and in the slightly longer insertions between the metal binding
ligands in B1 (for consensus sequences see Figure 1.10c). Two high-resolution B-box
structures are available, one of a B1 and the other of a B2 B-box domain (Figure 1.11b
and Figure 1.11c).
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Figure 1.10: Overview of human TRIM family members and domains.
a) Human TRIM proteins can be sub-classified according to their domain composition. The MuRF family
constitutes a distinct subclass. Identity, alternative names, chromosomal location and sub-class based on
domain composition are shown. b) Sub-classification based on C-terminal variable domains according to
Short & Cox (Short and Cox, 2006) (c ) Consensus of zinc-binding domains of the TRIM motif
(consensus based on: (Meroni and Diez-Roux, 2005).
Structure elucidation of the B2 domain from the TRIM protein Xenopus nuclear
factor-7 (XNF7) by means of NMR–spectroscopy (Borden et al., 1995) in combination
with titration experiments (Borden et al., 1993) revealed that of the eight conserved
metal ligands in the B-box motif, only four are involved in binding of one structural
zinc ion, leaving four potential metal binding ligands unoccupied. Interestingly, the
recently determined B1 solution structure of the TRIM protein midine-1 (MID-1,
TRIM18), which became available during formation of this manuscript, shows a
remarkably different topology (Massiah et al., 2006). While the B1 domain adopts a
RING-finger-like fold by ligation of two structural zinc ions, the XNF7 structure folds
into a unique topology through ligation of only one zinc atom. Apart from general
Sequence Consensus
RING (R)
C-x2-C-x11-16-C-x-H-x2-C-x2-C-x7-74-C-x2-[CD]
B-box 1 (B1)
C-x2-C-x7-12-C-x2-C-x4-C-x2-[CH]-x3-4-H-x4-9-H
B-box 2 (B2)
C-x2-H-x7-9-C-x2-[CDHE]-x4-C-x2-C-x3-6-H-x2-4-[CH]
a) b)
c)
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involvement in protein-protein interactions, a specific function has only been attributed
to the B-Box B1 of MID-1 so far. It was found to bind directly to Alpha4, a subunit of
the catalytic domain of microtubular phosphatase 2A (PP2Ac) (Liu et al., 2001).
Figure 1.11: Structurally characterized components of the TRIM motif.
a) The Ring domain of IEEHV was the first determined RING domain structure (Barlow et al., 1994).
Currently, 17 RING structures are available in the protein data base. The structure adopts a “cross-brace”
topology ligating two structural zinc ions (ligands shown as sticks, zinc atoms as blue spheres, sec.
structure elements: !-helix cyan, "-strands magenta). b) The B1 domain of MID-1 adopts a similar
RING-like topology and binds two zinc ions (Massiah et al., 2006). The structure has become available
after we have initiated structural studies on MuRF-1 B2. c) A unique fold was observed for XNF-7 B2
domain. Of the eight potential metal ligating residues only 4 participate in binding of one structural zinc
ion (Borden et al., 1995). This structure was the only available structure of a B-box available at the time
we have initiated our work. No structural information on the coiled-coil region exists to date.
In all TRIM containing proteins the B2 domain is always invariably followed by a
predicted coiled-coil region of approximately 100 residues, which is composed of two
or more segments (Torok et al., 2001). However, currently no structural data exists on
any coiled-coil region of TRIMs and the exact location of the coiled-coil segments can
only been inferred from predictions.
Functionally, the coiled-coil was found to be the critical determinant of homo-
oligomer formation leading to the formation of large macromolecular assemblies.
Through homo-/hetero-oligomerization the TRIM is able to target specific cellular
structures including cytoskeletal filaments, chromatin and also defines its own
structures of compartment character like for example nuclear bodies (Reymond et al.,
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2001). In contrast to Borden (Borden, 2000), Reymond et al. did not detect any RING-
dependence during formation of higher order assemblies for a broad range of TRIMs in
studies with recombinantly expressed proteins and size exclusion chromatography for
determination of the oligomeric state. The molecular basis of TRIM oligomerization is
currently unknown.
1.3.3 Variable C-terminal domain of TRIM containing proteins
More recently Cox et al. have sub-classified TRIM protein based on their unique
C-terminal domains and TRIM composition.
The most common motifs in the C-terminal region of TRIM proteins comprise the
B30.2 domain also known as ret finger protein-like domain (RFP-like; Henry et al.,
1998), NHL repeat domains (Slack and Ruvkun, 1998) and a PHD-BROMO domain
tandem (Torrok et al., 2001; Figure 1.10b). But also Ig, FnIII and Armadillo-repeats
(ARF) can be found in C-terminal position to the TRIM. These domains are not unique
to TRIM proteins and are found independently in many different eukaryotic and
prokaryotic proteins with a broad functional spectrum. Nevertheless, also unique C-
terminal sequences with no homology to any known motif as well as spliceoforms are
observed. Recently, Short and Cox have identified an approximately 60 residues long
sequence motif in the MuRF family members and other TRIM proteins that is
responsible for microtubule association (Short and Cox, 2006; chapter 1.2.10). It is
located at the C-terminal coiled-coil periphery.
TRIM-based diseases are often caused by mutations in the coiled-coil and the C-
terminal TRIM-associated domains or result from recombination of the TRIM motif
with specific kinases (Torok, 2000). As a primary effect in many disease models, an
incorrect oligomerization state of the TRIM protein can lead to a failure of identifying
its specific protein target. Second, given the E3 ligase activity of the RING, a direct link
between pathological phenotype and E3-activity of the TRIM proteins might exist in
many cases (Meroni and Diez-Roux, 2005).
Probably the most prominent example of a TRIM-based disease is caused by
mutations in the C-terminal rfp-like motif as well as in the TRIM motif of the E3
ubiquitin ligase MID-1 leading to Opitz/BBB syndrome. The mutations result in an
impairment of MID-1 binding to microtubules (DeFalco et al., 2003) As a secondary
effect, a diminished proteolysis of the catalytical subunit of microtubule associated
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phosphatase 2A is thought to lead to abnormal phosphorylation events in microtubule-
associated proteins and hence pathologically altered microtubule dynamics
(Trockenbacher et al., 2001).
1.3.4 The TRIM as an integrated fold
A striking feature of the TRIM fold is its conserved domain structure. The spacing
between as well as the order of RING, B-box and coiled-coil domain is absolutely
conserved in all TRIMs and throughout evolution (Reymond et al., 2001).
Rearrangements within the TRIM cause severe cellular dysfunctions (Torok et. a.
2001). This clearly highlights the functional relevance of the TRIM fold as an integrated
structural unit rather than a collection of individual motifs. On the primary sequence
level, the entire family is characterized by a low sequence homology apart from the
highly conserved metal binding ligands of RING and B-box domains and the heptad
repeats necessary for the “knobs-into-wholes” coiled-coil packing interactions.
Peng et al. have demonstrated by mutational analysis for the KRAB-KAP-1
transcriptional repression module that each subdomain of the TRIM protein KAP1 (now
termed TIF1-" or TRIM28) contributes to binding to the KRAB domain of the
transcription factor KOX-1. The RBCC domain either provides direct interaction
determinants or indirectly mediates formation of the appropriate homo-oligomeric state
of KAP-1 (Peng et al., 2000).
In the case of TRIM motifs containing two B-boxes, both are always of different
subtype B1 and B2, with B1 exclusively preceding B2. When only one B-box domain is
present in the motif, it is always of B2 type, suggesting a strong association of B2 and
coiled-coil domain potentially forming a single structural module within the TRIM
motif. A role of B2 in orientation of the coiled-coil moieties domain was proposed (Cao
et al. 1997). Furthermore, through intensive domain swapping experiments Peng et al.
show that RING, B-boxes and coiled-coils from highly homologues TRIMs cannot
functionally substitute each other. All these observations clearly suggest that the TRIM
fold serves as an integrated, functional scaffold involved in protein-protein interactions
either in the context of the TRIM proteins itself or to other cellular components.
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1.4 LAP2! , a nuclear scaffold protein involved in chromatin
organization
1.4.1 Nucleus, nuclear envelope and lamina
The nucleus is the defining feature of eukaryotic cells. Within this compartment a
number of important functions are carried out like DNA replication, RNA transcription,
RNA processing and ribosome assembly. Considering the high concentration of
macromolecules inside the nucleus, a high degree of spatial order is one essential
prerequisite (Dechat et al., 1998). At the periphery of the nucleus, organization is
provided by the two structurally and functionally distinct membrane systems of the
inner and outer nuclear membrane. The outer nuclear membrane is continuous with the
endoplasmatic reticulum (ER) and covered by ribosomes. Together with the perinuclear
space it is involved in protein translation and modification. The inner nuclear membrane
contains integral membrane proteins that link the membrane to the underlying
filamentous meshwork of the nuclear lamina and to other nuclear components. Nuclear
pore complexes (NPCs) at membrane junctions mediate macromolecular transport
across these two boundaries. Membranes, NPCs and the nuclear lamina together form
the nuclear envelope (NE), which separates cytoplasmatic and nucleic activities during
interphase and controls their interactions (Figure 1.12) However, it is primarily the
nuclear lamina, which contributes to the structural integrity of the NE (Dechat et al.,
1998; Gant et al., 1999; Gerace and Burke, 1988; Moir et al., 1995).
The lamina consists mostly of a set of self-assembling proteins called lamins that
form are type!V intermediate filament (IF) proteins. These nucleo-specific IF-proteins
line the nucleo-plasmatic face of the inner nuclear membrane with a two-dimensional,
quasi-tetragonal meshwork, which is supposed to provide size, shape and mechanical
stability of the NE (Stuurman, 1998). The reversible process of filament formation is
required for a proper disassembly and reassembly of the lamina during open mitosis in
eukaryotes and is controlled by mitose-specific phosphorylation (Dechat et al., 1998;
Nigg, 1992). However, single cell eukaryotes and plants do not have a nuclear lamina.
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Figure 1.12: Components of the nuclear envelope and nuclear interior associated with lamins.
Inner and outer nuclear membrane (INM, ONM) together with the peripheral nuclear lamina (in white)
and nuclear pore complexes constitute the nuclear envelope. The protein content of the inner nuclear
membrane consists of membrane and membrane anchored proteins, which provide attachment sites for
the lamina and chromatin. LAP2!  is found associated with intranuclear lamins, chromatin and
retinoblastoma protein (pRB) (Figure taken from: Foisner, 2001).
Lamins are classified as type A and type B according to homology in sequence,
expression pattern, biochemical properties and subcellular location. A-type lamins are
expressed in differentiated cells, have a neutral isoelectric point and are completely
soluble in the cytoplasm during mitosis. B-type lamins are constitutively expressed
throughout development in every cell, have acidic isoelectric points and remain
membrane associated during mitosis through C-terminal farnesylation. There are two B-
type lamins encoded on separate genes in vertebrates and one lamin A gene. Alternative
splicing generates at least three lamin B and four lamin A isoforms (Gerace and Burke,
1988).
Lamins directly bind to chromosomes, they are required for DNA replication and
are involved in chromatin (Dechat et al., 1998) and nuclear pore organization
(Markiewicz et al., 2002). Moreover, they are early targets of proteolytic degradation by
specific caspases during apoptosis (Gotzmann et al., 2000). Upon cleavage, the lamina
undergoes specific morphological changes that are typical of apoptotic nuclei. A
characteristic feature of lamins and other IF proteins is their chemical resistance against
denaturing agents and high salt washes.
Foisner, R. J Cell Sci 2001;114:3791-3792
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More recently, intranuclear structures containing only lamin A have been detected
during interphase (Dechat et al., 1998; Goldberg et al., 1999; Broers et al., 1999; Broers
et al., 2004). Besides providing mechanical stability, this tubular network in the nuclear
interior might also be involved in higher order chromatin organization (Dechat et al.,
1998; Gotzmann and Foisner, 1999; Broers et al., 2005).
Several lamina-associated proteins (LAPs) have also been implicated in the
structural organization of peripheral and intranuclear lamin (Figure 1.12). Among
these, LAP1A, 1B, 1C (Foisner and Gerace, 1993; Martin et al., 1995) and LAP2
(Furukawa et al., 1995) are type!II integral membrane proteins of the inner nuclear
membrane, which share a 43-residue homologous LEM domain near their N-termini
with two other inner nuclear membrane proteins named emerin and MAN1 (LAP2-
EMERIN-MAN).
LAP2, now called LAP2" (Vlcek et al., 1999), has been proven to bind directly to
lamin B at the nuclear periphery and most likely indirectly to chromosomes and
therefore might be involved in attaching nuclear envelope and chromosomes (Dechat et
al., 1998). LAP2!, the only non-membrane bound isoform of the LAP2 family of
proteins has been proven to associate preferentially with A type lamins in the nuclear
interior (Dechat et al., 2000).
1.4.2 Structure and interactions of lamins
Similar to many cytosolic intermediate filaments (e.g vimentin, desmin, keratin,
etc.) the nuclear lamins consist of a central rod domain comprising up to 350 residues
and contain a typical hydrophobic heptad repeat pattern. The central rod is a double
stranded !-helical coiled-coil flanked by two non !-helical domains, termed N-terminal
head and C-terminal tail domain. The rod and the tail domain together are responsible
for the myosin-like shape of the parallel lamin dimer in electron micrographs.
Phosphorylation sites can be found on both ends of the central rod domain. Mitose-
specific phosphorylation induces conformational changes leading to a complete
disassembly of the lamina (Gerace and Burke, 1988; Stuurman et al., 1998). The next
level of lamin assembly involves longitudinal association of dimers into head to tail
polymers (in contrast to cytoplasmatic IFs) and finally lateral association into filaments
or eventually paracrystalline arrays (Stuurman et al., 1998). It is noteworthy that
globular head and tail domains are present in over one million copies in the fully
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assembled lamin meshwork providing a huge surface for protein-protein interactions
(Zastrow et al., 2004).
The atomic structure of the C-terminal globular domain (residues 428-547) has
been determined by NMR (Krimm et al., 2002), and by X-ray crystallography (Dhe-
Paganon et al., 2002). The domain adopts a novel immunoglobulin fold (L-subtype)
composed of seven beta strands that are classical for s-type Igs (Bork et al., 1994) and
two lamin specific extra strands. The nine strands form two "-sheets of five and four
strands that are tilted against the axis of the two sheets by a large angle of 45°
(Figure!1.13d).
More recently, one fragment of the 310 residues long lamin A rod domain, termed
coil!2B has been characterized structurally by X-ray crystallography (Strelkov et al.,
2004; Figure 1.13e). Furthermore, the rod domain is sufficient for binding to mitotic
chromosomes. Lamin A has been found to interact with DNA by interactions with the
minor groove (Luderus et al., 1994; ). A large number of lamin binding partners have
been discovered (for a recent review see: Zastrow et al., 2004).
1.4.3 Structure and interactions of LAP2 isoforms ! and "
The LAP family of proteins can be divided into two main groups: LAP1 and
LAP2 isoforms. LAP1 isoforms 1A, 1B and 1C are membrane-bound forms exclusively
localized at the nuclear rim in a continuous pattern. They associate with lamin!A that
together with lamin!B forms the major component of the peripheral nuclear lamina
(Foisner and Gerace, 1993).
LAP2", the most extensively characterized isoform of LAP2, binds to the lamin!B
tail domain in a phosphorylation dependent manner (Dreger et al., 1999). The human
LAP2 isoforms " (51!kDa), %, &, ' and ( (39!kDa) are structurally related (Figure 1.14).
They all possess an N-terminus that is oriented towards the nucleoplasma, a single
trans-membrane domain (apart from LAP2() and a C-terminal domain located in the
luminal space between inner and outer nuclear membrane (Dechat et al., 2000b).
Isoforms %, &, '  and ( have only been reported as mouse mRNA transcripts so far
(Dechat et al., 2000).
All LAP2 isoforms possess a highly conserved LEM domain within the first 187
amino acid at their N-terminus. This region is termed LAP2 constant region and
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structural information has become available for residues 1-50 and 111-153 by solution
NMR (Laguri et al., 2001). The constant region seems to be composed of two
structurally independent, non-interacting globular domains connected by a highly
flexible linker. Both regions are composed of two helices connected by a long loop and
tilted 45° with respect to each other and are proposed to tumble independently in
solution (Figure 1.13!a and Figure 1.13!b).
The N-terminal “LEM-like” region is involved in direct DNA binding through
positively charged residues. The LEM domain (amino acids 67-137) interacts directly
with the DNA-bridging protein BAF (barrier to autointegration factor), which is
proposed to block the auto-integration of retroviral DNA by compacting it into a rigid
structure. Binding to BAF takes place via complementary, hydrophobic interactions
(Laguri et al., 2001).
Figure 1.13: Available structural information for lamin and associated.
a) LEM-like domain of LAP2 involved in direct DNA binding b) LEM domain of LAP2 involved in BAF
binding (Figure a and b, pdb: 1GJJ, Cai et al., 2001) c) C-terminal domain of MAN-1 involved in DNA
binding (Caputo et al. unpublished) Structure of the C-terminal tail Ig of human lamin A/C (Dhe-Paganon
et al., 2002) e) Structure of human lamin A/C coil 2B (Strelkov et al., 2004).
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The largest isoform of the LAP2 proteins is LAP2!. It is more distantly related to
the other isoforms and together with LAP2( the only non-membrane bound gene
product distributed in the nuclear interior (Figure 1.14). Apart from the constant 1-187
amino acids found in all LAPs, it possesses a unique 506 residues long C-terminal !-
specific region that contains the proposed binding site for lamin A between residues 615
and 693 (Dechat et al., 2000a). No structural information exists on the lamin binding
domains of any of the LAPs.
Figure 1.14: Localisation and domain organization of mammalian LAP2 isoforms.
a) The N-terminus is conserved in all alternatively spliced isoforms and consists of a LEM and LEM-like
domain separated by a flexible linker region. Sequence deviations occur in the nucleoplasmatic domains
(green); LAP2! is more distantly related to the other isoforms and has a unique nucleoplasmatic domain
(blue). On the protein level, only LAP2!, ", '  have been detected in humans. The other isoforms are
reported as mRNA transcripts in mouse; IM: inner nuclear membrane; OM: outer nuclear membrane;
NLS, nuclear localization signal. b) Binding partners of LAP2! and their reported binding region; LEM,
domain homologous in the nuclear envelope proteins LAP, Emerin and Man-1.
Furthermore, the unique C-terminus harbours a chromosome interaction domain
(between 270-615) that is functionally distinct from the N-terminal DNA interaction
region and essential and sufficient for targeting LAP2! to chromosomes (Vlcek et al.,
1999).
LEM-like LEM
NLS
189 195
LAP2! unique
67 137 BAF binding
270 615 chromatin binding
693
693 lamin A/C binding 615
LAP2!
1 85 chromatin binding
1     50       110   150
LEM-like      LEM
1     50       110   150  187
1     50       110 150 187
1     50       110 150 187
1     50       110 150 187
1     50       110 150 187
1     50       110 150 187
a)
b)
415                        615 retinoblastoma protein binding
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More recently an interaction of LAP2! with retinoblastoma protein (pRb) has
been described (Markiewicz et al., 2002). This protein is involved in regulation of cell
cycle progression by binding to the transcription factor E2F. It has a well-defined
domain structure consisting of an N-terminal oligomerization domain and three C-
terminal “pocket” domains. LAP2! has been found to bind to the pocket C domain of
Rb and anchors the protein inside the nucleus through selective retention. Binding takes
place within the !-specific region residues 415-693 (Dorner et al., 2006), which are
unique to LAP2!  and contains functionally significant motifs important for
chromosome targeting and lamin binding. This suggests the presence of trimeric
LAP2!, pRb, lamin A/C complexes that have been detected in coimmunoprecipitation
experiments. A function of this complex lies in the regulation of cell proliferation and
differentiation in adult stem cells (Markiewicz et al., 2002).
1.4.4 Function of LAP2s and binding partners in nuclear structure and dynamics
All higher eukaryotes undergo an open mitosis. Upon phosphorylation of lamins
and lamin binding proteins the nuclear envelope completely disassembles. The
condensing chromosomes detach from the nuclear lamina. Lamin A/C complexes stay
cytoplasmatic, lamin B structures remain membrane-associated and lamina associated
proteins loose their affinity for lamins.
By subcellular fractionation studies LAP2! has been found to be in soluble form
and to be localized in the nuclear interior during interphase (Dechat et al., 2000). It co-
fractionated with LAP2" in lamina enriched fractions after extraction with salt, urea and
nucleases. After reassembly it localized to distinct sites around decondensing
chromosomes prior to LAP2". In vitro dephosphorylation lead to its integration into
insoluble, chromatin associated structures. Two perfect and five minimal consensus
sites were found for p34cdc2 kinase (Gajensko et al., 2004).
Like LAP2" it associates also with the chromosomal surface with a region that is
not located within the first 187 amino acids. Hence the functional diversity of LAP2!
and LAP2" in postmitotic chromosome association depends on the isoform-specific
nuclear targeting domain (Vlcek et al., 1999). There is no need for active transport into
the nucleus since membranes are not entirely formed when LAP2! accumulates at
nuclear structures through selective retention.
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LAP2!  might have important functions in early, post-mitotic, nuclear
organization. The findings suggest that LAP2! binds decondensing chromosomes and
forms a structural scaffold for higher chromatin organization. At first, LAP2!
associates with its !-specific region to chromosomes prior to LAP2". In a second step
the N-terminal binding sites might recruite BAF, chromosomal proteins and DNA to
organize a higher order structure of the chromatin. Binding of the LEM-like domain to
DNA can only take place when LAP2! is a dimer. The temporal coordination of these
events can be maintained through phosphorylation and/or oligomerization (Dechat et
al., 2000b).
More recently, it became clear that LAP2! has distinct functions in nuclear
assembly during mitosis and in the progression of cells into S-phase. The inhibition of
nuclear assembly by overexpression of C-terminal nuclear targeting domain interferes
with endogenous LAP2! and shows that the N-terminal, constant region is necessary
for nuclear assembly, thereby competing for binding sites (dominant negative effect). In
contrast, cell-cycle arrest was caused by overexpression of full and C-terminal LAP2!,
which indicates a specific function of the C-terminus in this process.
LAP2! could control G1-S phase progression through binding to transcription
factors and pRb, which represses transcription of S-Phase genes. Furthermore it can
manipulate higher order chromatin organization and prevent DNA replication
(Markiewicz et al., 2002).
LAP2! has also a function during apoptosis since the lamina provides an attachment
site for the apoptotic machinery. LAP2!, LAP2" and lamins are early targets of
apoptotic caspases. Mislocalized lamins might trigger apoptosis (Gotzmann et al.,
2000).
1.4.5 Diseases associated with lamins
Mutations in genes encoding for nuclear lamina proteins have been found to cause
diseases called laminopathies, i.e. severe disorders of muscle and adipose tissue. The X-
linked form of Emery-Dryfuss muscular dystrophy is caused by mutations in the LEM-
domain containing protein Emerin. The autosomal dominant variety of EDMD is caused
by mutations in the lamin A/C. Since there is a reported direct interaction of Emerin
with lamin A/C, the molecular mechanism of the disease might involve the disturbance
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in lamin A/C-Emerin complexes caused by mutations. Because LAP2! has also been
described to interact directly with lamins, it is believed that the same is true for LAP2!-
lamin A/C complexes.
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1.5 Challenges of structural studies on filamentous proteins and
protein scaffolds
Filamentous proteins are challenging targets for structural studies employing X-
ray crystallography. To date, it remains the method of choice for structure determination
of protein complexes at atomic and sub-atomic resolution (Russel et al., 2004).
Difficulties when working with filamentous, structural proteins are encountered during
all stages of structure elucidation including construct design, isolation and purification,
biophysical characterization, crystallization and finally structure determination:
i.) Filamentous structural proteins are by definition elongated, multi-modular
assemblies of large size and molecular weight (in the case of titin over 1!µm in length
and up to 3.8 MDa) and cannot be analysed on the full protein level. The design of
working constructs for structural studies must carefully balance between the amount of
information gained and experimental constraints like solubility, chemical stability,
homogeneity, conformational rigidity and correct determination of domain boundaries
of all protein partners under investigation. Often initial biological interaction data are
present based on yeast two-hybrid screen (Y2H), immuno-fluorescence microscopy or
affinity tag methods (review Piehler, 2005). These methods serve as initial screening
tools for protein-protein interactions, but have a number of problems with both false
positives and negatives. The incidence of false-positive results particularly increases as
complexes become less stable and biophysical verification by other techniques like
mass-spectroscopy, calorimetry, analytical ultracentrifugation or light-scattering
techniques is indispensable. A particular problem when working with scaffolding
proteins is their high degree of molecular association and tight cellular regulation. As a
result, overexpression of modified constructs often leads to a so-called dominant-
negative phenotype, i.e. the overexpressed material interferes with endogenous protein
thereby disturbing the system. As a result the protein-protein interaction leading to the
observed phenotype might not be physiologically relevant and represent an
experimental artefact.
ii.) Many structural proteins are only stable in their natural context, i.e. in the
context of the filament, in association with binding partners or under specific
physiological conditions. Thus, isolation and purification is only applicable to the most
robust complexes. Crystallography requires milligram quantities of pure and
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monodisperse material and heterologous expression systems are a key factor to
efficiency. Post-translational modifications like for example phosphorylation,
ubiquitination, SUMOylation or glycosylation lead to an increase in complexity of the
system. Eukaryotic expression systems with their complex protein modification and
folding machinery might be required to express the target construct in large amounts
and functional form that is amenable to structural investigation. Furthermore, a key
question is, whether all partners of the complex need to be over-expressed
simultaneously or separate in vitro reconstitution of the complex is possible.
iii.) The fact that structural proteins rarely possess intrinsic activity, requires in
depth biophysical characterization using for example spectroscopic methods like CD- or
IR-spectroscopy or de novo design of functional assays to assess if the material is
correctly folded and active under the in vitro conditions. In many cases the oligomeric
state of the protein is directly linked to its functional activity and therefore of particular
interest for biophysical characterization. Frequently during in vitro characterization, a
disruption of the macromolecular assembly can occur during isolation steps, affinity
purification and biophysical analysis due to unsuitable buffer conditions or mechanical
forces. Thus, the experimental conditions need to be carefully established prior to the
measurement and the results critically scrutinized. Self-association of scaffolding
proteins can also be a major problem when working at high protein concentrations.
Unspecific aggregation leading to non-specific heterogenous precipitate is frequently
observed upon concentration of the protein sample.
iv.) Finally, elongated shape and high molecular weight leads to large unit cell
dimensions and high solvent content, both parameters critically affecting the resolution
of the diffracting experiment. Furthermore, observed oligomers present in the
crystalline state might represent nonphysiological oligomeric states as a result of the
specific aggregation events necessary for the crystallization process. To discriminate
between crystal contacts and real physiologically relevant protein interfaces might not
be trivial and requires additional complementary approaches employing for example
NMR spectroscopy, database comparison employing the quaternary structure database
or site directed mutagenesis in combination with functional assays.
.
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1.6 Focus of the work
A particular focus of this work lies in the characterization of the protein complex
between titin M-line domains A168-A170 and the ubiquitin-ligase MuRF-1. Currently
no structural data are available of this interaction, which is believed to have crucial
regulatory roles in myofibrillar protein turnover, sarcomere integrity and consequently
in the pathological events leading to muscular atrophy. With the aim to reveal the
molecular determinants of the recruitment of MuRF-1 to titin we have decided to
conduct structural studies on titin domain A168-A170.
The first goal was to elucidate the crystal structure of the interface region. Distinct
surface features as well as the overall domain orientation can be utilized to prompt
further studies directed to block the interaction with MuRF-1 and potentially cause
resistance to atrophy. The second goal was to characterize the binding site of titin
A168-A170 on MuRF-1, which was reported at the time to include the B-box!2 and the
adjacent predicted coiled-coil domain. Initial binding experiments between A160-A170
and MuRF-1 B-box carried out in our laboratory did not support an interaction of titin
with isolated MuRF-1 B-box. Consequently, our studies are focussed on the predicted
coiled-coil region, MuRF-1146-341, with the aim to quantify the interaction by means of
isothermal titration calorimetry. A168-A170 currently represents the largest poly-
domain construct of titin that is characterized on the molecular level. It comprises an Ig-
Ig as well as an Ig-FnIII transition that can serve as representative transitions and aid in
homology modeling of other titin domains and their interfaces. We could not determine
binding of MuRF-1 B-box to titin. Given the ill-characterized function of individual B-
box domains together with the vicinity to the believed titin binding region of MuRF-1,
we also aimed at solving the structure of MuRF-1 B-box. The frequent integration of
the B-box 2 subtype N-terminal of coil-coil homo-oligomerization motifs that are
involved in protein targeting should imply specific structural features that are unique to
this B-box subtype.
We also investigated the nuclear scaffold protein LAP2!, which recruits various
protein and DNA components during cell cycle progression and focused our attention in
particular on the C-terminal lamin A/C binding functionality. Detailed biophysical
characterization was directed on the determination of its homo-oligomerization state as
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well as on the assessment of the crystallization propensity of this disease-related nuclear
scaffold.
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Plasmids containing coding sequences for A168-A170 as well as MuRF-1 were
provided by PD Dr. Dietmar Labeit and Prof. Siegfried Labeit. Isothermal titration
calorimetry was done in collaboration with PD Dr. Heiko Heerklotz. All other work is
my own.
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2 Evidence for the recruitment of MuRF-1 to titin
Abstract
Titin forms a sarcomeric filament system in vertebrate striated muscle that has
both elastic and signaling properties. Near its C-terminus and directly preceding a
Ser/Thr kinase domain, titin contains a conserved pattern of Ig and FnIII modules
(IgA168-IgA169-FnIIIA170, hereby A168-A170) that recruit the ubiquitin-ligase MuRF-1
to the filament. This interaction is believed to regulate myofibril turnover and the
trophic state of muscle. We have elucidated the crystal structure of A168-A170 and
established its binding to MuRF-1 in solution. A168-A170 shows an extended, rigid
architecture where Ig-Ig and Ig-FnIII interfaces reveal conserved principles of
interdomain arrangements across titin. Its surface displays a shallow groove along
its full length as well as a unique loop protrusion, both features conceivably
mediating MuRF-1 binding. ITC data show that A168-A170 binds MuRF-1 with
high affinity. In MuRF-1, residues 166-315 are sufficient for this interaction. These
data suggest that this region of titin is of interest to attempt therapeutic inhibition
of MuRF-1-mediated muscle turnover.
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2.1 Materials and Methods
2.1.1 Cloning
The expression plasmid for A168-A170 was provided by Prof. Siegfried Labeit
and PD Dr. Dietmar Labeit at the Institut für Anästhesiologie und Operative
Intensivmedizin, Universitätsklinikum Mannheim, Germany. Coding sequences for
domains A168-A170 from human titin (residues 24431-24731, EMBL X90568) had
been cloned into the pETM-11 vector at restriction sites Nco-I and MIu-I. pETM-11
(EMBL vector collection) is a variant of pET-24d (Novagen) including an N-terminal
His6-tag and a TEV (tobacco etch virus) protease cleavage site prior to the inserted
gene.
An initial plasmid containing the sequence of full-length MuRF-1 was provided
by the collaborators mentioned above. Fragments from MuRF-1 (Swiss-Prot Q969Q1),
hereby termed MuRF-1166-341 and MuRF-1166-315, were PCR-amplified using the
following primer pairs:
MuRF-1166-315!forward: 5’-CGGGGTACCTTAATCTGTCCCAAAGTC-3’
MuRF-1166-315!reverse: 5’-CGGGGTACC TTACTGGTGTCCTTCTTCC-3’
MuRF-1166-341!forward: 5’-CATGCCATGGTGGTGGCGG GGAATG-3’
MuRF-1166-341!reverse: 5’-CGGGGTACCTTACTGGTGTCCTTCTTCC-3’.
Both constructs were inserted into pETM-11 via Nco-I and Kpn-I restriction sites and
correspond to a C280S mutated variant designed to prevent unspecific aggregation of
the samples due to oxidation during storage. Site-directed mutagenesis used the Qiagen
protocol and the following primers:
forward 5’-GCTTCCAAGGGCTCCCAGCTGGGGAAGACAGAGC-3’,
reverse 5’-GCTCTGTCTTCCCCAGCTGGGAGCCCTTGGAAGC-3’.
1.1.2 Protein production
Overexpression of A168-A170 was carried out in the E.!coli strain BL21(DE3)
Rosetta (Novagen). Cultures were grown at 37°C up to an OD600 of 0.6 in Luria Bertani
medium supplemented with 25 µg/ml kanamycin and 34 µg/ml chloramphenicol.
Expression was induced by addition of isopropyl-ß-D-thiogalactopyranoside (IPTG) to
a final concentration of 1!mM. Cultures were grown at 25°C for approximately 18
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additional hours. Cells were harvested by centrifugation at 2800*g and 4°C during 40
minutes. Bacterial pellet was resuspended in 50 mM Tris-HCl pH 8.0, 150 mM NaCl,
containing a protease inhibitor cocktail (Roche) and DNAse. Lysis was induced by
sonication (Branson sonifier) for 2 minutes at 4°C in the presence of lysozyme. The
homogenate was clarified by centrifugation at 15000*g at 4°C for 40 minutes. The
supernatant was applied to a Ni2+-chelating HisTrap column (GE Healthcare)
equilibrated in lysis buffer, with elution using 250 mM imidazole. The eluent was
dialyzed against 50!mM Tris-HCl pH 8.0, 150!mM NaCl, 2!mM DTT in the presence of
TEV protease. The protease digest, incubated for 16!h at 4°C and a 1:50 molar ratio
TEV:protein, resulted in 90% efficient tag removal. Given that A168-A170 still
interacted with the Ni2+-chelating resin after tag removal, the digested mixture was
further purified by gel filtration on a Superdex 200 Hiload 16/60PG column (GE
Healthcare) equilibrated in dialysis buffer. The samples were finally dialyzed against
25!mM MOPS pH 8.0, 150!mM KCl, 1!mM DTT, 1!mM EGTA and stored at 4oC for
further use. It was observed that the presence of 20 mM NaCl in the medium was
necessary to prevent protein precipitation. The expression yield of soluble titin A168-
A170 in E.!coli was approximately 10!mg of pure protein per 1!L culture. The protein
purity was assessed by SDS-PAGE.
MuRF-1 fragments were prepared as above, but purification of the protease digest
used subtractive affinity chromatography prior to gel filtration. The yield of both
MuRF-1 constructs was approximately 5!mg of pure sample per 1!L culture for MuRF-
1166-315 and 3!mg per 1!L culture for MuRF-1166-366.
All three proteins eluted in one single peak in gel filtration chromatography,
indicating chemical homogeneity and a stable oligomeric state. Figure 2.1 shows
sample preparations for all three constructs.
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a)
b)
c)
Figure 2.1: Size exclusion chromatograms of titin A168-A170 and MuRF-1 constructs.
All runs were in 50 mM Tris pH 8.0, 100 mM NaCl and used untagged samples. The signal shown
corresponds to A280nm. a)!Titin A168-170 (MW=33746!Da); b) MuRF-1
166-341 (MW=20429!Da); c)!MuRF-
1166-315 (MW=17293!Da).!The final purity of samples according to SDS-PAGE is shown on the right. Lane
M contains the LMW standard (GE Heathcare).
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2.1.3 Crystallization of titin A168-A170
Initial crystallization conditions for A168-A170 were sought using protein sample
supplied by Dr. Dietmar Labeit, Mannheim. This contained a non-cleavable C-terminal
His-tag and was in 25!mM MOPS pH 8.0, 150!mM KCl, 1!mM DTT and 1!mM EGTA
and at a concentration of 12!mg/ml (based on A280 values). Crystallization trials were
performed using vapor diffusion, where 1!µl of titin A168-A170 was mixed with 1!µl of
reservoir solution to form a 2!µl hanging drop. Each droplet was equilibrated against
500!µl of reservoir solution in VDX plates (Hampton Research). For initial screening,
the sparse matrix kits Hampton Research CS-I & II, Emerald Wizard I & II, Emerald
Wizard Cryo I & II, Molecular Dimension PSS-I & II were used.
Crystals grew in the form of thin, multiple plates with approximate dimensions of
100x40x10 µm3 after 4!days from a solution containing 10!% PEG 6000, 0.1!M HEPES
pH!7.5 and 5!% MPD. Refinement of these conditions required varying PEG and MPD
content followed by macroseeding with crystalline fragments. This yielded single
crystals (Figure 2.2) suitable for diffraction tests using synchrotron radiation. Best
crystals, grown from 7% PEG 6000, 0.1M HEPES pH 7.5 and 7% MPD, were frozen in
mother liquor supplemented with 20% glycerol for cryoprotection and subjected to
diffraction tests at beamline X06SA at the Swiss Light Source (SLS), Villigen,
Switzerland.
"
"
""
Figure 2.2: Refined crystals of His-tagged titin A168-A170 after macroseeding.
a) Thin plates with approximate dimensions of 100x40x10 µm3 grew from 10 % PEG 6000, 0.1 M
HEPES pH 7.5 and 5 % MPD after macroseeding with crystalline fragments; b) Close-up view of a).
200 (m 100 (m
a) b)
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The crystals diffracted anisotropically, with an approximate isotropic limit of 4!Å
resolution (Figure 2.3). The diffraction pattern could be indexed in an orthorhombic
cell (P222) with dimensions a=68.11!Å, b=97.66!Å, c= 353.25!Å (!="='=90°), where
the c axis is exceptionally long. No further attempts were made to improve the
diffraction quality of this crystal form since, at that point, crystals more amenable to
structure elucidation were obtained from untagged A168-A170 samples.
Figure 2.3: Diffraction pattern of crystals from C-terminally His-tagged titin A168-A170.
Data were recorded at *=1.00007 Å (12.3974 keV) on a MAR CCD165 detector exposing for 2 s. An
oscillation range of 1° was used.
Further crystallization trials were conducted with an untagged version of titin
A168-A170. Like the tagged sample, this was in 25!mM MOPS pH 8.0, 150!mM KCl,
1!mM DTT and 1!mM EGTA. The screening for initial crystallization conditions used
sparse matrix preparations from commercial suppliers as described above and protein
stocks concentrated to 12!mg/mL. This resulted in a significantly higher number of
initial hits. Table 2.1 summarizes all conditions in which titin A168-A170 crystals were
observed. Most crystalline formations exhibited needle or rod-like morphology,
hexagonal in cross-section, and were inter-grown or associated in clusters.
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Table 2.1: Crystallization conditions for titin A168-A170.
Condition Solution content Morphology
CSI-35 0.8 M NaH2PO4, 0.8 M KH2PO4, 0.1 M Na-HEPES, pH 7.5 needles
CSI-48 2 M NH4H2PO4, 0.1M Tris-HCl pH 8.5 needles
CSII-1 10% PEG 6000, 2M NaCl hexagonal plates
CSII-23 1.6 M (NH4)2SO4, 10% Dioxane, 0.1 M MES pH 6.5 needles
CSII-25 1.8 M (NH4)2SO4, MES pH6.5, 0.01 CoCl2 spherulites
CSII-32 1.6 M (NH4)2SO4, 0.1M Na-HEPES 7.5, 0.1 M NaCl needle cluster
CSII-42 1.5 M (NH4)2SO4, 0.1 M Tris-HCl pH 8.5, 12 % Glycerole spherulites
WizII-38 2.5 M NaCl, Na-Acetate pH 4.5, 0.2 M Li2SO4 needles
WizI-20 0.4 M NaH2PO4, 1.6 M KH2PO4, Imidazole pH 8.0, 0.2 M NaCl needles, single
CS: Crystal screen (Hampton Research); Wiz: Wizard screen (Emerald biosciences). The condition
shown in bold led to structure solution.
The most promising condition, Wizard-II-38 (Emerald Biosciences), resulted in
crystal growth after two days and in the form of multiple, long needles. This condition
was subsequently used as basis for a refined search by varying precipitant
concentration, pH, salt type and salt concentration as well as employing various
methods to slow down vapor diffusion. The latter included the addition of
polyvinylpyrolidone (PVP) and glycerol at various concentrations, as well as the
covering of the reservoir with mixtures of silicon and paraffin oil (Chayen 1997) that
led in cases to crystals of larger size and improved morphology. The modified condition
that finally resulted in crystals suitable for data collection (Figure 2.4) contained 2.1!M
NaCl, 0.6!M Li2SO4 and 0.1!M MES pH!5.5. Crystals grew over an extended period of
time (2-3 months) to a final size of 600x50x50 µm3. It is likely that during this time
desiccation of the drop facilitated the formation of large, single crystals. The yield of
best crystals, however, was minimal and only two optimal specimens were obtained,
both in one same drop (Figure 2.4b).
The crystals obtained from this single drop were used in the collection of native
data as well as in a three-wavelength MAD experiment required for phasing. To
perform the latter, a crystal was derivatized with the heavy atom cluster [Ta6Br12]
2+
(kindly donated by PD Dr. Joerg Stetefeld), which interacts with proteins via ionic
bonds and is a very strong scatterer (856 electrons) (Knablein et al., 1997). After
soaking the crystals for 30!min in solutions containing the [Ta6Br12]
2+  cluster at
saturation, an intensive green color was observed indicative of the incorporation of the
compound into the protein lattice. Crystals for native and derivative data acquisition
were shock-frozen in liquid nitrogen after being cryo-protected in mother liquor
supplemented with 20% glycerol. The cryo-protectant solution of the derivatized crystal
contained in addition [Ta6Br12 ]
2+ at saturation.
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Figure 2.4: Crystals of untagged titin A168-A170.
a) Crystals obtained from 2.1!M NaCl, 0.1!MES 5.5, 0.6!M LiSO4. Needles or rods with an hexagonal
cross-section, often forming clusters, could be observed in the drops after 1-2 weeks time. b) Crystals
used for native and MAD data collection after derivatization with [Ta6Br12 ]
2+. In this case, growth lasted
for two months.
2.1.4 Collection of a native data set
A native data set was collected from a best crystal of titin A168-170 at 100 K on
the synchrotron beamline ID-29-1, ESRF (Grenoble), which is equipped with a
Quantum ADSC Q210 detector. Data were collected in a series of 1° non-overlapping
oscillations and processed up to 2.9 Å resolution using the XDS/XSCALE package
(Kabsch, 1993). The lattice was identified as P3(x)21 (x=1 or x=2) with unit cell
dimensions a=b=125.16 Å, c= 134.54 Å (!="=90°, '=120°). A diffraction pattern is
shown in Figure 2.5 and data processing statistics are given in Table 2.2.
Table 2.2: Native data processing statistics.
Xray source ID29-1 (ESRF)
Detector ADSC Quantum Q210
Wavelength 0.9792
Resolution 15-2.9 (3.0-2.9)
Unique reflections 26792 (2619)
R-factor 7.3 (52.8)
Multiplicity 5.4 (5.4)
Completeness 97.5 (98.6)
I/# (I) 21.4 (3.6)
100 (m 100 (m
a) b)
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Figure 2.5: Diffraction pattern of titin A168-170 crystals.
Diffraction was observed up to a maximum of 2.7 Å resolution, but complete data of quality suitable for
structure elucidation could only be obtained to 2.9 Å resolution.
Images displayed with the program MOSFLM (Leslie, 1992).
2.1.5 Detection of non-crystallographic symmetry (NCS)
The analysis of the Mathews coefficient (Matthews, 1968) revealed that the
asymmetric unit of this crystal form must contain two to four copies of titin A168-A170
(VM=4.5 Å
3/Da for two!molecules per asymmetric unit leading to a solvent content of
72% and VM=2.2 Å
 3/Da for four molecules per asymmetric unit leading to a solvent
content of 46%). In the subsequent steps of structure elucidation it became clear that
only two molecules are present in the asymmetric unit of this crystal form, resulting in
an elevated solvent content. This possibly explaining the limited resolution of the
diffraction obtained from these crystals.
For the detection of the rotational component of the non-crystallographic
symmetry (NCS) axis a self-rotation function was calculated using the program,
AMORE (Navaza, 1994). The method correlates sets of self-vectors from two Patterson
maps. The solutions are given in Table 2.3.
2.7 Å
3.6 Å
5.5 Å
10.9 Å
2.7 Å
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Table 2.3: Euler and Polar rotational NCS relations as determined using AMORE.
Figure 2.6: Graphical representation of the self-rotation function calculated using POLARFN
Stereographic projection of section +=180°. The presence of NCS is shown by additional 2-fold axes
indicated by red arrows. The central peak indicates an NCS axis co-aligned with the crystallographic
three-fold along c.
A two-fold (+=180°) NCS axis was found to be co-aligned with the
crystallographic three-fold axis along c (,=-=0) (Figure 2.6). Peaks at -=30° and
-=90° (red arrows in Figure 2.6) result from the fact that the NCS axis is perpendicular
to the ab plane, thus generating additional two-fold NCS axes perpendicular to the
crystallographic axes a and b and indicating that the NCS axis must intersect a and b at
their origin. Thus, the NCS axis generates a pseudo hexagonal symmetry as indicated
by peaks in section +=60° resembling a P622 point group symmetry.
The position of the NCS axis in real-space was confirmed at a later stage by
analyzing initial electron density maps with the program GETAX (Vonrhein & Schulz,
1999). This showed that the NCS axis passed through the unit cell origin, perpendicular
to the ab plane (a=b=0) and parallel to c (Figure 2.7). Given that self-rotation
correlation values for this NCS axis were 60% at low resolution, this axis could be
expected not to be a perfect two-fold. In effect, further steps in the structure elucidation
process revealed that slightly divergent NCS operators related individual domain pairs
across molecular copies A and B. Thus, the two molecular copies do not exhibit
! " ' , - + Correlation (%)
SOLUTIONRS 120.0 0.0 0.0 0.0 0.0 120.0 100 (crystallographic symmetry)
SOLUTIONRS 180.0 0.0 0.0 0.0 0.0 180.0 60
SOLUTIONRS 60.0 0.0 0.0 0.0 0.0 60.0 60
The self-rotation function was calculated between a resolution of 20 and 5 Å.
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identical overall conformations, with their C-terminal domains A170 diverging most
pronouncedly from a two-fold relation.
a) b)
Figure 2.7: Real-space analysis of non-crystallographic symmetry using GETAX.
a) Density correlation search at 15-5 Å resolution and using a sphere radius of 20 Å. The position of the
NCS axis is indicated by accumulation of density along c (black). Shown are the molecular copies A
(green and red) and B (blue and magenta) of the final model of titin A168-170. Domain A170 is coloured
red and magenta in copies A and B, respectively; b ) Unit cell diagram showing the location of
crystallographic three-fold axes and “pseudo” two-fold NCS axes (marked by red and hollow obloids).
Red obloids show the locations were the local two-fold correlation calculated using GETAX is higher as
a result of the contribution from domains A168-A169 that diverge only slightly from a two-fold
symmetry. The hollow obloid represents a symmetrical copy of the NCS axis that displayed no detectable
correlation in GETAX (see a.) due to the local influence of domains A170 that diverge more notably
from a two-fold symmetry. Red arrows indicate additional 2-folds leading to the hexagonal
"pseudo"symmetry in the rotation function.
2.1.6 Phasing attempts by Molecular Replacement
Titin A168-170 is composed of two Ig and one FnIII domain, which are very
abundant folds in nature. Given the structural conservation of these folds, structure
solution by molecular replacement was attempted using the program PHASER (Storoni
et al., 2004). The program carries out a double three-dimensional search (three
rotations, three translations) to maximize the overlap of target and model self-vectors
based on maximum-likelihood calculations.
Structures of homologous domains were identified in the Protein DataBase by
sequence alignment with BLAST (Altschul et al., 1990). Three structures were chosen
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based on sequence identity levels (Figure 2.8), namely the crystal structure of telokin at
2.0!Å resolution (1FHG, 30% sequence identity to titin IgA168; Holden et al., 1992), an
NMR structure of Ig domain I18 from twitchin (1WIT, 30% sequence identity to titin
IgA169; Fong et al., 1996) and the NMR structure of A71 from the titin A-band (1BPV,
40% identity to titin FnA170; Muhle-Goll et al., 1998). All models were trimmed to fit the
side chain composition of titin A168-170.
Figure 2.8: Sequence alignment of domain homologues used in molecular replacement.
The crystal structure of 1FHG (Telokin, 30% identity) and the solution structures of 1WIT (I18 from
twitchin, 30% identity) and 1BPV (A71 from titin, 40% identity) were trimmed to match the side-chain
composition of titin A168-170 in volume. Trimmed residues are indicated in cyan, identical residues in
grey.
Multiple trials were carried out in PHASER considering space groups P3121 and
P3221, different number of molecules per asymmetric unit and variations in input
models. However, this did not result in any potential solutions. The failure might be
possibly due to the decrease of diffraction data quality at medium resolution together
with the use of NMR structures as search models. Next, MAD experimental phasing
was pursued.
2.1.7 MAD data collection
MAD data were collected at the beamline ID23-1, ESRF (Grenoble) on crystals
derivatized with the electron-rich compound [Ta6Br12 ]
2+ (for details on the derivatization
process see chapter 2.1.3). A three wavelength MAD experiment was carried out at the
LIII-edge of tantalum, using energies of E= 9.88256!keV (*peak=1.2546!Å) for the peak
corresponding to the maximal f''; E= 9.87887!keV (*inflexion=1.2550!Å) for an edge point
representing the minimal f' and E= 12.300!keV (*remote=1.008 Å) for a high-energy
remote point selected outside the L-edge (Figure 2.9). The data were collected in the
order peak, inflexion and remote wavelengths aiming at maximum completeness and
IgA168    ------PHFKEELRNLNVRYQSNATLVCKVTGHPKPIVKWYRQGKEIIADGLKYRIQEFKGGYHQLIIASVTDDDATVYQVRATNQGGSVSGTASLEVEV-
1FHG      EKPHVKPYFTKTILDMEV-VEGSAAFDCKVEGYPDPEVMWFKD-DNPVKESRHFQIDYDEEGNCSLTISEVCGDDDAKYTCKAVNSLGEATCTAELLVETM
1FHG_trim -----KPYFTKTILDMEV-VEGSAAFDCKVEGYPDPEVMWFKD-DNPVKESRHFQIDYDEEGNCSLTISEVCGDDDAKYTCKAVNSLGEATCTAELLVETM
IgA169    --------PAKIHLPK-TLEGMGAVHALRGEVVSIKIPFSGKPDPVITWQKGQDLIDNNGHYQVIVTRSFTSLVFPNGVERKDAGFYVVCAKNRFG-IDQKTVELDVADV--
1BPV      SPIDPPGKPVPLNITRHTVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKAN--------FSNILENEFT----VSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRD
1BPV_trim --------PVPLNITR-TVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKAN--------FSN--ENEFT----VSGLTEDAAYEFRVIAKNAAG-ISPPSEPSDA-----
FNA170    --P---DPPRGVKVSDVSRDSVNLTWTEPASDGGSKITNYIVEKCATTAERWLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITKEDKTRAMNYDEEV
1WIT      LKPKILTASRKIKIKAGFTHNLEVDFIG-APDPTATWT--VGDSGAALAPELLVDAKSSTTSIFFPSAKRADSGNYKLKVKNELG---EDEAIFEVIVQ-------------
1WIT_trim --PKILTASRKIKIKAGFTHNLEVDFIG-APDPTATWT--VGDSGAALAPELLVDAKSSTTSIFFPSAKRADSGNYKLKVKNELG---EDEAIFEVIVQDVEA---------
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redundancy of the Bijvoet pairs. A total rotation of 120° was recorded per wavelength
in 1° oscillations and two seconds exposure time per frame. Data collection was carried
out at a maximum “edge-of-detector” resolution of 3.2!Å.
Figure 2.9: Real (f’) and imaginary (f’’) components of the anomalous signal from tantalum.
Theoretical plot of f’ and f’’ versus energy. For MAD data collection, wavelengths were selected
experimentally based on a fluorescence scan (data not shown). The individual wavelengths used for data
collection are indicated.
2.1.8 Data processing
Data were processed using XDS (Kabsch et al., 1993) by treating the Bijvoet pairs
F+ and F- as separate reflections. Unmerged data collected at edge and remote energies
were scaled against the peak set as reference wavelength using XSCALE. For
derivative-to-native scaling the program FHSCAL (Kraut et al., 1962) was used
applying Kraut’s scaling procedure. Data processing statistics are provided in
Table!2.4.
Table 2.4: MAD data processing statistics on [Ta6Br12 ]
2+-derivatized titin A168-170
Xray source ESRF-ID-23-1
Detector MAR CCD 225
Peak Edge Remote
Resolution (Å) 20-3.35 (3.4-3.35) 15-3.45 (3.5-3.45) 15-3.5 (3.55-3.5)
Wavelength (Å) 1.2546! (9.88256!keV) 1.2550 (9.87887 keV) 1.008 (12.300 keV)
No. Bijvoet reflections 33994 (1556) 31059 (1347) 29580 (1216)
Rsym (I) (%) 11.1 (42.6) 10.6 (41.6) 12.9 (47.5)
Multiplicity 3.9 (3.9) 3.7 (3.7) 3.9 (3.9)
Completeness 98.8 (99.7) 98.2 (99.4) 98.2 (98.9)
I/# (I) (%) 9.8 (3.5) 10.1 (3.5) 9.2 (3.1)
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The anomalous scattering contribution of [Ta6Br12]
2+ clusters was initially
estimated in XDS, as an indication of whether the compound had become specifically
bound to the protein (Table 2.5). The cluster is a regular octahedron consisting of six
metal atoms with 12 bridging bromine atoms along the 12 edges of the octahedron. Its
radius is about 4.3!Å. At low resolution (approximately <6 Å) all atoms of the cluster
scatter in phase and the cluster can be treated as a super-atom (Knäblein et al., 1997).
Table 2.5: Estimation of anomalous signal with XDS.
Resolution S_norm/S_ano
Peak Remote Inflex
15.00 2.31 1.55 2.00
13.00 1.99 1.26 1.51
12.00 1.51 1.13 1.17
10.00 1.48 1.08 1.18
6.00 1.20 1.02 1.06
5.00 1.03 0.99 1.01
S_norm: mean value of Sigma(I) for acentric reflections assuming Friedel’s law is valid.
S_ano: mean value of Sigma(I) for acentric reflections assuming Friedel’s law is violated.
Anomalous scattering contributions to the intensities are indicated by S_norm/S_ano >1
2.1.9 Determination of the sub-structure of anomalous scatterers
In order to obtain experimental phases, the position of anomalous scatterers in the
unit cell was determined using the program CNS (Brunger et al., 1998) on anomalous
difference Patterson maps calculated between 12-6.0 Å resolution and derived from
peak-wavelength data (Figure 2.10a). The features of this map were consistent with
those of isomorphous difference maps (Figure 2.10b) and anomalous difference
Patterson maps derived from high-energy remote data. The clear predominance of peaks
at sections w=0.33 and w=0.66 indicated that these were Harker sections and, thus, that
a screw symmetry axis was present along c. This confirmed the space group to be either
P3121 or P3221, as previously deducted from the systematic absence of diffraction
indices. Two anomalous scatterers were located (Figure 2.10a). Their positions were
first refined in Patterson space using both CNS and VECREF (CCP4) and plotted onto
the Patterson maps with VECTOR (CCP4) for visual inspection. Phases were then
calculated and refined in SHARP (De la Fortelle and Bricogne, 1997) using native data
up to 3.0!Å resolution and derivative data to 4.5!Å resolution. The refined positions of
the heavy atom substructure are listed in Table 2.6. As a cross-validation, an iterative
approach was followed were phases were calculated from one single scatterer (in this
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case the primary site, site 1 in Table 2.6) and the location of the second scatterer
confirmed through anomalous and isomorphous difference Fourier maps. Neither the
analysis of difference Patterson or Fourier maps revealed any additional sites for
[Ta6Br12 ]
2+ scatterers.
Figure 2.10: Anomalous and isomorphous difference Patterson map at Harker section z=0.33.
a) Anomalous difference Patterson map of the peak wavelength using data between 15 and 6!Å..
Contouring starts at 2#, with contour increments representing 0.5#. The numbering is as Table 2.6. b)
Isomorphous difference Patterson map between inflexion and the native Contouring starts at 1#, with
contour increments representing 0.5#.
Given the ambiguity in space group symmetry remaining at that point (P3121 and
P3221 enantiomeric lattices) and the intrinsic handness uncertainty of the Patterson map,
both direct and inverted positions of heavy atom clusters where assayed in phasing.
Visual inspection of the resulting Fourier maps clearly revealed this crystal form to
belong to the space group P3121. For better assessment of phase quality, the phasing
statistics prior to density modification are summarized in Table 2.7. Phasing based on
the two cluster sites yielded electron density maps, which had clearly identifiable
solvent-protein regions and partially interpretable features upon solvent flattening using
the SOLOMON procedure (Abrahams and Leslie, 1996) implemented in SHARP and
assuming a solvent content of 70%.
Table 2.6: Positions (in fractional coordinates) of heavy atom clusters as refined by SHARP.
X Y Z
Site1 0.5131 0.6076 0.011
Site2 0.1490 0.1710 0.0105
a) b)
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Table 2.7: Phasing statistics prior to density modification calculated using SHARP.
Peak Inflexion Remote
Phasing power (iso/ano) 1.46/1.58 1.34/0.96 1.13/0.87
R-cullis (iso/ano) 0.66/0.71 0.67/0.86 0.71/0.86
Figure of Merit 0.66
(resolution < 4.5 Å)
2.1.10 Density modification
Skeletonization and subsequent skeleton editing of the initial electron density map
calculated using SHARP allowed determining the orientation and position of the
individual domains FnIIIA170 and IgA169. The domain IgA168 could not be located at that
time, but its position was estimated based on that of the neighboring domain IgA169. In
order to improve the quality of the electron density maps, density modification
techniques were applied by imposing theoretical constraints to the density in real space
and by calculating a combined and improved phase estimate (Cowtan and Zhang, 1999).
Two density modification approaches have been particularly helpful in solving the
structure of titin A168-A170: solvent flattening and NCS averaging. Solvent flattening
benefited from the high solvent content in these crystals and used Wang’s method for
the automatic calculation of a solvent mask (Wang, 1985). NCS averaging exploited the
presence of local symmetry in the asymmetric unit. As a complement, histogram
matching was applied in conjunction with these approaches. This adjusted the
experimental protein density distribution to that expected for proteins at this resolution
(Zhang and Main, 1990).
Density modification was carried out with the program DM using initial phases
computed with SHARP (Cowtan, 1994). As a pre-requirement for NCS averaging,
operators for individual domains where calculated using the least square superposition
routine of the program O (Jones, 1991) and three NCS masks covering the individual
domains were created in MAMA (Uppsala Software Suite). The NCS-operators were
refined based on electron density correlation using IMP (Uppsala Software Suite).
Figure 2.11 shows a comparative cross-section of the electron density obtained by
solvent treatment within SHARP and after density modification in DM (solvent
flattening, NCS averaging, histogram matching and phase extension to 3.0 Å).
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Figure 2.11: Projection of z-sections of electron density maps contoured at 1!#.
a) Electron density map after solvent flipping in SOLOMON (SHARP). A solvent-protein boundary is
detectable.
b) DM map after solvent flattening, histogram matching and NCS averaging. After the density
modification steps, a Figure of merit of 57!% (resolution shell 10-3!Å) was achieved. Both projections
include 50 sections along the z-axis. Maps were displayed with mapslicer (CCP4).
2.1.11 Model building and refinement
As a first step towards model building, poly-alanine variants of homologous
structures were manually positioned in skeletonized electron density maps (homologues
are described in chapter 2.1.6) and progressively edited in iterative cycles of model
building and refinement. The structure was refined against native data between 15-2.9!Å
resolution in CNS (Brunger et al., 1998). The R-free was used as a cross-validation
indicator (Brunger 1993), for which reflections were partitioned into a working and a
free set using FREERFLAG (CCP4). Model refinement included overall anisotropic B-
factor scaling, bulk solvent correction, conjugate gradient minimization of atomic
coordinates and grouped B-factor refinement with two B-factor values per residue (one
for the main chain and one for the side chain). Tight NCS restraints were applied during
refinement, where a weight of 500 kcal/(mol*Å2) was applied to geometrical restraints
and B-factor values were restrained to two sigma differences. For the refinement of
initial models, a maximum-likelihood target function taking experimental phases into
a) b)
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account was employed – such phases were excluded at later stages. Solvent atoms were
identified with the water-pick routine of CNS and visually validated in O. In the last
cycles of refinement, NCS restraints were decreased to a weight of 150 kcal/mol*A2 and
excluded residues 142-146 (Ig A169), which were close to a lattice contact point and
adopted different conformations in copies A and B. The final model contained 292
protein residues per chain and 45 solvent molecules. 12 C-terminal residues were not
identified as they were disordered in both NCS copies, while two residues in –1 and –2
position, remnants of the TEV protease cleavage sequence, were modeled. Figure 2.12
shows a progression of the improvement in electron density maps during refinement.
The Ramachandran plot (Ramachandran et al., 1963) is given in Figure 2.13 and final
refinement statistics are summarized in Table 2.8.
Figure 2.12: Improvement of the quality of electron density maps during structure solution.
a) Electron density map calculated using experimental MAD phases prior to solvent flattening
b) Solvent flattened electron density map after SOLOMON.
c) Electron density map after density modification in DM.
d) (2Fobs-Fcalc)!calc map of the refined model.
All maps are contoured at 1 # and the final model is shown.
a) b)
c) d)
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Table 2.8: Final Refinement statistics of titin A168-A170.
Figure 2.13: Ramachandran diagram of the two NCS-related copies of titin A168-A170.
Plot generated using PROCHECK (Laskowski et al, 1993).
2.1.12 Isothermal titration calorimetry (ITC)
Isothermal titration calorimetry is frequently used for the characterization of
macromolecular interactions in solution. It does not require any chemical modification
or immobilization of the interacting components. The released or absorbed heat upon
binding provides the basis for the determination of the binding constant (Ka), the
standard enthalpy/entropy changes ($H0/$S0) in the binding reaction and the
stoichiometry of the reaction (Doyle, 1997).
In this study all data were recorded with the power-compensation calorimeter VP-
ITC (Microcal) at 25°C. The device consists of a reference cell (filled with buffer) and a
sample cell (filled with the macromolecule) both situated in an adiabatic jacket. The
instrument measures the electrical power, which is required to maintain the same
temperature in the sample cell as in the reference cell upon titration with the ligand from
a syringe.
All samples were previously dialyzed against 50!mM Tris-HCl pH 8.0, 20!mM
NaCl. Titrations consisted of 5-7!µl injections of A168-A170 concentrated to 1.4 mg/ml
into MuRF-1166-341 or MuRF-1166-315 solutions at 1!mg/ml and 0.7!mg/ml, respectively (as
Number of reflections in working/ free set 25645 / 1147
Number of protein residues / solvent molecules 584 / 45
R-factor / R-free (%) 21.8 / 27.6
rmsd bond length (Å) / bond angle (°) 0.010 / 1.59
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determined by BCA assay; Brown, 1989). The time interval between injections was
200-300!s. The data were corrected for the heat of dilution by subtraction of the small
constant heat obtained at the end of the titration, where no further binding occurs. All
measurements were done in collaboration with PD Dr. Heiko Heerklotz (Biozentrum
Basel).
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2.2 Results
2.2.1 Structure of A168-A170
The structure of A168-A170 from human titin has been elucidated at 2.9!Å
resolution using X-ray crystallography. A168-A170 comprises two Ig domains (IgA168-
IgA169) and one FnIII (FnA170). The molecule adopts an extended conformation with an
end-to-end distance of ~115 Å, where the two N-terminal Ig lie almost perfectly
coaxial, but the FnIII domain is bent away from the molecular axis (Figure 2.14). The
crystal form used in this study contains two A168-A170 copies in its asymmetric unit.
Figure 2.14: Crystal structure of A168-A170.
Ribbon representation. The insertion loop in IgA169 is displayed in cyan. The inset shows the molecular
conformation schematically.
They are essentially identical in conformation (rmsd 0.68!Å for 288 C! atoms of
the whole molecule, calculated with SPDBV; Guex and Peitsch, 1997), suggesting that
this fragment of titin has a well-defined long-range order and a high degree of stiffness.
Domains IgA168 and IgA169 belong to the I (intermediate)-set of Ig folds (Harpaz and
Chothia, 1994). They share 20% sequence identity and a high structural similarity (rmsd
0.99 Å for 82 matching C! atoms, SPDBV). Both belong to the “N-conserved” type of
127°
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Ig from titin (Marino et al., 2005), characterized by a N-terminal loop cluster
comprising proline residues from "-strand A, a PxP motif in the BC loop and an
extended FG "-hairpin hosting an NxxG sequence.
This Ig type predominates in the Z-disc, the skeletal I-band and the A-band
fractions of titin, but not in its constitutive cardiac I-band. Domains IgA168 and FnA170
show no significant deviation from other equivalent modules across titin, as reflected by
a structure-based sequence alignment of single domains of titin with known structure
(Figure 2.15).
Figure 2.15: Structure-based sequence alignment of titin Ig and FnIII of known structure.
"-Strand composition is shown in yellow, residues at Ig-Ig and Ig-FnIII interfaces are in red and cyan,
respectively. Features characteristic of “N-conserved” Ig (A168, A169, I1, Z1, Z2 and M5) are given in
blue. I91 was formerly I27. Strand nomenclature for Ig as in Harpaz and Chothia, 1994, and for FnIII as
in Leahy et al., 1992. The distinct loop of IgA169 is shown in grey.
IgA169, however, shows a unique 9-residue loop protrusion between "-strands A
and A’ with sequence PKTLEGMGA and adopting in part an !-helical conformation
(Figure 2.15 and Figure 2.16). A loop insertion at this position is not detectable in any
other Ig of titin.
2.2.2 Domain interfaces
The domains of A168-A170 form a tight tandem. They are connected through
one-residue linkers in extended conformation that effectively result in the continuation
of structural elements from one domain into the next. The extended arrangement of the
molecule is characterized by domain interfaces with unusually small buried areas
(Table 2.9) and engaging a minimal number of residues in each domain. Both Ig-Ig and
Ig-FnIII interfaces are void of specific interactions and only involve small hydrophobic
clusters.
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Figure 2.16: Structural superimposition of Ig domains from titin.
Superimposition of Ig domains from titin for which a structural model is available, namely IgA169 (cyan),
IgA168 (green), I1 (magenta; PDB accession code 1G1C), M5 (yellow; 1NCT), Z1 (salmon; 2A38) and Z2
(grey; 2A38). The unique loop insertion of IgA169 is clearly identifiable. The C! atoms of its component
residues are displayed as solid spheres and the sequence given. I91 (formerly I27), which does not belong
to this Ig subgroup and has shorter loop clusters, is excluded from the superimposition to ease
visualization. As the other Ig, I91 does not comprise loop insertions in its N-terminal "-strand region.
Table 2.9: Domain arrangement in poly-domain fragments from titin.
               Opening anglea Torsionb  Distancec              Buried surface area (Å2)
IgA168IgA169            176°       +89° 43.3 Å            212    (.1.4%)
IgA169FnA170 127°                             -- 40.2 Å            308   (.2.0 %)
IgZ1IgZ2XTAL
d 146°   +75° 49.4 Å            160  (.1.4 %)
IgZ1IgZ2RDC/SAXS
d 136°       +85° 44.5 Å            165  (.1.4%)
IgZ1IgZ2Tele
d 167°       +48° 52.4 Å            235  (.2.0%)
a Angle defined by the primary axes of inertia (longitudinal) of consecutive domains;b Angle defined by
the projection of secondary axes of inertia (cross-sectional) of consecutive domains onto a common
plane;c Distance between centers of mass of individual domains; d Crystallographic coordinates for free
Z1Z2 (IgZ1IgZ2XTAL) derive from PDB entry 2A38 (Marino et al., 2006); domain arrangement of Z1Z2 in
solution was calculated from SAXS data and NMR residual dipolar couplings (IgZ1IgZ2RDC/SAXS) as
reported (Marino et al., 2006) and crystal coordinates of Z1Z2 complexed to telethonin (IgZ1IgZ2Tele)
derive from 1AY5 (Zou et al., 2006).
Chapter 2: Evidence for the recruitment of MuRF-1 to titin                                            82
Domains IgA168-IgA169 interact through hydrophobic groups that surround the linker
strand dorsally and ventrally (Figure 2.17a). Given their coaxial orientation, the
interacting residues originate from the linker region (V92, aliphatic portion of E93,
V94) and the C-terminus of "-strand A’ (aliphatic portion of R13, Y14) in the preceding
domain IgA168 and the conserved elements of this Ig type in the following IgA169, namely
the FG turn (F180) and the PxP motif of the BC loop (P128, K127) (Figure 2.15). A
comparison of IgA168-IgA169 and Z1Z2 (the only other Ig doublet of titin structurally
characterized) (Zou et al., 2006; Marino et al., 2006) reveals certain similarities.
Figure 2.17: Domain interfaces in the titin A168-A170 structure.
a) IgA168-IgA169 and b)  IgA169-FnA170 interfaces. Domain color code as in Figure 2.14. Hydrophobic
contributions are shown in green. Selected van der Waals surfaces are displayed. The C!-atoms of
residues in the NxxG motif of the FG "-turns of both IgA169 and FnA170 are shown as spheres. Hydrogen
bonds are indicated by dotted lines.
Also Z1Z2 exhibit an extended conformation, lack specific interdomain contacts
and include a small hydrophobic cluster between modules. As that of IgA168-IgA169, the
cluster of Z1Z2 comprises residues C-terminal to "-strand A’, the BC loop and linker
residues (Figure 2.15). Despite, Z1Z2 displays a different domain orientation
(Table!2.9) and it has a longer, three-residue linker that allows a moderate modular
dynamics (Marino et al., 2006). It can then be concluded that the mere presence of
elements characteristic of the “N-conserved” Ig type does not determine domain
orientations in these doublets. Since the identified interface residues are not conserved
in Ig across titin (Witt et al., 1998), it cannot be predicted how closely the observed
conformations represent those of other tandems. Yet, the overall structural principles of
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Ig arraying revealed by these studies are likely to be generic to the titin filament
(Marino et al., 2005).
The interface of domains IgA169-FnA170 presents a hydrophobic component as that
of IgA168-IgA169 (Figure 2.17b). Similarly, contacts involve "-strand A’ (H111) in the
initial domain IgA169 and the NxxG motif of "-turn FG in FnA170 (K272, F273). However,
in contrast to Ig, the FG turns in FnIII of titin are highly conserved in sequence
(alignment used CLUSTALW; Higgins et al, 1994). FnIII following an Ig domain
within A-band repeats consistently host a conserved residue pair - a charged group
followed by an aromatic (Y or F) - in the variable positions of their NxxG motif
(Figure!2.18). Since these residues are part of the modular interface, a shared
interdomain conformation can be expected for these other Ig-FnIII pairs. Strikingly, the
charges within this motif are distinctly distributed along the 11-domain super-repeats of
the C-zone, where every first FnIII hosts a negative charge and the rest a positive group
(Figure 2.18). Such segregation is not observed in the 7-domain super-repeats of the
preceding D-zone.
In the current crystal structure, the lateral amino group of K272 is not involved in
interactions, suggesting its availability for binding to other sarcomeric proteins. Myosin-
binding protein C (MyBP-C) binds to titin through the first Ig domain of every super-
repeat at the C-zone, thereby possibly aiding the regular polymerization of myosin
filaments (Freiburg and Gautel, 1996). Given that the FG "-turn of FnA170 is located
towards the inter-modular space, its charge might be speculated to contribute to MyBP-
C docking. Interestingly, the FG turns of FnIII domains at other positions within repeats
of the D- and C-zones also exhibit certain conservation of their sequence motifs
(Figure!2.18), suggesting that these might be generically important for FnIII-FnIII
arrangements and/or interactions to other A-band components.
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Figure 2.18: Ig-FnIII domain interfaces in the titin A-band.
Ig and FnIII domains are shown as filled boxes, where Ig domains flanked by FnIII are in brown, FnIII following an N-terminal Ig in grey, other FnIII in white and Ig
followed by another C-terminal Ig in blue. FnA71, the only other FnIII of titin with known structure (1BPV), is in cyan. The two residues in variable positions of the
NxxG b-turn of FnIII domains are displayed. Domain super-repeats are indicated. The pattern of alternating charges is displayed, where red and blue indicate negative
and positive charges, respectively.
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2.2.3 MuRF-1 binding
The surface of A168-A170 reveals a shallow groove at the concave side of the
molecule that spans its full length (Figure 2.19a). Based on SPOTS blots of MuRF-1
peptides, the latter has been proposed to bind titin through a sequence just prior to its
acidic C-terminal tail (Figure 2.20, Witt et al., 2005).
a) b)
Figure 2.19: Surface features of titin A168-A170 and model for MuRF-1 interaction.
a) Surface representation in two related views where green emphasizes the local curvature. A ridge is
present in the concave side of the molecule. The distinct loop of IgA169 is marked; b) Docking of an a-
helical peptide in coiled-coil conformation onto the surface of A168-A170 to satisfy shape
complementarity. The helical peptide shown derives from lamin coil 2B (PDB code 1X8Y).
According to our own analysis (Jpred software; Cuff et al., 1998), the C-terminal
half of MuRF-1 (including the proposed binding sequence) has tendency to !-helical
formation, with its middle section predictably following a coiled-coil association
(Figure 2.20) (COILS; Lupas et al,. 1991).
Both manual examination and docking prediction software (PatchDock;
Schneidman et al., 2005) indicate that the dimensions and geometry of the surface
groove in A168-A170 can well accommodate an !-helix along its length. In particular, a
best docking is obtained if the helix exhibits a long-range bending of its axis as that of
components of a dimeric coiled-coil (Figure 2.19b), like human lamin 2B (Strelkov et
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al., 2004) used as template in this study.
Figure 2.20: MuRF-1 domain composition and constructs used in ITC experiments.
The extent of ring finger, MuRF-specific (MFC) and B-box domains is as reported (Centner et al., 2001).
The helical fraction, including an expected coiled-coil motif, predicted from sequence data is in orange.
The sequence previously identified as primary titin binding site (Witt et al., 2005) is shown as an open
box in blue. The C-terminal acidic tail (AT) is in red.
This suggests that MuRF-1 interacts with titin through an extensive contact area,
involving more than one module. This is in agreement with biochemical data that show
how domains IgA168, IgA169 and FnA170 in isolation are not able to secure MuRF-1 binding
(Center et al., 2001). IgA169 might, however, be central to the interaction. Its unique loop
insertion, located towards the middle point of the groove (Figure 2.19a  and
Figure!2.19b), could be speculated to play a role in MuRF-1 binding or function.
We have confirmed the interaction between A168-A170 and the helical fraction of
MuRF-1 using soluble, recombinant samples. This study used two N-terminally
truncated MuRF-1 constructs, MuRF-1166-341 and MuRF-1166-315 (Figure 2.20), where the
latter lacks in addition the acidic C-terminal tail. Binding monitored by isothermal
calorimetry (ITC) showed that both MuRF-1 variants interacted strongly with A168-
A170, yielding heat release values of 14 and 28 kcal/mol and Kd affinities of 35 and 37
nM, respectively (Figure 2.21). The finding that saturation occurs at a molar ratio of
~0.1 indicates that the MuRF-1 species were only partially active (possibly due to
aggregation) and/or that two or more MuRF-1 molecules bind one A168-A170. Since
Kd values are similar for both constructs, it can be concluded that the acidic tail of
MuRF-1 does not influence binding.
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a.
b.
Figure 2.21: ITC data on MuRF-1:A168-A170 binding.
a) Experimental pattern of injections for MuRF-1166-341; b) Heats of binding for titrations of A168-A170
into MuRF-1166-341 (filled circles) and MuRF-1166-315 (open triangles) recorded in 50!mM Tris-HCl pH 8.0,
20!mM NaCl at 25oC. Both curves show the same Kd and "H and differ only slightly in the active fraction
of MuRF-1.
2.3 Discussion
The muscle filament titin, despite its colossal dimensions, has a simple and
repetitive architecture consisting of linear tandems of Ig and FnIII modules. The
structure of A168-A170 reveals the molecular details of Ig-Ig and Ig-FnIII interfaces,
whose global features are likely to be generic to domain arrangements across titin
(Marino et al, 2005). A168-A170 has a pronouncedly extended conformation and
exhibits a well-defined long-range order with limited conformational freedom. The
latter seems to result from extremely short linker sequences and the presence of small
hydrophobic clusters that restrict the modular orientations. Specific contacts are not
found across any of these domain pairs. Hydrophobic interactions include groups from
similar structural elements in Ig and FnIII modules (Figure 2.15), with residues around
the linker region and the FG #-turn being central in both cases. The observed Ig-Ig
contacts are poorly conserved (Figure 2.15). In agreement, domain orientations in Ig
A168-Ig A169 and Z1Z2 differ somewhat (Table 2.9). On the contrary, sequence
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conservation at the Ig-FnIII interface indicates that this modular conformation might be
common to equivalent pairs from the A-band. It is yet to be established whether the
conservation of interface groups in this case, in particular the FG b-turn of FnIII
domains, might play an additional role in interactions to other sarcomeric proteins –
such as MyBP-C (Freiburg & Gautel, 1996).
A168-A170 recruits MuRF-1 to the M-line region of titin. The specificity of the binding
might be achieved through two idiosyncratic features of this fragment of titin:
i) the topography of a shallow groove spanning the length of its surface and defined by
the long-range domain arrangement of this distinct tandem; and ii) the unique loop
insertion of IgA169 (Figure 2.19).
ITC data show that the titin/MuRF-1 interaction is of high affinity, where the
putatively a-helical region of MuRF-1 (residues 166-315) is sufficient for binding. The
groove in A168-A170 could host up to 70% of the maximal hypothetical coiled-coil
length achievable by MuRF-1, if its full helical region was to form such motif. These
data suggest that the A168-A170 region of titin could serve as a potential therapeutic
target against muscle atrophy, where binding of small molecules to its distinctive
structural features could block access of MuRF-1.
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3 The B-box 2 domain of MuRF-1
Abstract
The B-box motif is the defining feature of the TRIM family of proteins,
characterized by a RING-finger/B-box/coiled-coil tripartite fold. We have
elucidated the crystal structure of the B-box type 2 (B2) from human MuRF-1 at
1.9!Å resolution. MuRF-1 is an E3 ubiquitin ligase involved in myofibril turnover
and the regulation of the trophic state of muscle. The structure of MuRF-1 B2
shows that this motif has an a/b architecture, which coordinates two zinc ions in a
cross-brace topology, thus, belonging to the RING finger-like superfamily. MuRF-
1 B2 adopts a distinct dimerization pattern as revealed by crystallographic and
NMR data, which differs from that of other dimeric RING finger-like structures.
Our findings  represent the molecular basis of B2 contribution to TRIM self-
assembly. By analysis of surface features we identify a long shallow grove
encircling the C-terminal metal binding site that contains a group of conserved
hydrophobic residues which potentially mediate protein-protein interactions of
this motif. Finally, we have comparatively analyzed the RING finger-like folds
including RING-fingers, PHD, U-box, FYVE, ZZ domains, B1 and B2 boxes. This
reveals the extent of shared structural features among these, otherwise highly
variable, folds and allows inferring the distinctive features of the B2 class of B-
boxes.
The B-box 2 domain of MuRF-1 is a dimeric RING-finger                                          91
3.1 Materials and Methods
3.1.1 Cloning
The coding sequence for human MuRF-1 B-box (residues 105-149) was cloned
into the vector pETM11, a variant of pET24d (Novagen) containing an N-terminal His6-
tag and a TEV protease cleavage site prior to the cloned gene. A B2C21D mutated variant
was engineered in pETM-11 using the QuikChange protocol (Stratagene) and primers
5’-CATCTACTGTCTCACGGACGAGGTGCCCACCTGC-3’ (forward)  and 5’-
GCAGGTGGGCACCTCGTCCGTGAGACAGTAGATG-3’ (reverse).
3.1.2 Protein production
Protein production used E.!coli BL21(DE3) Rosetta (Novagen). Cultures were
grown at 37°C up to an OD600 of 0.6 in Luria Bertani medium supplemented with 25
µg/ml Kanamycin and 34 µg/ml chloramphenicol. Protein production was induced with
0.2!mM isopropyl-ß-D-thiogalactopyranoside (IPTG) and growth continued for further
18 hours at 25°C. For successful protein folding, media were supplemented with 50 µM
ZnCl2 upon induction. Cultures were harvested by centrifugation at 2800 g and 4°C for
40 minutes. Pellets were resuspended in 50 mM Tris-HCl pH 8.0, 100 mM NaCl, 10
mM #-mercaptoethanol in the presence of a protease inhibitor cocktail (Boehringer).
Lysis was by addition of 0.1!mg/ml lysozyme and French pressing at 1500 psi and 4°C.
DNAse and RNAse were added to a final concentration of 5!µg/ml. The homogenate
was clarified by centrifugation and the supernatant applied to a Ni2+-chelating HisTrap
column (GE Healthcare) equilibrated in lysis buffer supplemented with 20!mM
imidazole. Elution used 250 mM imidazole. The elutant was dialyzed against 50 mM
Tris-HCl pH 8.0, 150 mM NaCl, 10 mM #-mercaptoethanol in the presence of TEV
protease at 4°C for 16 h. Subsequent purification was by reverse metal affinity
chromatography on a HisTrap column followed by gel filtration on a Superdex 75
Hiload 16/60PG column (GE Healthcare) equilibrated in lysis buffer (Figure 3.1a and
Figure 3.1b). This procedure yielded 1-3 mg of soluble, pure protein per litre of
bacterial culture. Finally, samples were concentrated to 10!mg/ml as determined by
BCA assay. It should be noted that zinc was only added during expression and that no
zinc was present in the solutions during the purification and crystallization steps.
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b)
Figure 3.1: Purification of MuRF-1 B-box wildtype and C21D mutant.
a) Size exclusion run of B-box proteins on Superdex75 (16/60PG) equilibrated in 50!mM Tris, 150!mM
NaCl and 10!mM #-Mercaptoethanol. A large portion of the soluble protein elutes in the void and is
highly aggregated (black curve). The two peaks in the profile correspond to a dimeric protein (peak1) and
an unfolded species (peak2) as identified by NMR spectroscopy (Figure 3.2).
b) SDS-PAGE of wildtype B-box. Fractions 1-6 correspond to protein in the void. Fraction 7-10
correspond to the first peak, fraction 11-14 to the second peak in the elution diagram shown in a). A
polypeptide standard is shown in lane M (Mw(WT)=5010 Da).
Interestingly, both peaks1 and peak2 in Figure 3.1a contained B-box peptide
(black curve). Since The B2 domain of XNF-7 was reported to be monomeric (Borden
et al., 1995), fractions of peak2 were pooled and used in crystallization experiments due
to the lower apparent oligomerization state. The protein so obtained crystallized in
initial crystallization screens.
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a)
b)
c)
Figure 3.2: 1D-NMR spectra of soluble MuRF-1 B-box 2 wildtype and refolded C21D mutant.
1D-NMR spectrum of a) WT native peak 1, b) C21D mutant peak2, c) C21D mutant peak 1. The 1D
spectrum of soluble WT protein peak 1 fractions shows identical resonances to the refolded C21D mutant
peak 1. The spectrum of refolded C21D peak2 material is indicative of an unfolded state. Peak numbering
as in Figure 3.1.
Expression of the B2C21D variant (as described for the wild-type) yielded mostly
insoluble material. Only a small soluble fraction of B2C21D eluted as one peak from the
size exclusion column at an elution volume corresponding to peak2 of wildtype (blue
curve in Figure 3.1). Thus, bacterial pellet resuspended in lysis buffer (see above)
supplemented with 8!M urea was subjected to affinity purification under denaturing
conditions. Eluted fractions were dialysed overnight into a refolding buffer containing
50 mM Tris pH 8.0, 150 mM NaCl, 10!mM #-mercaptoethanol, 1!mM ZnCl2. Refolded
protein was applied to a gel filtration column equilibrated in refolding buffer. Pure
samples were then concentrated to 10!mg/ml.
1H NMR spectroscopic analysis of both peak fractions of the refolded material
revealed that peak1 represents a well-folded dimeric protein (Figure 3.2c), whereas
peak2 corresponds to an unfolded protein population (Figure 3.2b). Subsequent NMR
investigation of protein corresponding to WT peak1 indicated a well-folded species
WT peak 1
C21D peak 2
C21D peak 1
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(Figure 3.2a). Most likely, the pooled protein fraction of WT peak2 used initially to
crystallize the protein still contained enough material of peak1 to form crystals. In line
with the predominantly unfolded material present, large amounts of amorphous
precipitate have been observed in hanging drops. Moreover, pooled fractions from C21D
peak2 did not result in crystal formation, while screens with peak1 containing fractions
yielded a higher number of initial hits.
3.1.3 Crystallization
Untagged protein was present in 0.05 M Tris pH 8.0, 0.15 M NaCl and 10 mM #-
mercaptoethanol at a concentration of 10 mg/mL as determined by the BCA assay. The
reducing agent was present to avoid protein oxidation by the sulfhydryl goups involved
in zinc ligation. DTT was avoided since the bipartite thiol groups in DTT can efficiently
compete with the protein for a loosely bound zinc atom. Initial crystallization conditions
were found using the Personal structure screen PSS-I-32 (Molecular Dimensions).
Crystals grew from solutions containing 1.8!M ammonium sulfate, 0.1 M Tris pH 8.5 in
hanging-drops composed of 1µl protein and 1µl reservoir solutions suspended over
500!µl mother liquor in Linbro trays. Hexagonal crystals with typical dimensions of
200x200x100 µm3 grew within two days at 4 °C (Figure 3.3). These were often affected
by macro-twinning, which was detectable by visual inspection. To avoid cluster
formation, the rate of diffusion within the drop was reduced by addition of varying
amounts of glycerol together with lowering the temperature to 4°C. A large fraction of
the protein aggregated in form of amorphous precipitate (see above). After refinement,
the reservoir condition contained 1.8!M Ammoniumsulfate, 0.1 M Tris pH 8.5, 15!%
glycerol. Crystals were carefully selected by visual inspection to avoid macro-twinning
and finally yielded interpretable diffraction patterns.
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Figure 3.3: Refined conditions of MuRF-1 B-box crystals.
Single hexagonal plates of 200x200x100!µm3 grew within three days under conditions 1.8!M
Ammoniumsulfate, 0.1 M Tris pH 8.5, 15!% glycerol at 10 mg/mL protein concentration.
3.1.4 Data collection of the high resolution set
Cryo-cooled crystals used for structure determination diffracted up to 1.9!Å in a
synchrotron beam at the Swiss Light Source beamline PX1. Diffraction patterns were
recorded on a marCCD detector (MAR Research). Due to the presence of structural Zn
ions, the “pseudo” native data set was collected at a wavelength of $Native=1.008!Å
(12.300 keV) that was well above the absorption edge of the Zn to avoid anomalous
contribution and increased radiation damage.
During data collection often split spot profiles were observed and the presence of
a second crystal lattice was suspected. Several crystals were tested and finally it was
possible to index the crystal in space group P61/522 with unit cell dimensions of a=
76.92 Å, b= 76.92 Å and c=146.92 Å. All data were integrated, scaled and merged with
the XDS package (Kabsch, 1993). The mosaicity as estimated by the program was
0.135. The presence of a 61 or 65 screw axis was indicated by systematic absences in 00l
reflections. Table 3.1 describes the statistics of the high-resolution set and Figure 3.4
shows a representative diffraction image.
100 µm
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Table 3.1: X-ray data of the high resolution set
Native set
Xray source SLS-PX1
Detector MAR-CCD
Resolution 18-2.0 (2.1-2.0)
Wavelength 1.008 (12.300 keV)
Unique reflections 17628 (2333) 
R-factor 6.7 (25.5)
Multiplicity 10.4 (10.7)
Completeness 99.2 (99.3)
I/% (I) 22.74 (11.31)
Figure 3.4: Diffraction pattern of MuRF-1 B-box crystals.
Crystals of MuRF-1 B-box diffracted to 1.9 Å in a synchrotron beam. The space group was identified as
P6522 with unit cell parameters of a=b=76.21 Å, c=146.59 Å, !=#=90°
 ,  &=120°.
1.9 Å
1.8 Å
2.4 Å
3.7 Å
7.9 Å
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Calculation of the Matthew coefficient led to the assumption that the asymmetric
unit of this crystal must contain three to six copies (Table 3.2), most likely four based
on a value of VM=2.8. A search for non-crystallographic relationships was carried out
using the programs AMORE (Navaza 1994), and POLARFN (CCP4) between a
resolution of 15-4 Å.
Table 3.2: Calculation of the Matthews coefficient.
Number of molecules VM [Da
3/Da] Solvent content [%]
3 3.7 66.7
4 2.8 55.6
5 2.2 44.5
6 1.9 33.4
Space group and Unit cell dimensions: P61/522: a=b=76.21 Å, c=146.59 Å, !=#=90
', &=120'.
The Matthews coefficient VM is calculated with VM=V/Mw*Z*N.
V: unit cell volume (737324.812 A3)
Mw: molecular weight of a B-box monomer (5010 Da)
N: number of molecules/ASU, Z: ASU/unit cell
Z: 6 for space group P6
A partial specific volume for proteins of 0.74 cm3*g-1 can be assumed.
A distance distribution was calculated with the program MOLEMAN (CCP4)
from the existing model of XNF B-box yielding a maximum distance in the monomer of
31!Å. Thus a Patterson radius of integration of 20!Å was used as parameter in for the
self-rotation function. No clear NCS peaks could be identified with both programs. The
small overall dimensions of the molecule might lead to a weak correlation in self-
rotation searches.
3.1.5 MAD data collection
Anomalous diffraction data were collected at the ESRF beamline ID-23,
exploiting the anomalous scattering properties of the B-box’s endogenous zinc ions. An
X-ray absorption spectrometry scan was performed prior to the data collection to
determine the absorption edge of the anomalous scatterer. A clear fluorescence signal
indicated the presence of the anomalous scatters. A plot of anomalous scattering factors
against the beam energy yielded the exact wavelengths for the experiment (data not
shown). Figure 3.5 shows a theoretical plot. Based on the diagram, a three wavelength
anomalous dispersion experiment was carried out at the Zn K-edge in the order peak,
high energy remote and inflexion ($peak =1.28270 Å (9.6602 keV), $inflection =1.28315
(9.6624keV), $remote =1.21555 (10.200!keV). The exposure time was increased during
The B-box 2 domain of MuRF-1 is a dimeric RING-finger                                          98
data collection ranging from 0.1 s for the peak, 0.15 s for the remote and 0.2 s for the
inflexion wavelength.
Figure 3.5: Real (f’) and the imaginary (f’’) components of the anomalous scattering at zinc.
From the plot the wavelengths for the MAD experiment can be derived. For the MuRF-1 B-Box crystal
the wavelengths were used: $peak = 1.28270 Å (9.6602 keV), $inflection = 1.28315 (9.6624keV), $remote =
1.21555 (10.200!keV). Wavelengths used in the MAD experiment are indicated.
An oscillation range of "( = 0.75° was chosen for all three sets and for every
wavelength 105° degree were collected in 140 frames aiming at maximal redundancy.
Table 3.3 describes the crystallographic statistics.
Table 3.3: X-ray data of the MAD set.
Xray source ESRF-ID-23-1
Detector ADSC Quantum Q210
Peak Inflexion Remote
Resolution (Å) 20-3.35 (3.4-3.35) 15-3.45 (3.5-3.45) 15-3.5 (3.55-3.5)
Wavelength (Å) 1.2546! (9.6602!keV) 1.28315 (9.6624 keV) 1.21555 (10.200 keV)
No. Bijvoet reflections 33994 (1556) 31059 (1347) 29580 (1216)
Rsym (I) (%) 11.1 (42.6) 10.6 (41.6) 12.9 (47.5)
Multiplicity 3.9 (3.9) 3.7 (3.7) 3.9 (3.9)
Completeness 98.8 (99.7) 98.2 (99.4) 98.2 (98.9)
I/% (I) (%) 9.8 (3.5) 10.1 (3.5) 9.2 (3.1)
Friedel pairs are treated as different reflections
All data were collected under cryogenic conditions and processed with the XDS
package (Kabsch, 1993). A first estimate of the anomalous difference signal was
obtained after scaling the data in XDS. A comparison between the mean intensity error
of symmetry related reflections assuming the situation that Friedel’s law is valid versus
the situation that symmetry-related reflections do not have the same intensity due to
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anomalous contribution revealed the presence of anomalous scatterers in the crystal
(Table 3.4).
Table 3.4: Estimation of anomalous signal with XDS.
Wavelength S_norm/S_anoa
Native (reference) 1.11 (1.01)b
Peak 1.27 (1.02)
Remote 1.22 (1.02)
Inflexion 1.16 (1.01)
aS_norm: mean value of Sigma(I) for acentric reflections assuming Friedel’s law is valid.
 S_ano: mean value of Sigma(I) for acentric reflections assuming Friedel’s law is violated.
 Anomalous scattering contributions to the intensities are indicated by S_norm/S_ano >1
btotal between 16-2.1 Å; in brackets highest shell 2.2-2.1 Å.
3.1.6 Determination of heavy atom sub-structure and phase calculation
The subsequent steps in the structure elucidation of MuRF-1 B-box aimed at the
determination of heavy atom positions to obtain experimental phase information. Thus,
a heavy atom search was carried out using the program SOLVE (Terwilliger, 1999).
Input files for the three wavelengths contained the raw, unmerged intensities of the three
wavelength MAD experiment. The program SOLVE searches for heavy atoms using
difference Patterson methods and scores potential solutions on the basis of agreement
with the Patterson map, the difference Fourier map, the presence of solvent and protein
regions in a native electron density map, and the Figure of merit of phasing.
Given the presence of at least three to six molecules per asymmetric unit as determined
from the Matthew coefficient a search for eight Zn sites was carried out using data
between 18 to 2.3!Å resolution. Theoretical f’ and f’’ values were used at the
corresponding wavelengths. The program unambiguously determined the coordinates of
six Zn ions in the asymmetric unit that are summarized in Table 3.5. Figure 3.6 shows
the harker peaks in anomalous difference Patterson maps.
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Table 3.5: Real space positions of the six  Zn-sites in the asymmetric unit.
Table 3.6 shows the phasing statistics after the SOLVE run, which yielded the
initial electron density maps.
Table 3.6: Phasing statistics prior to solvent flattening.
Resolution Total 7.81 5.09  4.03  3.44  3.04  2.76  2.55  2.37
Reflections 11772  678 1014  1268  1454  1618  1779  1908  2053
Figure of Merit 0.81 0.88 0.86  0.90  0.88  0.84  0.78  0.76  0.68
X Y Z Peak height
ATOM 1  Zn 40.895 56.067 5.419 45.81
ATOM 2  Zn 11.910 8.324 0.480 51.77
ATOM 3  Zn 44.075 41.235 10.850 45.79
ATOM 4  Zn 10.545 24.737 9.954 40.07
ATOM 5  Zn 20.903 25.421 6.534 43.73
ATOM 6  Zn 42.283 35.630 1.606 35.13
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Figure 3.6: Experimental anomalous difference Patterson maps at P6522 Harker sections.
The Maps were calculated with FFT (CCP4) and heavy atom coordinates superimposed with the program
vector (Evans, 1990). A contour level of 1.5 % is shown with an increment of 0.5 %. Peaks are found at
Harker sections w=0.33 and w= 0.17 as well as three sections below Harker level at w=0.30.
The initial maps were density modified assuming a solvent content of 50% with
the program RESOLVE (Terwilliger, 2000; Terwilliger, 2002). Resolve uses a
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maximum-likelihood approach to do solvent flattening, while other methods modify a
map to meet expectations and the obtained new phases are recombined with
experimental phases. In RESOLVE the correlation between the experimentally available
and the expected map is maximized in a simultaneous manner by statistical methods. A
process called prime and switch phasing is applied to reduce model bias (Terwilliger,
2000). Resolve also carries out an automatic model building. At first elements of
secondary structure are built, which are then extended by addition of tri-peptide
fragments followed by the building of side chains according to a given sequence. The so
obtained model (after RESOLVE; Table 3.7) was directly used for automated model
building and refinement with the program ARP/wARP (Lamzin and Wilson, 1997) and
REFMAC (Murshudov, 1997). Non-crystallographic symmetry was neglected during
the building.
Table 3.7: Phasing statistics after solvent flattening with RESOLVE
Acentric reflections
 DMIN FOM-Prior FOM-Map FOM-
Total
CC-Prior-
Map
Fraction Prior <m> total    N
 ALL:  0.83 0.70  0.89    0.72    0.66    0.89 9356
  6.6  0.92 0.88  0.98    0.82    0.60    0.98  306
  4.1  0.91 0.88  0.97    0.82    0.57    0.97 1172
  3.3  0.91 0.87  0.97    0.84    0.61    0.97 1551
  2.9  0.87 0.76  0.93    0.78    0.67    0.93 1615
  2.5  0.79 0.62  0.86    0.67    0.67    0.86 2878
  2.3  0.71 0.49 0.77    0.53    0.68    0.77 1834
3.1.7 Model building
The structure of MuRF-1 B-box domain was automatically built with the program
ARP/wARP (Lamzin and Wilson, 1997) using the warpNtrace procedure shown in
Figure 3.7.
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Figure 3.7: Schematic description of the option warpNtrace in ARP/wARP.
The steps of automated model building in ARP/wARP. For MuRF-1 B-box the initial steps were carried
out in the SOLVE/RESOLVE package and a starting model was already available after RESOLVE
(Figure taken from Morris, 2000).
This procedure initially positions unconnected atoms into the electron density and
then searches for protein-like patterns by applying stereochemical constraints to build
the main-chain. In an iterative procedure the existing model is updated by the density-
based addition of more and more atoms in real space and fitting of the calculated and
observed structure factor in reciprocal space.
The structure was built in 10 consecutive cycles of automatic model building and
refinement using REFMAC against a data set with a resolution of 1.9 Å. Three
monomers were build in the asymmetric unit. The progress of rebuilding and refining
was monitored by the decrease in the R-factor and the R-free as well as by inspection of
%a-weighted 2Fobs-Fcalc maps. Finally the solvent model was build in ARP/wARP
running in solvent mode and was manually completed in O in a Fobs-Fcalc map that was
contoured at 3.5!%. Finally the data were refined against a data set that contained data to
1.9 Å resolution. The presence of two zinc ions in each of the three NCS-related
monomers in the asymmetric unit is evident in an anomalous difference Fourier map
Resolve Model
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after RESOLVE contoured at 4!% using the peak data (Figure 3.8a). The quality of the
final 2Fobs-Fcalc is shown in Figure 3.8b.
Figure 3.8: Electron density map after RESOLVE and final 2Fobs-Fcalc map.
a) Electron density at 2.3 Å resolution after RESOLVE is shown in grey contoured a 1.5!% . An
anomalous difference Fourier map contoured at 4!% confirms the presence of two zinc ions in the fold.
The metal ligating residues are shown as stick and zinc ions are shown as spheres. b) Final 2Fobs-Fcalc map
at 1.9 Å resolution contoured at 1.5 %.
The final Rfactor was 21.6 and the Rfree was 25.6 excluding 853 (5% of the unique
reflections as test set). The refinement statistics can be found in Table 3.8.
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Figure 3.9: Ramachandran plot for three molecules of MuRF-1 B-box in the asymmetric unit.
All protein residues are located within the colored areas (apart from Gln47) indicating allowed values for
( and ) angles. The plot was calculated with the program PROCHECK.
Table 3.8: Final Refinement statistics
The structure was analyzed with the program PROCHECK. Only one residue was found
to be in disallowed regions in all three NCS copies (Figure 3.9).
Number of reflections in working/ free set 19667 / 853
Number of protein residues / solvent molecules 139/145
Number of Zn atoms 6
R-factor / R-free (%) 21.2 / 25.5
rmsd bond length (Å) / bond angle (°) 0.012 / 1.47
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3.1.8 Crystal packing and Dimeric arrangements
After determining the position of the heavy atoms with SOLVE, it became clear
that three molecules per asymmetric unit are present in MuRF-1 Box!2 crystals. These
NCS copies are referred to as A, B, C. Given the proposed dimerization propensity of
XNF B-box (Borden 1995), crystal packing and NCS were analyzed for potential and
physiologically relevant dimeric interactions. Based on the orientation, distance and
interface area of molecules A and B in the asymmetric unit a NCS related dimerAB was
identified. A second interaction resulted from the crystallographic relation between
NCS copies C and B’ across different asymmetric units, termed dimerBC. Figure 3.10
shows the interrelationship of crystallographic and NCS-related dimer.
Figure 3.10: Crystallographic and NCS interactions in MuRF-1 B-box crystals.
Two dimeric arrangements based on orientation, distance and interface area of monomers are
characterized by either non-crystallographic two-fold symmetry between NCS copies A and B or
crystallographic 2-fold symmetry between NCS monomers C and B’ of adjacent asymmetric units (dotted
lines). NCS copies in the asymmetric unit: A (green), B (cyan) and C (magenta).
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3.1.9 Crystallization and data collection of the C24D mutant of MuRF-1 B-box
Protein crystals of mutated B-box grew in form of thin long needles of 400x20x20
µm3 in condition PSS-I-32 (Molecular dimension) containing 1.8!M Ammoniumsulfate,
0.1!M Tris pH 8.5 (Figure 3.11). The final condition included additionally 5 %
glycerole. Crystals appeared after five days at 4°C.
Figure 3.11: Refined condition of C21D mutant of MuRF-1 B2 crystals.
Single long needles of 400x20x20!µm3 grew within five days under conditions: 1.9!M Ammoniumsulfate,
0.1 M Tris pH 8.5, 5!% glycerol at 10 mg/mL protein concentration.
Data on MuRF-1 B-box crystals were collected in house using an Eliot GX20
rotating disc anode. This source yielded X-rays with a wavelength of $=1.5418!Å. The
detector was a MAR345 (X-ray Research) image plate detector. Crystals were exposed
for 1h per frame in 1° oscillations. In total 120 frames were recorded at cryogenic
temperature (100K). The data were processed with the XDS package (Kabsch, 1993).
The crystal lattice could be indexed assuming a primitive orthorhombic cell with cell
dimensions of a= 60.8 Å, b=66.9 Å, c=77.4 Å and !=#=&=90°. The diffraction limit
was 3.4!Å. Table 3.9 shows the overall statistics of data collection on B-box C24D
crystals.
Calculation of the Matthew coefficient indicated that between three (VM= 4.8
[Å3/Da]; 74!% solvent content) and eight (VM= 1.8 [Å
3/Da]; 31!% solvent content)
copies can be expected in the asymmetric unit.
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Table 3.9: Overview of data collection on B-box mutant C24D.
Xray source Eliot GX20
Detector MAR-345 image plate
Resolution 15-3.4 (3.5-3.4)
Wavelength 1.5418 Å (8.040 keV)
Unique reflections 4542 (365)
R-factor 16.5 (28.3)
Multiplicity 3.4 (3.5)
Completeness 97.2 (96.6)
I/% (I) 7.8 (4.75)
3.1.10 Phase determination and Model building
The structure of the B-box was phased by molecular replacement with the
program PHASER (Storoni et al., 2004) using the NCS related dimerAB as search
model.
The PHASER output model was subsequently refined with CNS (Brunger et al., 1998)
in the absence of zinc ions against the 3.4!Å data set. The model for refinement was
characterized by an Rfactor of 35!% and and Rfree of 38!% (4.5!% reflection in test set).
Conjugate gradient and grouped B-factor refinement against a maximum likelihood
target function improved the model to an Rfactor of 27.4 % and an Rfree of 35.8!%.
Inspection of 2Fobs-Fcalc electron maps for the presence of two zinc was carried out with
the program O (Jones et al., 1991). Table 3.10 summarizes the statistics of refinement.
Table 3.10: Refinement of MuRF-1 B-box C21D mutant.
3.1.11 NMR experiments
Uniformly 15N-labelled wild-type B2 protein was derived from M9 minimal
medium using 15NH4Cl as the sole nitrogen source. Otherwise, expression protocols
were as above. In this case, only insoluble sample was obtained presumably due to the
formation of Zn3(PO4)2 and the absence of soluble pools of zinc from the medium. Thus,
refolding and purification protocols as those described above for B2C21D were followed.
Number of reflections in working/ free set 3988 / 208
Number of protein residues / solvent molecules 285 / -
Number of Zn atoms 12
R-factor / R-free (%) 30.3 / 36.6
rmsd bond length (Å) / bond angle (°) 0.009 / 1.52
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NMR spectra were recorded at 3!mM sample concentration in 20!mM Tris-HCl at pH
7.0, 75!mM NaCl, 10!mM ß-mercaptoethanol. The appearance of 1H-15N HSQC NMR
spectra was consistent with a well-structured sample. The oligomeric state of the sample
was estimated from 1H T2 spin echo relaxation measurements as well as 
15N T1, T2 and
15N-heteronuclear NOE data (Barlow et al., 1994). The protein backbone 15N and 1H
resonances were assigned with 15N separated NOESY and TOCSY spectra. Residual
dipolar couplings (RDCs) were measured in a solution of 1!mM protein dissolved in 20
mM Tris pH 7.0, 75 mM NaCl and 10!mM ß-mercaptoethanol supplemented with Pf1
phage (ASLA Biotech) (Hansen et al., 1998) to a final phage concentration of
15!mg/ml. The electrostatic alignment was tuned down by the addition of NaCl to a
final concentration of 150!mM NaCl. Inter-subunit NOEs to residue F32 were identified
with a 2D NOESY spectrum with a mixing time of 100!ms. All spectra were recorded
on a BRUKER DRX 600 equipped with a TXI probe and on a BRUKER DRX 800
spectrometer equipped with a TCI cryoprobe. Data were processed with NMRPipe
(Delaglio et al., 1995) and analyzed with PIPP (Garrett et al., 1991).
3.2 Results and Discussion
3.2.1 Crystal structure of MuRF-1 B2
The crystal structure of the B2 box from human MuRF-1 has been elucidated at
1.9!Å resolution. The crystal form used in this study contains three molecular copies in
its asymmetric unit (chains A, B and C) that are basically identical (average rmsd is
0.30 Å for 43 matching C!  atoms as calculated using SPDBV; Guex and Peitsch,
1997). MuRF-1 B2 consists of a structural core formed by a !-helix (!1) that packs
against a three-stranded anti-parallel #-sheet (#1-#3). This core supports three dominant
loop regions (L1, L2, L3) involved in zinc binding (Figure 3.12). Anomalous difference
Fourier maps unambiguously revealed that each molecular copy of B2 binds two zinc
ions. Metal ligation is mediated by a “cross-brace” topology closely related to that of
RING finger domains (Kentsis and Borden, 2000), where zinc-binding site I (ZnI) is
formed by the first and third ligand pairs and zinc-binding site II (ZnII) by the second
and fourth ligand doublets.
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Figure 3.12: Structure of B2 and B1 boxes.
a) Structure of MuRF-1 B2, where metal binding ligands have been displayed. The N- and C-terminal
zinc ions are shown in blue and red, respectively. Secondary structure elements and loop regions are
labelled; b) Superposition of MuRF-1 B2 (cyan), ATDC B2 (PDB entry C2SV) (green) and MID1 B1
(PDB entry!2FFW) (blue). The B2 boxes show a close structural similarity. Loop insertions in the B1
class with respect to B2 sequences are shown in red; c) Structure-based sequence alignment of B-boxes of
known structure. Secondary structure elements and loop regions are indicated and coloured as in a).
Metal ligands are highlighted in black, numbered and coloured according to the metal site they form. The
cross-brace topology is indicated.
In MuRF-1 B2, site ZnI is constituted by residues C6xxH9 from the N-terminal
L1 loop and C26xxC29 spannig the C-terminus of strand #2 and N-terminus of helix
!1. Site ZnII involves C18xxC21 and H35xxC38 located in L2 and L3, respectively
(Figure 3.12a and Figure 3.12c). The C-terminal cysteine ligand, C38, is a unique
feature of human MuRF proteins. This residue is a conserved histidine in all other B2
boxes, but the possible functional implications of this substitution are currently
unknown. Overall, MuRF-1 B2 constitutes a compact, spherical structure with an inter-
zinc distance of ~11!Å, currently the shortest among RING-related domains.
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The fold and zinc ligation properties of MuRF-1 B2 resemble those of MID1 B1
(Massiah, 2006) and ATDC B2 (PDB 2CSV) (Figure 3.12b), but differs strongly from
those described for B2 from XNF7 (Borden et al., 1995). The latter adopts a topology
unique among zinc-binding folds and coordinates one single zinc ion leaving four
potential metal ligands unoccupied. The B2 boxes of XNF7 and MuRF-1 share 24%
sequence identity and the position of all zinc ligands is conserved (Figure 3.12c). Thus,
the structural differences in these domains are surprising. In order to investigate
whether such divergence could derive from the presence of an unusual zinc-ligand
aspartate (D20) in XNF7 B2 leading to altered zinc binding properties, we analyzed a
C21D mutated variant of MuRF-1 B2 (B2C21D). This was expected to mimic the zinc
ligation properties of XNF-7. However, 1H-NMR experiments showed that both MuRF-
1 wild-type B2 and its B2C21D variant shared a high spectral similarity indicative of
common structural features. This was confirmed by a subsequent crystallographic
analysis of B2C21D, which demonstrated that an aspartate residue at this position does
neither disrupt the zinc binding properties of the B2 fold nor affects its topology. This
conclusion is supported by the recent model of ATDC B2 (PDB 2CSV), which also
contains an aspartate residue at this position and exhibits structural features closely
related to those of MuRF-1 B2 (Figure 3.12b). Thus, a further examination of XNF7
B2 directed to elucidate the source of this discordance is prompted.
3.2.2 Oligomeric state of MuRF-1 B2
The crystal forms of wild-type MuRF-1 B2 and its variant B2C21D contained
identical dimeric formations in their asymmetric units. In order to investigate whether
these represent the oligomeric state of the B2 motif in solution, we analyzed both
samples by NMR-spectroscopy. The correlation time *c at 25 °C estimated from 1H T2
as well as a complete set of 15N relaxation data was 6 ns, corresponding to a molecular
weight (Mw) of +12 kDa, approximately twice that of a B2 monomer (Mw = 5.5 kDa)
confirming that the molecule is dimeric in solution.
To assess whether the structure of the dimer in solution corresponds to that in the
crystalline state, models were compared to experimental 15N-1H residual dipolar
couplings (RDCs) recorded from weakly aligned samples in a solution containing Pf1
phage. RDC data were fitted to i) monomeric models, ii) the dimer observed in the
crystallographic asymmetric unit and iii) one additional dimeric form that arises in the
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lattice by effect of crystallographic two-fold symmetry (Figure 3.13a). RDC
measurements agreed excellently with the tertiary structure of the monomer (quality
factor Q=0.21; Q-factor definition as in Cornilescu et al., 1998) indicating that the
crystal structure of MuRF-1 B2 closely represents that of the protein in solution. The
fitting of RDCs to dimeric models unambiguously identified the dimer in the
asymmetric unit (Q=0.22), and not that generated by crystallographic symmetry
(Q=0.64), to agree with the quaternary structure of the sample in solution. It should be
noted that the Q-factor value of this dimer was nearly identical to that calculated from
fits to a single protomer. Furthermore, monomeric spectral species could not be
observed in a dilution series of the sample monitored by NMR. Since the sample
remained fully assembled at the minimal concentration assayed of 20!µM, the Kd of the
interaction must be well below that value. Equivalent results were obtained from B2C21D
samples, proving that the substitution of the zinc-ligand at that position does not affect
the dimerization properties of the motif. The stable dimerization of this domain as
measured by NMR points to a physiological role of the B2 motif in the self-assembly of
MuRF-1.
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Figure 3.13: The dimeric structure of MuRF-1 B2
a) Fitting of 1H15N RDC data to the crystal structures of the monomer (upper panel), the dimer in the
asymmetric unit (middle) and the dimer formed by two-fold crystallographic symmetry (bottom). Q-
factors below 0.25 are expected for fittings of high resolution crystal structures (Cornilescu, 1998); b)
Intersubunit NOEs (16 in total) measured between protons of F32 and neighbouring hydrophobic residues
are shown as dashed lines; c) Surface representation. The groove encircling the metal site ZnII is
indicated. The exposed side chains of hydrophobic residues are coloured green and the conserved
aromatic Y17 is labelled. d) Interface contacts in the crystal structure of dimeric MuRF-1 B2.
Hydrophobic groups are shown in green and highlighted using van der Waals spheres. Polar interactions
are given as dashed lines.
3.2.3 Structure of the MuRF-1 B2 dimer
The dimeric structure of MuRF-1 B2 exhibits a two-fold symmetry, where the !1
helix of one subunit packs against a concave depression formed by the !-helix and #-
sheet of the other (Figure 3.13b). The interface contains both hydrophobic and polar
interactions, which are mediated by groups of sequential residues that form segregated
clusters in space (Figure 3.13d). Inter-subunit polar contacts are primarily established
by a charged sequence segment, D11-N15, located at the N-terminal L1 loop and just
prior to strand #1 (Figure 3.12d). This generates a salt bridge, D11-K13, and a
hydrogen bonded pair, E12-N15. One additional polar contact is that established by the
mutual packing of residues S27 from the !1 helices of each subunit. Hydrophobic
interactions involve residue I16 in strand #1 and the sequence V40-A41-P42 in strand
#3 of one subunit, which pack against the hydrophobic side of the amphipathic helix
!1, comprising M28 and the C-terminal flanking group F32, in the other. These
interactions were confirmed by NMR measurements that identified 16 inter-subunit
NOEs between F32 and I16, V40, A41, P42 (Figure 3.13b), thereby corroborating the
structure of the dimer in solution.
The hydrophobic groups of strands #1 and #3 as well as those of helix !1 are well
conserved across members of the B2 family (according to an analysis of 52 B2
sequences). Remarkably, positions S27 and F32 are subject to compensatory sequence
variations in the family so that, in fact, position 27 commonly hosts a hydrophobic
group - often an aromatic – and position 32 is most frequently occupied by a serine
residue. Also a preference to host charged residues at the L1 loop exists in the family,
although no strict sequence conservation can be observed in this region. Thus, members
of the B2 family have the potential to dimerize following the same pattern of MuRF-1
B2, indicating that self-assembly might be a generic property of this fold. On the other
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hand, it can be predicted that B1 boxes are unlikely to adopt this dimerization model.
B1 and B2 motifs are characterized by different sequence length and metal ligand
composition (Meroni and Diez-Roux, 2005). Contrary to the short loops of B2 motifs,
which are conserved in length, B1 boxes contain two long variable regions following
the second and seventh metal binding ligand (Figure 3.14c). In MID1 B1 the C-
terminal insertion adopts a bulky, “lasso-like” structure stabilized by conserved proline
residues that results in an unusual Hx9H metal binding pair that is not present in any
known B2 (Figure 3.12b). This long, charged loop insertion would prevent the
formation of a dimeric arrangement as that of MuRF-1 B2 by causing steric clashes
across subunits. Thus, a differential propensity to dimerization specific to B2 but not B1
boxes might be inferred. This is in agreement with the evolutionary invariability of the
B2 domain directly preceding the CC region that suggests a functional division of the
TRIM fold into RING, B1 and B2-CC domain (Reymond et al., 2001), where the latter
possibly acts as an integrated module in self-association securing the correct quaternary
structure of the TRIM protein.
The B-box motif is known to mediate heterologous protein-protein interactions,
but structural data on these complexes are yet to become available. In an attempt to
reveal the possible determinants of B2-mediated interactions, we have examined the
surface of MuRF-1 B2. Each protomer exhibits a long, shallow groove that encircles the
C-terminal metal binding site ZnII formed by loops L2 and L3 (Figure 3.13c and
Figure 3.12c). In one of side of the semicircle, the groove includes a hydrophobic
cluster centered on the solvent exposed surface of the b-sheet and containing a highly
conserved aromatic residue, Y17 (Figure 3.13c). It can be speculated that this groove
and its hydrophobic features might confer MuRF-1 B2 the capability to mediate
interactions to MuRF-1 binding partners. Alternatively, this feature might play a role in
the domain organization of MuRF-1 or in its formation of high-order oligomeric states.
It should be noted that the characteristics of this groove, which appear conserved
throughout the B2 family, do not resemble those defining ubiquitin ligase activity in
clefts of RING finger domains (Zheng et al., 2000). In the latter the groove is shaped by
long C-terminal loop insertions, which exist only as short sequences in B2 motifs
(Figure 3.14a and Figure 3.14c). Thus, a possible involvement of MuRF-1 B2 in
ubiquitination events cannot be inferred from its structure.
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The dimerization pattern of MuRF-1 B2 is unique among those of RING finger-
like domains. The RING finger of RAG1 (Bellon et al., 1997), the heterodimeric
BRCA1/BARD1 tumor suppressor (Brzovic, et al., 2001), the homodimeric FYVE
domain from EEA1 (Dumas et al., 2001) and the U-box of protein CHIP (Xu et al.,
2006) self-assemble via additional !-helical fractions, mostly C-terminal to the zinc-
binding domain. In those cases where additional direct contacts across the zinc-binding
motifs are observed, these commonly involve #-sheet components and/or its
neighbouring loop region. Helix !1 invariably lies in the outside, opposite to the dimer
interface. In the absence of their additional helical extensions, the self-association of
these motifs appears weak, as confirmed by recent data on Prp19 U-box (Vander Kooi
et al., 2006). In contrast, the association of B2 is comparatively more stable, suggesting
that its contribution to overall protein self-assembly might be more manifest than that
mediated by those other motifs.
3.2.4 Comparative analysis of B2 and RING finger-like motifs
The structures of the B2-boxes from MuRF-1 and ATDC show that this motif
belongs to the RING finger superfamily of zinc-binding motifs. RING (Barlow et al.,
1994), PHD (Capili et al., 2001), FYVE (Misra et al., 1999), ZZ (Legge et al., 2004), U-
box (Ohi et al., 2003) and B-boxes B1 (Massiah et al., 2006) and B2 are structurally
related (Figure 3.14a) Each of these folds exhibits a high variability and, apart from a
few residues defining the hydrophobic core and the metal binding groups, little
conservation characterizes the respective classes (Figure 3.14c
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Figure 3.14: Comparative analysis of RING finger-like zinc-binding motifs.
a) Compendium of representative RING-like folds structurally characterized to date. PDB accession
codes are given in brackets. Throughout, N- and C-terminal zinc ions are shown in blue and red,
respectively; b) Superposition of all domains shown in a. The shared structural core consisting of helix
!1 and strands #1 and #2 is revealed (coloured). The most structurally similar region encompasses the
metal site ZnI, while the architecture surrounding site ZnII is largely variable; c) Comparison of
consensus sequences for the fold classes displayed in a. Metal binding residues are numbered and
coloured according to the metal site they form. The position of hydrophobic residues is indicated by ,
and highlighted in yellow. It should be noted that in MuRF-1 B2, hydrophobic residues do not form part
of a motif core but that they are mainly solvent exposed. Other conserved residues within the classes are
indicated. Consensus sequences for individual folds have been adapted from: RING and PHD domain
(Capili et al., 2004); B1 (Massiah et al., 2006); ZZ (Meroni et al., 2005); FYVE (Stenmark et al., 2002);
U-box Ohi et al., 2003).
Despite, a similar architectural !/#-core is shared by most of these motifs. It
consists of an N-terminal, two-stranded, antiparallel #-sheet that leads to a !-helical
formation of longer or shorter length (Figure 3.14b). Conserved hydrophobic residues
within the classes are primarily located around the fifth metal binding residue, in the
sequence connecting strand #2 to the !-helix (Figure 3.14c). They play a role in the
packing of the #-sheet against the helix. Interestingly, the hydrophobic residues of
MuRF-1 B2 at this position do not form part of a motif core, but of the dimerization
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interface. In fact, MuRF-1 B2 does not posses a defined hydrophobic core beyond the
interaction of V40 with the aliphatic chain of K30, indicating that this motif might be
stabilized mostly by its metal binding and dimerization. The shared !/#-topology
supports in all cases the ligation of two zinc ions in a “cross-brace” fashion, as first
described for the RING finger domain (Barlow et al., 1994). Remarkably, the U-box
domain, which is closely related to the RING motif, does not bind zinc. Instead, it
houses a decentralized network of hydrogen bonds and salt bridges (Ohi et al., 2003).
The different folds become individualized through the nature of their metal binding
ligands and the length and composition of the spacing sequences. Strictly conserved
spacing across folds is observed only between the first two metal ligand residues, which
are separated by 2-3 variable residues. Other spacings can vary largely (Figure 3.14c).
Of all “cross-brace” zinc-binding motifs known to date, the B2 domain adopts the most
compact structure as a consequence of the short sequence insertions between its metal
binding residues. This results in an inter-zinc distance of +11 Å, similar to that of the
FYVE motif, but shorter than that of ZZ (+13 Å), RING and PHD domains (+14 Å).
The variable loop insertions confer substantial structural plasticity to this group of
motifs and allow for a broad range of protein interactions and, hence, cellular roles to be
supported. RING, PHD and U-box show E3-ligase activity but, apart from the
mediation of protein-protein interactions, no other common function has yet been
attributed to the remaining motifs.
The structural !/#-core of these folds maintains the architecture of the zinc-
binding site ZnI. This constitutes the most structurally similar region across motifs. In
contrast, the loops forming the C-terminal site ZnII – and in particular loop L3 - display
enormous structural variability across motifs. Such C-terminal sequences often form
additional secondary structure elements such as an extra #-strand (#3) that extends the
#-sheet (Figure 3.14a). In fact, the length and composition of these loops is likely to
determine the specific domain functionality by affecting the groove surface topography,
which is allegedly involved in protein-protein interactions in these folds. Metal site ZnII
has been shown to have a lower affinity for zinc in RING fingers and, in some cases,
does not even seem required for primary folding (Kentsis et al., 2002). Thus, this area
might be under lower structural pressure and has higher evolvability. While the ZnII site
architecture of MuRF-1 B2 is closely related to that of the ZZ domain, both showing a
very short loop that leads into a third strand #3, that of the U-box resembles RING
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domains. The C-terminal regions of PHD and FYVE motifs significantly differ from
those of any other class, with the FYVE fold representing a convolution of RING
topologies where site ZnII shows an own RING !/# architecture.
3.2.5 Final remark
The structure of MuRF-1 B2 aids our understanding of the TRIM integrated
fold, whose biological function relies in its ability to self-assemble into higher-order
oligomers. We found that isolated MuRF-1 B2 adopts a highly stable dimeric state,
suggesting that this motif is likely to participate in self-association together with the
coiled-coil fraction. Given the defining nature of the B2 domain within the TRIM fold,
its dimerization might be critical for the higher order assembly of these proteins and/or
the structural integrity of this fold. The B2 motif might contribute to ensure the
stoichiometry and/or registry of the CC fraction. Although CC are established
oligomerization motifs in proteins, their association properties are not always uniquely
defined and they can be found in proteins in combination with other motifs that
influence their association. A prominent example is that of the trimeric CC of fibritin,
which is followed by a C-terminal extension of +30 residue length that folds into a
b-hairpin (Tao et al., 1997). This intertwines with equivalent b-hairpins from other
subunits, being essential to achieve stable CC trimerization in that case. An additional
example is that of Dystrophia Myotonica Kinase, whose assembly into dimers is
essential for activation. Although its self-association was thought to be mediated by a
C-terminal CC domain, it has been recently shown that this CC in isolation forms
trimeric assemblies, possibly unrelated to the physiological state of the kinase, while
sequence segments flanking the catalytic kinase fraction itself are responsible for the
dimeric state of this protein (Garcia et al., 2006). Thus, it should be investigated to
which extent the assembly properties of the B2 under study are essential for MuRF-1 to
achieve a functional quaternary structure. Furthermore, it should be examined whether
the B2 motif of MuRF-1 plays a central physiological role in muscle by being involved
in the recruitment of MuRF-1 binding partners to this signalling spot in the sarcomere.
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4 Biophysical characterization of LAP2!
Abstract
The non-membrane bound scaffolding protein LAP2! is critically involved in
the recruitment of retinoblastoma protein as well as chromatin to the filamentous
intranuclear structures of lamin A. Binding to these factors is mediated through a
unique C-terminal domain only present in the LAP2! isoform. To gain an insight
into the architecture of specific nuclear structures formed by LAP2! as well as to
assess its behavior with respect to further crystallization attempts, we have
initiated biophysical characterization on recombinantly expressed, purified full
length protein and on a C-terminal construct LAP2!410-693 that contained the
proposed lamin A binding region.
We demonstrate based on size exclusion chromatography that full length
LAP2! forms higher order homo-oligomeric structures. By contrast, size exclusion
chromatography in connection with multile-angle light scattering as well as
ultracentrifugation revealed that C-terminal LAP2!410-693 exists in a homo-dimeric
form in solution. Furthermore, LAP2!410-693 possesses a high degree of !-helical
secondary structure content as deduced from CD-spectroscopy. Both constructs
show a pronounced oxidation tendency due to exposed surface cysteines and were
found to be associated with DNA fragments.
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4.1 Materials and Methods
4.1.1 Cloning
Plasmids containing coding sequences for full-length human LAP2!  and
LAP2!410-693 were provided by Prof. Roland Foisner (Vienna Biocenter). Those
sequences had been cloned into the plasmid pET-23a(+) via Nhe-I and Xho-I as
described (Vlcek et. al., 1999). A cystein-to-serine mutant (LAP2!410-693Cys-Ser) was
generated by Barbara Korbei (Vienna Biocenter) by means of site-directed mutagenesis,
where C517, C560, C569, C657 and C683 became exchanged by serine residues. All
exchanges were validated by DNA sequencing.
4.1.2 Protein preparation
Expression of LAP2! constructs was carried out in E.!coli strain BL21 (DE3)
Rosetta (Novagen). Cultures were grown at 37 °C up to an OD600 of 0.6 in Luria Bertani
medium supplemented with 100 µg/ml ampicillin and 34 µg/ml chloramphenicol.
Induction of LAP2!1-693 was achieved by addition of 0.6 mM isopropyl-#-D-
thiogalactopyranoside (IPTG), while the truncated variant LAP2!410-693 required 0.05
mM or total absence of IPTG in order to reduce inclusion body formation. Media were
replenished with ampicilline after initiation of induction and cultures were grown at
25°C for approximately 18 additional hours. Cells were harvested by centrifugation at
2800*g and 4°C during 40 minutes. Bacterial pellets were resuspended and lysated in
0.1 M phosphate buffer pH 7.5, 0.1 M NaCl, 10!mM #-mercaptoethanol containing a
commercial protease inhibitor cocktail (Boehringer). Lysis was achieved by sonication
(Branson sonifier) at 4°C in the presence of lysozyme. DNAse and RNAse were added
to a final concentration of 5 µg/ml. The homogeneate was clarified by centrifugation at
15000*g at 4°C during 40 minutes. The supernatant was applied to a Ni2+-chelating
HiTrap column (GE Healthcare) equilibrated in lysis buffer with additional 40!mM
imidazole. The eluate was dialyzed against a buffer containing 100 mM sodium
phosphate pH 7.5, 100 mM NaCl and 10 mM DTT at 4°C for 16h, concentrated to
about 20 mg/ml (according to A280) and applied to a size exclusion chromatography
column (Superdex 200 Hiload 16/60PG; GE Healthcare) equilibrated in dialysis buffer.
The protein so obtained was pure according to SDS-PAGE and mass spectrometry. All
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purification procedures were carried out at room temperature. The protein was stored at
4°C at concentrations up to 15 mg/ml. SDS-PAGE was performed using 6% stacking
and 12% resolving gels.
Overexpression of a cysteine-to-serine mutated variant, LAP2! 410-693Cys-Ser,
followed protocols as described for the corresponding wild type construct.
4.1.3 Mass spectrometry (MS)
The molecular mass of purified LAP2!410-693 was determined on a TOF-mass
spectrometer (TSQ-7000, Finnigan, San Jose, CA) with ESI-MS. The protein at a
concentration of 10!mg/ml in 100!mM Na-phosphate pH 7.5, 100!mM NaCl, 10!mM
DTT was diluted 1:100 with water prior to the measurement. Mass determination was
carried out by Paul Jenö (Biozentrum, Basel).
For chemical modification of LAP2!410-693, protein solutions were adjusted by
appropriate dilution with buffer to 1!mg/ml and 1-2!mM DTT. The buffer contained
iodo-acetic acid (IAA) in various concentrations between 5 and 50!mM. Samples were
incubated at room temperature or 37°C for 1!h followed by quenching with an at least
double molar excess of DTT and subsequently digested with trypsin. The fragments
were analysed by ESI-MS (peptide mapping). The proteases trypsin, Asp-N, Lys-C and
V8 (Sigma Aldrich) were used to generate diverse peptide fragments to resolve the
position of all cysteine residues. As a positive control a reaction mix was supplemented
with 8!M urea before quenching and incubated for additional 1!h at 37°C. Urea
containing samples were dialyzed against water overnight, digested with trypsin and
analyzed by LC-MS.
4.1.4 Circular dichroism spectroscopy (CD)
Purified, concentrated LAP2! constructs were extensively dialysed against a
buffer solution containing 100 mM sodium phosphate pH 7.5, 100 mM NaCl, 5 mM
DTT and diluted prior to the experiment to a final concentration of 0.5-1.0 mg/ml with
similar buffer but containing only 1!mM DTT. The far-UV circular dichroism (CD)
spectra were measured at 4°C and 22°C on a circular dichroism spectropolarimeter
(62A DS, AVIV) equipped with a temperature-controlled quartz cell of 1!mm path.
Data were averaged from four scans and normalized for concentration, buffer and path
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length. Thermal denaturation curves were recorded by monitoring the change of
ellipticity as a function of temperature at a fixed wavelength of $=230 nm. The heating
rate was 30 °C/h and data points were acquired for every degree centigrade.
4.1.5 Analytical Ultracentrifugation (AUC)
Sedimentation velocity and equilibrium measurements were performed on a
Optima XL-A analytical ultracentrifuge (Beckman Instruments) equipped with an An-
60 Ti Rotor at 20°C. Samples were dialyzed against final conditions or taken directly
after size exclusion chromatography. Concentration was monitored by A280 against
reference buffer. A protein partial specific volume of 0.73 ml/g was used, while solution
density was assumed to be 1.003 g/ml.
Sedimentation velocity data were obtained by centrifuging LAP2! samples at
54000!rpm for 46!min recording radial scans at $=277!nm every 10!min. The data were
analyzed with the program SEGAL21 (Machaizde and Lustig, 2006). All measurements
were done in collaboration with Ariel Lustig (Biozentrum, Basel).
4.1.6 Transmission electron microscopy (TEM)
Purified recombinant LAP2!410-693 was taken from current preparations and
diluted to appropriate protein concentrations with different buffer/salt solutions.
Samples were mixed with glycerol to a final concentration of 30% directly before the
experiment and sprayed onto freshly cleaved mica using an airstream. The dried
specimens were rotary shadowed with platinum and carbon using an electron gun. The
replicas were floated on distilled water and collected on formvar-coated grids. The
replicas were examined in a Zeiss 9/2 120!kV transmission electron microscope.
Samples were prepared and analyzed by Bohumil Maco.
4.1.7 Size exclusion chromatography with multi-angle light scattering (SEC-
MALS)
The oligomeric state of LAP2!410-693 in solution was determined via SEC-MALS
measurements performed on an ÄKTA explorer 10 system (GE Healthcare) connected
to a tri-angle light scattering detector and a differential refractometer (miniDAWN
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Tristar and Optilab, respectively; Wyatt Technology). A Superdex 75 HR 10/30 column
(GE Healthcare) equilibrated in 0.1!M Na-Phosphate pH 7.5, 0.1!M NaCl, 10!mM DTT
at a flow rate of 0.5!ml/min was used. A sample volume of 100!µl was injected at a
concentration of 2!mg/ml. Data were processed using ASTRA software (Wyatt
Technology) assuming a specific refractive index increment (dn/dc) of 0.185 ml/g. To
determine the detector delay volumes and the normalization coefficients for the MALS
detector, a BSA sample (Sigma A-8531) was used as reference. Neither despiking nor
band broadening correction was applied and molecular masses were calculated based on
the refractive index.
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4.2 Results
4.2.1  Characteristics of LAP2! constructs
The work focused on the analysis of full-length LAP2! and a truncated, C-
terminal construct, LAP2!410-693, hosting a lamin A/C binding domain between residues
615-693 (Dechat et al., 2000). Table 4.1 summarizes the biophysical properties of these
protein constructs. All LAP2! forms contained cysteine residues that led to aggregation
via formation of intermolecular disulfide bridges resulting from the oxidation of surface
sulfhydryl groups. Hence, to prevent oxidation, the protein was kept under reducing
conditions at all times during preparation. Figure 4.1 shows the number and position of
cysteine residues potentially involved in oxidation events Table 4.1. The full-length
protein contains ten cysteines and the C-terminal truncated domain LAP2!410-693
contains six. Given that LAP2! is localized in the nuclear interior in vivo, all cysteine
residues could be expected to be in a reduced state under native conditions.
The sequences of human and mouse LAP2! share 72% sequence identity (for an
alignment see appendix 6.3). The mouse isoform contains four additional cysteines that
are not present in the human form. Residue C683 in the human isoform is substituted by
a histidine in the mouse sequence, whereas H640 is a cysteine in the mouse isoform.
We hypothesize that these residues could be involved in the formation of a metal,
possibly zinc, binding motif. However, no canonical metal binding motif could be
identified using prediction tools on available sequences.
Table 4.1: LAP2! constructs used in this study.
Protein aa Mr [Da] pI No. Cys Tag
LAP2!410-693 296 32477 6.7 6 C-term. His6
LAP2!1-693 703 76670 7.3 10 C-term. His6
LAP2!410-693Cys-Ser 296 32397 6.7 1 C-term. His6
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Figure 4.1: Schematic representation of LAP!.
The LAP2! unique region comprises residues 187-693 (in various shades of blue), where residues 615-
693 (shown in light cyan; Dechat et al., 2000) constitute the proposed lamin binding domain. Depicted in
yellow are the LEM and LEM-like domains present in all LAP2 isoforms. Phosphorylation sites are
indicated in green. In the central region four potential caspase cleavage sites have been identified
(Gotzmann et al., 2000). Depicted in red are residues that have been exchanged against serine in the
mutant LAP2!410-693Cys-Ser.
4.2.2 Protein preparation of LAP2!410-693
The yield of pure, soluble protein that was obtained by overexpression at low
IPTG levels and temperature was around 5-10!mg per 1 L of E.!coli culture. After
purification, the soluble fraction was homogeneous as evidenced by SDS-PAGE and
size exclusion chromatography (Figure 4.2). The solubility limit was reached at a
concentration of about 20!mg/ml in PBS buffer.
In size exclusion chromatography, LAP2!410-693 elutes at 70.3!ml. Assuming a
globular shape of the molecule, this is indicative of a trimeric state of the sample or
potentially of an elongated dimer (see appendix 6.4 for calibration curve). To further
investigate the oligomeric state of LAP2!410-693 we used analytical ultracentrifugation as
well as size exclusion chromatography in connection with multi-angle static light
scattering (SEC-MALS; see chapter 4.2.6), a technique that is independent of the
molecular shape.
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a)
b)
Figure 4.2: Size exclusion chromatography and final purity of LAP2!410-693.
a) Size-exclusion chromatogram from a Superdex 200 (PG 16/60) column. The protein elutes as one
single species at 70 mL. The small pre-peak at 60 mL contains a fraction of LAP2! and the E.!coli
chaperone DnaK as identified by mass-spectroscopy. b) SDS-PAGE of elution fractions from size
exclusion chromatography. A black bar indicates the composition of the main peak. Lane 1 shows the
applied sample, lane 9 the low molecular weight standard. Lane 2 corresponds to the pre-peak shown also
in a). LAP2!410-693 appears at an apparent molecular mass of 35!kDa. Lane 2 shows the presence of the
chaperone DnaK at an apparent molecular mass of 69 kDa as determined by mass-mapping of gel bands.
A main impurity at an apparent molecular mass of 69 kDa in SDS-PAGE
Figure!4.2b) was identified by mass-mapping of gel bands to be the E.!coli chaperone
DnaK. The latter influences the partitioning of functional protein between soluble and
insoluble fraction (Gonzalez-Montalban et al., 2006). It potentially binds to LAP2!
populations to enhance their solubility. No further characterization was carried out in
this respect since DnaK could be effectively removed by size exclusion
chromatography.
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The purified and concentrated protein showed a pronounced temperature
dependence of solubility. At 4°C the solubility limit in a buffer containing 50!mM
Tris!pH 7.5, 100!mM NaCl, 5!mM DTT decreased to approximately 5!mg/ml and the
protein gradually precipitated upon storage. Since this could result from a pH shift of
the solution with temperature due to the properties of the Tris buffer, this was replaced
with phosphate buffer. This alleviated to a certain extent the solubility of the sample in
cold temperatures.
4.2.3 Overexpression and purification of full-length LAP2!1-693
The amount of pure, soluble LAP2!1-693 was approximately 1!mg per 1 L E.!coli
culture – significantly less quantity than that obtained from LAP2!410-693. Only a small
amount of LAP2!1-693 was found in the insoluble fraction after cell lysis and the full
protein did not precipitate upon cooling or storage.
In size exclusion chromatography (Figure 4.3), LAP2!1-693 elutes at a volume
corresponding to a high apparent molecular mass, possibly larger than 400!kDa
(MWmonomer= 76670.3 Da). Although molecular weight estimates at elution volumes
close to the column void are prone to large errors and cannot be interpreted reliably.
This indicates that the full-length protein has a higher oligomeric state than its truncated
version LAP2!410-693. Potentially it could also represent unspecifically aggregated
material. The result stands in contrast to cross-linking experiments followed by semi-
native PAGE that suggest that LAP2!1-693 forms dimers, trimers or tetramers in solution
(Snyers et al., submitted manuscript; see appendix 6.5). No further attempts were made
to determine the molecular mass of full-length LAP2! at that time.
Frequently, LAP2!1-693 yields a second, variable elution peak in size exclusion
chromatography. This elutes close to the exclusion limit of the column (600 kDa) and
indicates the presence of very high molecular mass species in the sample (Figure 4.3).
The peak showed lower absorption at $=280 nm than at $=260 nm. Most likely, it
contained DNA fragments resulting from nuclease treatment during cell lysis that have
propagated through previous purification and dialysis steps and remained associated
with LAP2!. To further investigate this we used electron microscopy (chapter 4.2.8).
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Figure 4.3: Size exclusion chromatography of full-length LAP2!1-693.
a) Size exclusion chromatogram obtained on a Superdex 200 (16/60PG) column. Peak!1 has a high
absorption at $=260!nm and contains LAP2! based on detection by SDS-PAGE. Peak!2 contains
LAP2!1-693 multimers with an apparent molecular mass of > 400 kDa; b) SDS-PAGE. LAP2!1-693 has an
apparent molecular weight of 75 kDa. Lane 1 shows the low molecular mass standard, lane 10 the applied
sample.
4.2.4 Mass spectroscopy on LAP2!410-693
ESI-MS was applied to investigate the exact length of the LAP2! protein
products obtained by bacterial overexpression. The results indicate that LAP2!410-693 had
a molecular mass of 32351.0 Da. The measured mass is inferior, "Mexp/theo=126.8, to that
calculated from sequence data, Mw=32477.8 Da. This can be speculated to be due to
the removal of the N-terminal methionine (MMet=131.2 Da) in the E. coli system.
Initiator methionines are frequently cleaved by methionine aminopeptidases (MetAPs)
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if they are followed by small and uncharged residues (Alanine and serine in the case of
LAP2!410-693).
Full-length LAP2!1-693 could not be analyzed this way since the protein did not
elute from the liquid chromatography (LC) column employed prior to sample injection.
A reason for this might be its high oligomeric state and/or unspecific interaction with
the column material (Paul Jenö, personal communication).
4.2.5 Circular dichroism spectroscopy on LAP2!410-693 and LAP2!1-693
The far-UV CD spectrum (the peptide region) of a globular protein primarily
reports on its secondary structure. Accordingly, CD-spectroscopy was used to gain
information about the folding status of recombinant LAP2! products. The CD-spectra
of LAP2!410-693 under native and denaturing conditions is shown in Figure 4.4a.
The position and intensity of the CD-bands reflect spectral features that are
characteristic of a protein with a high !-helical content, i.e. a minimum at $=222 nm
and $=208 nm.
Equation 1: Degree of !-helicity as derived from the far-UV CD-spectra.
[.mrw] : molar mean residue ellipticity at given wavelength
Using Equation 1, the ! -helical content of the protein was determined to be 47!%
(based on [.mrw] at $=208 nm) and 57!% based on [.mrw] at $=222 nm).
! 
%" # helix =
([$
mrw
]
208nm
+ 4000)
(#29000)
%100%
! 
%" # helix =
([$
mrw
]
222nm
# 3000)
(#39000)
%100%
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Figure 4.4: CD-spectra of LAP2!410-693 and LAP2!1-693.
a) Far-UV CD-spectrum of native (black curve) and denaturated (6!M urea, red curve) LAP2!410-693.
Shown is the molar ellipticity after buffer correction. The insert shows the final protein purity (SDS-
PAGE; lane M corresponds to the LMW-standard); b) Far-UV CD-spectrum of native (black curve) and
denaturated (6!M urea, red curve) LAP2!1-693. All spectra were recorded in 100!mM phosphate buffer pH
7.5, 100!mM NaCl, 1!mM DTT in a 1!mm cuvette. The samples were measured at a protein concentration
of 0.5!mg/ml at 5°C.
Similar to LAP2!410-693, the full-length protein also shows an absorption minima at
$=208!and $=222!nm (Figure 4.4b). The content of !-helix for the full protein is about
15!% determined at $=208!nm or 23!% at $=222!nm. These percentages are equivalent
to those of the shorter C-terminal construct, if the latter were recalculated to account for
the full protein sequence, suggesting that no additional !-helical regions are present in
the protein (apart from the ~90 residues of N-terminal LEM-like and LEM domain).
This is indicative of potentially unstructured regions.
In addition, to gain an insight into the stability of the protein, a heat denaturation
experiment was recorded at $=230!nm. Figure 4.5 illustrates that the heat unfolding of
both LAP2!1-693 and LAP2!410-693 could be described by a two state model based on the
sigmoidal shape of the transition curve. Two clear plateaus were reached at the
beginning and the end of the experiment. However, for both proteins the transition to
the unfolded state was irreversible and resulted in insoluble aggregates. Refolding under
those conditions compatible with CD recording was probably troubled by the presence
of the cysteine groups. The apparent transition temperatures recorded were 53°C for
LAP2!410-693 and 57°C for the full-length protein, indicating a high stability of the
samples.
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a) b)
Figure 4.5: Thermal denaturation of LAP2!410-693 and LAP2!1-693.
a) Temperature denaturation curves of LAP2!410-693 (black curve) and LAP2!1-693 (red curve) were
recorded at a wavelength of $=230 mn. b) LAP2!410-693 (black curve) shows an apparent transition
temperature of 53°C, whereas the full protein (red curve) denatures at 57°C (first derivative shown). All
spectra were recorded in 100!mM phosphate buffer pH 7.5, 100!mM NaCl, 1!mM DTT in a 1!mm cuvette
path.
4.2.6 Size exclusion chromatography with multi-angle light scattering on
LAP2!410-693
Static light scattering in connection with refractive index measurements yield an
accurate determination of the molecular mass of proteins in solution, which is
independent of molecular shape or hydrodynamic parameters. The intensity of the
scattered light is directly proportional to the weight–averaged molar protein mass and
concentration based on Zimm’s formalism of the Rayleigh-Debye-Gans model (Zimm,
1948). The measurements are carried out online, directly after a size-exclusion column,
which provides a fractionation of the sample population and aids assessing the possible
presence of polydisperse states.
Analysis of LAP2!410-693 by size exclusion chromatography combined with multi-
angle light scattering (SEC-MALS) reveals a molecular mass of 66.3!±!1!kDa. This is
within excellent agreement of the calculated theoretical mass of 65 kDa for a dimer of
this construct (Figure 4.6). Only one single oligomeric species could be detected in
solution, indicating a high monodispersity of LAP2!410-693 populations forming homo-
dimers.
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Figure 4.6: Analysis of LAP2!410-693 with SEC-MALS.
The normalized refractive index signal of the peak region of a size exclusion chromatogram (Superdex 75
HR 13/30) performed in 0.1!M Na-Phosphate pH 7.5, 0.1!M NaCl, 10!mM DTT is shown as solid line.
The weight-averaged molecular mass measured inside the peak area at volume intervals is displayed as
filled squares. A black line indicates the theoretical mass of a dimer.
4.2.7 Analytical Ultracentrifugation on LAP2!410-693
In addition to SEC-MALS, the oligomeric state of LAP2!410-693 solutions was
analyzed using ultracentrifugation. Samples were investigated at protein concentrations
between 0.6!mg/ml and 2.5!mg/ml in Tris and phosphate buffer conditions. Table 4.2
summarizes the measured Mw. Samples at concentrations of 1.2 and 0.6 mg/ml showed
a very low signal-to-noise ratio due to the interference of reducing agent in the sample.
Due to their poor interpretability, those data were discarded.
The average molecular mass over all runs was 74!kDa ± 5!kDa (Figure 4.7). This
indicates the presence of a dimer of LAP2!410-693 in solution and is in agreement with
SEC-MALS data. No significant dependence on concentration was found between 1.2
and 2.5!mg/ml, i.e. the protein seems to form an isolated, non-aggregating dimeric
particle. The sedimentation coefficient Sw,20°C of 4.2 x10
-13s-1 resembles that of BSA
(Sw,20°C= 4,3x10
-13s-1) and points towards a globular overall shape.
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Table 4.2: Ultracentrifugation experiments carried out on LAP2!410-693.
Protein Buffer Concentration
[mg/mL]
Speed
[rpm]
Mol. Mass [kDa]/
Sedimentation
coefficient [Svedberg]
LAP2!410-693 20!mM phosphate pH 7.5
100!NaCl
5!mM DTT
1.2
0.6
0.6
15000
15000
54000
101a
99a
4.2 S
LAP2!410-693 100!mM phosphate pH 7.5
100!NaCl
5!mM DTT
1.3 8000 77b
LAP2!410-693 100!mM Tris pH 7.5
500!NaCl
10!mM DTT
2.5
1.5
2.5
1.5
13000
13000
18000
18000
68
78
75
75
LAP2!410-693 100!mM Tris pH 7.5
500!NaCl
10!mM DTT
20 mM CHAPSc
2 13000 70
a treated as outliers; not shown.
b interference optics were used.
c five times the critical micellar concentration (4mM).
Figure 4.7: Molar masses of LAP2!410-693 calculated by sedimentation equilibrium.
LAP2!410-693 shows a molecular mass of 68-77kDa at all concentrations indicating the presence of a dimer
in solution (linear fit in red).
4.2.8 Transmission electron microscopy (TEM) of LAP2!410-693 and LAP2!1-693
The goal of our TEM experiments was to monitor the dispersity of LAP2!
samples in solution for future crystallization trials. Samples were investigated in
different buffer conditions and at concentrations up to 2!mg/ml. Under all conditions
assayed, LAP2!410-693 showed a same globular shape and defined appearance
(Figure!4.8a). Hence, the protein solutions appeared homogeneous, free of aggregate
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formation, and suitable for crystallization trials. These data, however, do not preclude
that a different behavior of the protein might occur at concentrations higher than
2!mg/ml as routinely employed in crystallization (>10 mg/ml).
Occasionally, long rope-like objects with an approximate diameter of 5-8!nm
could be seen among the globular LAP2!410-693 specimens (Figure 4.8b). In some cases,
branched or overlapping structures could also be detected, but did not co-localize with
LAP2!410-693. Visualization of full-length LAP2!1-693 revealed the presence of similar
objects. In this case, they appeared much more pronounced, distributed over a larger
area and apparently co-localizing with LAP2!1-693 (Figure 4.9b). Purified material that
was lysed in the presence of 500!mM NaCl did not contain such fibrous objects,
indicating an ionic interaction. However, the LAP2!1-693 sample so produced could be
visualized as globular particles, inhomogeneous in their size distribution and exhibit
certain clustering (Figure 4.9a) , indicating that this sample is unlikely to be amenable
to crystallization.
Figure 4.8: TEM images after low-angle rotary shadowing of LAP2!410-693.
a) The protein is in 20!mM sodium phosphate pH 7.5, 100!mM NaCl, 5!mM DTT at 1.7!mg/ml and
appears homogeneously distributed on the grid; b) protein in 50!mM Tris pH 7.5, 100!NaCl, 5!mM DTT
at 1.0!mg/ml. Several filamentous objects could be observed.
c) LAP2!410-693 was loaded onto a 5 % CTG-Agarose gel, which was subsequently stained with EtBr.
Lane 1: DNA-Marker (100!bp ladder; BIORAD)
Lane 2: DNA-Marker (Marker X, BIORAD)
Lane 3: LAP2!410-693 (7 mg/ml)
Lane 4: LAP2!410-693 (20 mg/ml)
Lane 5: BSA (10 mg/ml)
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Given that LAP2!  is thought to complex DNA, we speculated that the
filamentous formations observed by TEM might be DNA chains. Thus, we analyzed
purified LAP2!410-693 using 5% CTG-agarose gel stained with ethidium-bromide
(Figure 4.8c). This dye intercalates between aromatic base pairs forming the DNA
polymer and gives rise to an increased fluorescence upon UV excitation. The
pronounced fluorescence of LAP2!410-693 protein solutions is indicative of the presence
of DNA fragments, which were probably generated during cell lysis, carried through
affinity and size exclusion steps and eventually concentrate together with the protein.
Yet, it remains to be determined if the protein binds specifically to them, particularly in
its full-length form.
Figure 4.9: TEM images after low-angle rotary shadowing of full LAP2!1-693.
a) The protein was present in 50!mM Tris pH 8.0, 100!mM NaCl, 5!mM DTT at 1.0!mg/mL.
500!NaCl was used in the lysis step. LAP2!  appears as locally clustered, globular object of
approximately 20!nm.
b) The protein was present in 20!mM Phosphate ph 8.0, 250!mM NaCl, 5!mM DTT at 1.9!mg/mL.
4.2.9 Oxidation of LAP2! protein solutions
During purification and biophysical characterization of LAP2! it became clear
that both full LAP2!1-693 and the C-terminal region LAP2!410-693 form higher order,
covalent oligomers via oxidation of their solvent-exposed sulfidryl groups in the
absence of reducing agents. Overnight dialysis in the absence of reducing agent led to
severe oxidation of the C-terminal domain LAP2!410-693 as shown by size exclusion
chromatography and the fact that a large fraction of the protein precipitated. The elution
Chapter 4: Biophysical characterization of LAP2!                                                       139
peak of the supernatant subjected to gel filtration shifted from 71!ml under reducing
conditions close to the void volume of the size exclusion column (V0=!40!mL), thus
indicating a molecular mass higher than 600 kDa (Superdex 200; Figure 4.10a). Clearly
two or more cysteine residues must be exposed on the protein surface to form such
higher order aggregates.
In order to detect protein oxidation by means of SDS-PAGE, it was necessary to
avoid reducing conditions during electrophoresis, since denaturing conditions together
with the reducing agent reduced the oligomers to their monomeric components and the
detection of higher order, covalent aggregates became troubled. Hence, LAP2!410-693
samples were dialysed against a buffer containing 50!mM Tris pH 7.5, 100!mM NaCl
and an identical buffer containing additionally 20!mM #-ME. The protein precipitated
slightly after 16!h dialysis under both conditions. After centrifugation, the protein
pellets were washed with dialysis buffer in the absence of a reducing agent, re-dissolved
in buffer plus urea and loaded onto the gel after mixing with a sample buffer containing
#-ME or with a buffer containing no #-ME (Figure 4.10b). The protein pellet resulting
from precipitation after four days of non-reductive dialysis was also checked under the
same conditions. In both pellet fractions covalent aggregation was detectable.
Accordingly, aggregation disappeared in the presence of reducing agent in the sample
buffer. The same behaviour was observed in LAP2!1-693 (data not shown).
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Figure 4.10: LAP2!410-693 protein solutions show a propensity to oxidate.
a) Size exclusion chromatography of LAP2!410-693 on a Superdex!200 16/60PG column after overnight
dialysis against 100!mM sodium phosphate pH 7.5, 100!mM NaCl (non-reducing condition). The elution
peak is shifted from 71!ml to the void volume of the column indicating a high oxidation state.
b) SDS-PAGE of LAP2!410-693 pellet fractions under reducing (lane 1-3) and non-reducing (lane 4-7)
conditions. The pellet fractions contain high molecular mass aggregates that can be reduced.
Lane 1: pellet after non-reductive dialysis
Lane 2: pellet after reductive dialysis
Lane 3: supernatant after reductive dialysis
Lane 4: LMW-marker
Lane 5: pellet after non-reductive dialysis (4 days) and no #-ME in sample buffer
Lane 6: pellet after non-reductive dialysis (1 day) and no #-ME in sample buffer
Lane 7: supernatant after reductive dialysis and no #-ME in sample buffer
Spontaneous disulfide cross-linking is a distinct source of heterogeneity in
LAP2! samples, that will most likely interfere with its crystallization since this
involves timescales in the days-to-weeks range, perhaps even months. In an attempt to
overcome this problem by cysteine-to-serine residue exchanges, we pursue the
identification of exposed cysteines involved in the oxidation process by chemical
modification with an alkylating agent followed by mass-spectroscopic analysis.
4.2.10 Carboxymethylation of LAP2!410-693 with iodo-acetic acid
Upon incubation of LAP2!410-693 with the carboxy-alkylation reagent iodo-acetic
acid (IAA) at room temperature, the molecular mass of the protein increased by
approximately 179 Da according to full mass determination. This was indicative of a
triple alkylation of accessible cysteine residues (Mwcarboxymethyl= 59!Da). At 37°C a mixed
    Reducing
sample buffer
    Non-reducing
    sample buffer
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population of three and four (approximate mass increase 230 Da) modified residues was
observed (Table 4.3). These data clearly suggest the presence of at least three exposed
sulfhydryl groups involved in protein oxidation.
Table 4.3: ESI-MS results after carboxymethylation of LAP2!410-693 with iodo acetic acid (IAA)
Protein IAA concentration Molecular mass (mass shift) [Da]a Interpretationb
LAP2!410-693, 1!mg/ml 20!mM IAA
1!h, RT standing
32530 ("179) 3x modified!
LAP2!410-693, 1!mg/ml 25!mM IAA
1!h, 37°C shaking
32580 ("230) 4x modified
LAP2!410-693, 1!mg/ml 10!mM IAA
1!h, 37°C shaking
32526 ("174)
32582 ("232)
3x modifed
4x modified
a The theoretical mass of the protein is 32477 Da, the observed experimental mass is 32351 Da (cleavage
of N-terminal methionine). b Each modification contributes with 59 Da.
To identify those cysteine residues exposed and accessible to IAA,
carboxymethylated LAP2!410-693 was subjected to protease digestion followed by mass-
mapping of resulting proteolytic fragments. Four separate reactions with different IAA
concentrations were tested as well as a control probe with urea-denatured protein
(Figure 4.11). The data indicate that C517, C560, C569 and C657 are modified by the
reagent and, hence, most likely exposed. The two cysteines,!C560 and C569, initially
could not be resolved since both were located in a same tryptic fragment. Mass
estimations indicated that one of them must be exposed. In a separate reaction and using
different proteases, both residues were found to be modified, so that it was not possible
to identify the residue with higher propensity to oxidation. By contrast, C628 was never
found modified. In a series of reactions, C683 was only detected once as modified. In a
control reaction in the the presence of urea, all cysteines were found to be modified
Figure 4.11 and Table 4.4.
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Figure 4.11: ESI-MS results after alkylation of LAP2!410-693 by iodo acetic acid (IAA).
Indicated are modified, unmodified and not determined cysteines as deduced from fragment mass after
alkylation and proteolytic digest. They were generated in four reactions at various IAA concentrations
(Table 4.4). A cross indicates the detection of modified cysteine containing fragments, unmodified
fragments are marked by a check.
Table 4.4: Mass mapping results for LAP2!410-693 after carboxymethylation
Reaction Molecular
Mass
IAA
Conc
Protease modified unmodified unclear
1a 32526 Da
"174 (3x)
32582 Da
"232 (4x)
10 mM
1h
trypsin C517
C560 or C569
C683
C628 C657
2 5 mM
1!h
Asp-N
Lys-C
V8
C517
C517, C657 C683
3 20 mM
1!h
Asp-N
Lys-C
V8
C517, C569
C517
C517, C657
C560
C560
4 50 mM
1 h
Asp-N
Lys-C
V8
C517
C560, C569
control 5 mM
4!M Urea
2!h
Asp-N
Lys-C
V8
C517, C657, C683
C517, C560, C569
C628, C517, C628, C657
a The full intact molecular mass was only determined for the first reaction.
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4.2.11 Generation of a cysteine-to-serine mutant of LAP2!410-693
To avoid protein oxidation a mutated variant of LAP2!410-693, LAP2!410-693Cys-Ser,
was created in which five of the six cysteine residues were substituted by serine. Given
that C628 did not appeared exposed in alkylation studies, it was not modified.
Overexpression of LAP2!410-693Cys-Ser was carried out under conditions similar to those
of applied to the wild-type. However, a dramatic decrease of solubility was observed in
this case. Only a small amount of the protein was present in solution after affinity
purification (data not shown). One reason for this might be that mutation of five
cysteine residues to serine potentially impaired the formation of a possible metal
binding motif leading to the observed protein insolubility. Alternatively serine
substitution might have interfered with protein folding in a non-metal dependent way, if
for example buried or partially buried positions required mutation into alanine residues
instead.
4.3 Discussion
LAP2! is one of six alternatively spliced products of the LAP2 gene, which
share a common N-terminal region. In contrast to the other isoforms, which also share
domains in their C-termini, LAP2! has a large unique C-terminal region that contains
binding sites for chromatin, A-type lamins, and retinoblastoma protein. Full-length
LAP2!1-693 and its C-terminal region LAP2!410-693 could be produced in soluble form
through recombinant expression in E.!coli. Furthermore, samples of a high degree of
purity could be obtained by chromatographic procedures, making their biophysical
characterization feasible. LAP2! forms higher order structures containing multiple
molecules in vivo and complex formation is primarily mediated by its C-terminus (see
manuscript in appendix 6.5). We have reliably determined the oligomerization state of
LAP2!410-693 by ultracentrifugation and multi-angle light scattering. Consistently, both
techniques have proven LAP2! C-terminal fragment to be dimeric. Furthermore,
recombinant full-length LAP2! forms high molecular weight oligomers in vitro in
agreement with data from cell preparations (appendix 6.5).
CD-spectroscopy revealed that C-terminal LAP2!410-693 is well folded and mainly
composed of !-helical secondary structure elements under buffer conditions close to
physiological. An apparent transition temperature of 55-57°C indicates that both the
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full-length sample and its truncated C-terminus are stable protein products. Despite this
apparent fold stability, the truncated construct LAP2!410-693 showed a high tendency to
precipitation upon storage in solution and at cold temperatures if buffers other than
sodium phosphate were employed. This could have resulted from a pH shift of the
solutions upon temperature changes when buffers, such as Tris-HCl, were assayed. An
alternative reason for a phosphate-dependent solubility might be a strong affinity of the
protein for phosphate groups, which might provide additional charges thereby
increasing the protein solubility. Binding of phosphate groups seems likely given the
proposed direct interaction of LAP2! with chromatin (Vlcek et al., 1999). In line with
this observation and using electron microscopy, preparations of both constructs were
found to contain filamentous formations, most likely consisting of DNA. In agreement,
LAP2!410-693 solutions showed a strong fluorescence after reaction with ethidium-
bromide, indicating the presence of DNA in the preparations. Solutions of full-length
LAP2! appeared to be even more populated by DNA fibers as indicated by the more
abundant and longer filaments observed in TEM images compared to C-terminal
fragment. Taken together, these data suggest that phosphate/DNA binding sites in the
scaffold LAP2! become occupied in vitro either by buffer ions or by DNA fragments
mimicking the native conditions of the protein in the cell nucleus.
Both LAP2! constructs under investigation contain cysteine residues that lead to
aggregation by oxidation. High molecular mass aggregates were detected in size
exclusion chromatography after non-reducing dialysis. They also became evident by the
presence of SDS-resistant species in SDS-PAGE under non-reducing conditions. The
addition of reducing agents like #-mercaptoethanol and DTT as well as the degassing of
buffers and their subsequent flushing with nitrogen, effectively prevented aggregate
formation and was indispensable for protein preparation and storage. These procedures,
however, can only maintain a reducing environment for a limited period of time and
thus, they cannot ensure the long-term monodispersity of the sample expected to be
required for crystallization. Thus, to overcome oxidation on permanent basis, sample
variants were produced, where cysteine residues were exchanged by serines. However,
the overexpression of mutated variants did only result in minimal amounts of soluble
protein, suggesting a disruption of the fold. Although the basis of such disruption is
currently unknown, the possible alteration of a zinc-binding motif cannot be discarded
even if such motif could not be predicted from LAP2! sequence data.
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The initial objective of this work was to obtain a crystallographic model for the C-
terminal, lamin binding domain of LAP2!. For successful crystal growth, monodisperse
protein solutions that are stable over time at sufficiently high concentration are
desirable. Sources of protein heterogeneity such as chemical impurities, multiple
oligomeric states and conformational flexibility resulting from poorly ordered regions
are likely to impair the formation of well-ordered crystals. LAP2! suffered from several
of these problems in combination and accordingly crystallization attempts to this date
have been unsuccessful. The current characterization, however, will serve as basis for
the further refinement of protocols directed to achieve LAP2! samples amenable to
crystal formation.
Chapter 5
Conclusions
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5 Conclusions
Titin is the longest molecule known to date and pivotal component of the
sarcomere, a cellular compartment that requires a unique biochemical and structural
composition to adapt to an extreme biomechanical environment. The molecule utilizes
the unique mechanical and protein interaction properties of the Ig and FnIII fold to
constitute spatially isolated, functional modules involved in structural integrity (Z-disc,
M-line), elasticity (I-band), molecular templating (A-band) and signaling (Z-disc, I-
band, M-line).
Similar to poly-domain structures from the cell adhesion proteins fibronectin
(Leahy et al., 1996, Sharma et al., 1999), tenascin (Lundell et al., 2004) to the Z1Z1 Ig
tandem of titin (Marino et al., 2006; Zou et al., 2006) individual subunits of A168-A170
are arranged in an extended manner. We attributed the limited conformational freedom
to hydrophobic clustering at the interface and to the absence of particular linker
residues. From our studies, several molecular features can be identified that exemplify
how the titin scaffold confers specificity to its distinct regions. At first, the potential
binding site for MuRF-1 on titin A168-A170 involves cooperative interactions of all
three domains in form of a surface groove. Thus, the inter-domain orientation is a
critical parameter in the formation of a specific interface. In addition, the presence of a
unique helical insertion between #-strand A and A` in IgA169, i.e. in the central region of
the putative interface, seems to be directly involved in MuRF-1 binding. By contrast,
the only other structurally characterized interface of titin, the Z1Z2-telethonin complex,
despite also composed of two Ig domains in an extended conformation, possesses
different domain orientation and moderate conformational freedom across domains as a
result of a longer linker length. Apart from that, binding to telethonin is mediated
through #-strand cross-linking and involves exclusively sequence-independent main-
chain interactions. Yet again, specificity is created by cooperative binding of telethonin
to both domains. Thus, although composed of highly conserved Ig/FnIII frameworks,
both interface regions are structurally unrelated and represent “insulated” components
in two distinct functional modules of the Z-disc and the M-line.
What is more, titin utilizes a super-repeat pattern covering different regions of the
filament to modulate its mechanical properties as well as most likely its binding
specificity. Through sequence comparison we have been able to correlate the presence
of a sequence motif in the FG turn of the highly conserved IgA169-FnIIIA170 interface that
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seems to be generic for the whole A-band C-zone and is absent in the D- and P-zone.
Potentially, this observed repetitive pattern is involved in directing the binding of
MyBp-C and consequently the myosin filament to a particular A-band region.
Moreover, MuRF-1 is a member of the TRIM family of proteins that is known to form
homo-/heterooligomers. By means of ITC, we have mapped the binding site of titin to
the central region of the predicted coiled-coil region on MuRF-1.
We have also determined the crystal structure of MuRF-1 B-box and its
oligomeric state. Unexpectedly we found that, structure adopts RING-finger-like
topology and exists in a dimeric form in solution. Clearly, an additional level of
specificity of the interaction to titin can be induced if oligomerization of the titin ligand
MuRF-1 is required for binding. Both, the CC and the B2 are involved in homo-
oligomerization of MuRF-1. Given the serious consequences of MuRF-1 ubiquitination
on its sarcomeric targets, all of the above factors aid in increasing the selectivity of
interactions, thereby prohibiting unspecific binding events along the titin scaffold.
Finally we also show that the scaffolding events at the nuclear platform LAP2!
also critically depend on homo-oligomerization of the protein.
Chapter 6
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6 Appendix
6.1 Sequence alignments of A-band Ig and FnIII domains
Figure 6.1: Sequence alignment of titin Ig domains of A-band short super-repeat.
Secondary structure elements (based on: Kabsch and Sander, 1983) are indicated for structure of Ig A168.
Colour coding based on equivalence (highlighted in red are 100% identical residues). Alignment created
with the program ESPRIPT (Gouet et al., 1999; http://espript.ibcp.fr/ESPript/ESPript/).
Figure 6.2: Sequence alignment of titin Ig domains of A-band long super-repeat.
Secondary structure elements and colour coding as in Figure 6.1.
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Figure 6.3: Sequence alignment of titin FnIII domains of A-band short super-repeat.
Secondary structure elements are indicated for FNIII A170. Colour coding as in Figure 6.1.
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Figure 6.4: Sequence alignment of titin FnIII domains of A-band short super-repeat.
Secondary structure elements are indicated for FNIII A170. Colour coding as in Figure 6.1.
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6.2 Sequence alignments of B-box B1 and B2 subtypes
Figure 6.5: Sequence alignment of B-boxes of subtype B2.
Colour coding as follows: red, negatively charged residues (D, E); blue, positively charged residues (K,
R); green, hydrophobic residues (L, I, V, M, A, F, W, P). Secondary structure elements as in MuRF-1 B2.
The “cross-brace” zinc ligation scheme is indicated underneath. In bold: structurally characterized B2
domains.
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Figure 6.6: Sequence alignment of B-boxes of subtype B1.
Colour coding as in Figure 6.5. Secondary structure elements as in MID-1 B1 (Massiah et al., 2006).
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6.3 Sequence alignment of human and mouse LAP2!
Figure 6.7: Sequence alignment of human and mouse isoforms of LAP2!.
LEM-like and LEM domain are indicated as determined by Cai et al., 2001. The LAP2! unique C-
terminus starts at residue 187 (indicated by an arrow). The full protein contains ten cysteines in the mouse
isoform. The C-terminal construct LAP2!410-693 (indicated by an arrow) contains six cysteines in the
mouse isoform. Highlighted in cyan are histidine/cysteine substitutions.
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6.4 Calibration curve of Superdex 200 (16/60PG)
Figure 6.8: Calibration curve of size exclusion column superdex 200 (16/60 PG).
Indicated are nolecular mass estimates for LAP2!1-693 and LAP2! 410-693(chapter 4.2.2). The chart
equation is given.
6.5 Manuscript in preparation: Homo-oligomerization of LAP2!
requires its C-terminal domain and is unaffected by a disease-
causing mutation
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The nucleoplasmic protein, Lamina-
associated polypeptide (LAP) 2! , is one of six 
alternatively spliced products of the LAP2 
gene, which share a common N-terminal 
region. In contrast to the other isoforms, 
which also share domains in their C-termini, 
LAP2!  has a large unique C-terminal region 
that contains binding sites for chromatin, A-
type lamins, and retinoblastoma protein. By 
immunoprecipitation analyses of LAP2!  
complexes from cells expressing differently 
tagged LAP2!  proteins and fragments, we 
demonstrate that LAP2!  forms higher order 
structures containing multiple LAP2!  
molecules in vivo, and that complex formation 
is mediated by the C-terminus. In vitro cross-
linking of LAP2!  complexes revealed the 
existence of stable homo-oligomeric structures 
of 200-250 kDa. In vitro binding studies and 
multi-angle light scattering of purified LAP2!  
fragments showed homo-dimerization of 
LAP2! , involving the most C-terminal 
fragment comprising residues 410-693. Finally 
we show that, in contrast to the LAP2!-lamin 
A interaction, its self-association is not 
affected by a disease-linked single point 
mutation in the LAP2!  C-terminus.  
 
Key Words: chromatin, lamins, nuclear 
organization, homo-oligomerization 
 
 
INTRODUCTION 
The nuclear envelope comprises the inner 
and outer nuclear membranes, the nuclear pore 
complexes and the nuclear lamina, which 
underlies the inner nuclear membrane (1,2). The 
nuclear lamina is the major structural framework 
in the nucleus of multicellular eukaryotes and is 
composed of a filamentous meshwork of type V 
intermediate filament proteins, the lamins. B-
type lamins, encoded by two human genes 
(LMNB1 and LMNB2) are essential for cell 
viability. In contrast, the four A-type lamins (A, 
C, C2 and Adelta10), representing splicing 
isoforms of the LMNA gene, are dispensable for 
viability of individual cells but have crucial 
functions in development and tissue organization 
after birth (3,4).  
In addition to the lamins, the nuclear lamina 
contains a number of integral membrane proteins 
of the inner nuclear membrane, the best 
characterized of which are the Lamin B receptor, 
Lamina-associated polypeptide (LAP)1 and the 
three LEM-domain containing proteins LAP2", 
emerin and MAN1 (5,6). All these proteins 
interact with lamin A/C and/or B and contribute 
to anchorage of the nuclear membrane to the 
lamina. The LEM-domain, a conserved 40 amino 
acid motif located near the N-terminus of the 
LEM family proteins, interacts with the DNA-
binding protein Barrier-to-Autointegration Factor 
(BAF) and thus mediates the binding of these 
proteins to chromatin (7). In LAP2 proteins a 
LEM-like segment at the very N-terminus has 
been shown to interact with DNA directly (8). 
The family of LAP2 proteins includes six 
alternatively spliced isoforms derived from the 
same gene (9). Most LAP2 isoforms are closely 
related structurally and functionally and are 
localized to the inner nuclear membrane, such as 
LAP2". In contrast, LAP2! shares only the N-
terminal 187 amino acids with the other 
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isoforms, including the LEM and LEM-like 
domains, but otherwise possesses a unique 506 
amino acid C-terminal region without a 
transmembrane domain (Fig. 1A), encoded by 
one large exon found only in mammals (10).  
LAP2! is exclusively located in the 
nucleoplasm in interphase and interacts with 
lamin A/C (11) and hypophosphorylated 
retinoblastoma protein (pRb) via distinct C-
terminal domains (12,13). The LAP2!-lamin 
A/C-pRb complex is thought to regulate cell 
proliferation and differentiation in adult stem 
cells (3,12). During mitosis, LAP2! dissociates 
from chromosomes in a phosphorylation-
dependent manner and is redistributed 
throughout the mitotic cytoplasm, like most 
nuclear lamina components (14,15). However, 
during anaphase, LAP2! associates with the 
telomeres of separated sister chromatids and 
subsequently forms stable structures associated 
with decondensing chromatin before the nuclear 
envelope is formed (14). While LAP2! can 
interact with BAF and DNA via its common 
LEM and LEM-like motifs, its C-terminus was 
shown to be essential and sufficient for 
chromatin association during mitosis (16,17). 
Intriguingly, a mutation causing an amino acid 
substitution (Arg690 to Cys) near the C-terminus 
of LAP2! has been associated with dilated 
cardiomyopathy (DCM) (18), a condition also 
known to be caused by mutations in the LMNA 
gene (5). The mutation altered the observed 
LAP2! interaction with A-type lamins in vitro 
and may represent a rare cause of DCM. 
In this study, we show that LAP2! is 
engaged in homo-oligomerizaton via its unique 
C-terminal domain and that the C-terminal half 
of this domain forms stable dimers in vitro.  
These homo-oligomeric units might constitute 
the basis for the formation of higher-order 
structures containing LAP2! and other proteins.  
  
EXPERIMENTAL PROCEDURES 
Reagents - Mouse monoclonal anti-LAP2 (6E10) 
and rabbit polyclonal anti-myc antibodies were 
obtained from Abcam. Rabbit anti-LAP2! 
antiserum and monoclonal anti-LAP2! !antibody 
15/2 and 12 were described (16,17). Polyclonal 
anti-GFP antibodies were from Clontech 
Laboratories Inc; polyclonal anti-DsRed 
antibody from BD Biosciences; anti-Protein C 
affinity matrix (mouse monoclonal antibody 
HPC4, immobilized) and mouse monoclonal 
anti-myc antibody (9E10) from Roche 
Diagnostics; protein G-agarose conjugate from 
Sigma. 
 
Vector construction and expression of 
recombinant proteins - cDNA coding for 
monomeric Red Fluorescent Protein 1 (mRFP1) 
was amplified from pRSETB-mRFP1 (a kind gift 
of Dr. R. Tsien, Howard Hughes Medical 
Institute, University of California, San Diego) 
and inserted into the vector pCI (Promega). The 
resulting plasmid was used to create N-
terminally tagged mRFP1-LAP2! and mRFP1-
LAP2!(188-693), by ligating amplified 
fragments of LAP2! !in frame with mRFP1. 
mRFP1-LAP2! and mRFP1-LAP2!(188-693) 
were then excised and ligated blunt into the 
EcoRV site of eukaryotic expression vector pEF-
puro.PL3 (19). Plasmids pEF.mRFP1-LAP2! 
!and pEF.mRFP1-LAP2!(188-693) were 
transfected into HeLa cells using lipofectamine 
(Invitrogen), and clones were selected in 2 µg/ml 
puromycin.  
For the construction of PC-myc-mRFP1-
LAP2!(188-693) and PC-myc-LAP2!(188-
693), a sequence coding for Protein C epitope 
EDQVDPRLIDGK fused to the myc-tag 
EKLISEEDL was inserted into the EcoRV site of 
pEF-puro.PL3. The resulting plasmid was 
linearized with EcoRV and ligated in frame with 
mRFP1-LAP2!(188-693) or a fragment 
encoding LAP2!(188-693).  
For GFP-LAP2! carrying the DCM mutation, 
vector gAG43 was constructed by shuttling wild-
type LAP2! cDNAs from gAG41 (18) into GFP-
destination vector pcDNA-DEST53 by the LR-
reaction (Invitrogen). The vector pAG39 
containing mutated LAP2! cDNA was generated 
from pSV5 using the Quick-ChangeTM site-
directed mutagenesis kit (Stratagene) using the 
following primers: 5`-
GGAGGAGAAGTATGCAAAGTAATTAAAA
AGTGTGGAAATAAACAC-3`, and 5`- 
GTGTTTATTTCCACACTTTTTAATTACTTT
GCATACTTCTCCTCC-3`. The bacterial 
expression vectors encoding His-tagged LAP2! 
fragments are described elsewhere (16).  
For bacterial expression, proteins were expressed 
in E. coli strain BL21(DE3) using the inducible 
T7 RNA polymerase-dependent pET vector 
system as described previously (11,16). Protein 
expression was induced with 0.5 mM isopropyl-
ß-D-thiogalactopyranoside for 3 h. Bacteria were 
harvested by centrifugation at 4,000 rpm for 5 
min (Heraeus Megafuge, 1.0R) and lysed in one-
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tenth of the original culture volume of Tris 
buffer (20 mM Tris-HCl, pH 8, 500 mM NaCl, 5 
mM imidazol, 1 mM dithiothreitol, protease 
inhibitors) by freezing and thawing and addition 
of 0.1 mg/ml lysozyme, 0.1% Triton X-100, 10 
mM MgCl2, 50 "g/ml DNase, and 20 "g/ml 
RNase. Following a 30 min incubation at 30°C 
the samples were centrifuged for 10 min at 
14,000 rpm and pellets resuspended in one-tenth 
of the original culture volume of Tris buffer plus 
7 M urea and incubated for 1h at room 
temperature. Cell lysates were centrifuged at 
45,000 rpm  for 30 min, and supernatants were 
aliquoted and stored at -20°C. If fragments were 
soluble, urea was added directly to the cell 
extract prior to centrifugation at 14,000 rpm. 
Renaturation of recombinant proteins was 
achieved by dialyzing twice against KHM buffer 
(78 mM KCl, 50 mM HEPES, pH 7.4, 8.4 mM 
CaCl2, 10 mM EGTA, 4 mM MgCl2, 1 mM 
dithiothreitol) and cleared by centrifugation at 
4000 rpm for 5 min. For light scattering, 
expression of LAP2!(410-693) was induced 
with 0.05 mM IPTG at 25°C for 18 h. Bacterial 
pellets were resuspended in 100 mM phosphate 
buffer, pH 7.5, 100 mM NaCl, 10 mM beta-
mercaptoethanol, incubated in the presence of a 
commercial protease inhibitor cocktail 
(Boehringer), lysozyme, DNase and RNase and 
finally sonicated. The homogenate was 
centrifuged at 15,000g at 4°C for 40 min and the 
supernatant applied to a Ni2+-chelating HiTrap 
column  (GE Healthcare) equilibrated in lysis 
buffer plus 40 mM imidazole. Elution used 200 
mM imidazole. The elutant was dialyzed against 
100 mM sodium phosphate pH 7.5, 100 mM 
NaCl, 10 mM DTT at 4°C and further subjected 
to gel filtration (Superdex 200 Hiload 16/60PG; 
GE Healthcare). The protein so obtained was 
pure according to SDS-PAGE and mass 
spectrometry.  
 
Immunoblotting - Cells extracts in 20 mM Tris-
HCl, pH 8.0, 130 mM NaCl, 1% Triton X-100, 
and the protease inhibitors aprotinin, leupeptin 
and pepstatin (10 mg/ml each, Sigma) or 
Protease Inhibitor Cocktail Tablets (Roche 
Diagnostics) were centrifuged at 13,000g for 10 
min and pellet and supernatant fractions were 
analyzed on 10% polyacrylamide gels and 
electrotransferred to nitrocellulose (Schleicher 
and Schuell Inc.). Blots were blocked for 60 min 
in Tris-buffered saline, pH 8.0 0.1% bovine 
serum albumin, and 5% non-fat dry milk, 
incubated with primary antibody in Tris-buffered 
saline, 0.1% bovine serum albumin for 60 min, 
and with anti-mouse (Sigma) or anti-rabbit 
(DAKO) alkaline phosphatase-conjugate, and 
visualized using BM Purple AP Substrate, 
Precipitating (Roche Diagnostics). 
Semi-native gels contained SDS only in the 
running buffer (0.1% SDS); no SDS was present 
in the sample buffer or the polyacrylamide gels 
themselves. 
 
Immunoprecipitations - Confluent cell 
monolayers in 10 cm dishes were lysed in TNCT 
(20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM 
Ca2+, 1% Triton X-100 and protease inhibitors) 
and centrifuged for 10 min at 13,000g. 
Supernatants were incubated with 25 ml anti-
Protein C matrix for 1h. Bound complexes were 
washed 4 times with TNCT and eluted by boiling 
in SDS-PAGE sample buffer. Samples were 
processed for immunoblotting. Alternatively, 
supernatants were divided in two parts; one half 
was incubated on ice with monoclonal anti-myc 
(2 mg) or monoclonal anti-LAP2 (15 mg) 
antibody and the other half with a control 
monoclonal antibody (mouse monoclonal anti-
HRV2, a kind gift of Dr. Blaas, Max Perutz 
Laboratories, Vienna) for 30 min. Immuno-
complexes were bound to 12.5 ml Protein G-
agarose for 1h, washed with TNCT and eluted in 
sample buffer. 
 
Immunofluorescence microscopy - Cells on 
coverslips were fixed with 3% paraformaldehyde 
in PBS and quenched in 50 mM NH4Cl. They 
were permeabilized in 0.1% Triton X-100, 
blocked in 5% FCS and incubated with 
monoclonal anti-myc antibody at 1 mg/ml in 
PBS containing 1% FCS. The secondary 
antibody was anti-mouse Alexa 488 (Molecular 
Probes). Preparations were mounted using 
Citifluor AP1 (PLANO) and examined with a 
Nikon Eclipse 800 fluorescent microscope. 
 
Chemical Cross-linking - HeLa cells were 
resuspended in KHM buffer and homogenized 
on ice by pressing the suspension 10-15 times 
through a metal ball cracker (EMBL, 
Heidelberg). Cell lysates and dialyzed 
recombinant proteins were mixed with various 
concentrations of cross-linking agent 
Dithiobis(succinimidylpropionate) (DSP, Pierce) 
for 2h on ice, and the reaction was stopped by 
quenching free active groups with 50 mM Tris-
HCl, pH 6.8, for 1h on ice. Samples were 
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analyzed by SDS-PAGE in the presence or 
absence of 100 mM DTT. 
 
Blot overlay assays - Recombinant polypeptides 
were resolved by SDS-PAGE and blotted to 
nitrocellulose membranes as described (11). 
Membranes were stained with Ponceau S, 
washed with PBS containing 0.05% Tween 20 
and incubated in overlay buffer (10 mM Hepes, 
pH 7.4, 100 mM NaCl, 5 mM MgCl2, 2 mM 
EGTA, 0.1 % Triton X-100, 1 mM DTT) for 1h. 
After blocking with 2 % BSA in overlay buffer, 
membranes were probed 3 h with 35S-
methionine-labeled polypeptides diluted 1:50 in 
overlay buffer plus 1% BSA. Membranes were 
washed extensively with overlay buffer and 
bound proteins were detected by 
autoradiography. 
 
In vitro transcription/translation and GFP-
immunoprecipitation - 150"l protein A 
sepharose were coupled overnight with 6 "l 
polyclonal anti-GFP antibodies and 150"l 
protein G sepharose with 1 ml monoclonal anti-
LAP2 antibody 12. [35S]-labeled wild-type or 
mutated LAP2! were expressed by in vitro 
transcription/translation using the TNT Quick 
Coupled Transcription/Translation reaction mix 
(Promega) either alone or together with GFP-
tagged wild-type LAP2! (pSV5, pSV5 and 
gAG43, pAG39, pAG39 and gAG43). After 
incubation at 30°C for 3 h binding buffer (50 
mM HEPES pH 7.4, 50 mM NaCl, 5 mM MgCl2, 
1 mM EGTA, 0.1 % Triton, 1 mM DTT and 1 
mM PMSF) was added to 225 "l. For pre-
clearing samples were incubated with 20 "l 
protein A sepharose or protein G sepharose for 
15 min and centrifuged at 1000 rpm for 3 min. 
Supernatants were incubated with antibody-
coupled beads (see above) for 2 h at 4°C and 
beads centrifuged through a 30 % sucrose 
cushion. Supernatants (S) and beads (P) were 
mixed with SDS sample buffer and analyzed by 
gel electrophoresis and autoradiography. 
 
Size exclusion chromatography combined with 
multi-angle light scattering (SEC-MALS)-  The 
oligomeric state of LAP2!(410-693) in solution 
was determined by SEC-MALS measurements 
performed on an ÄKTA explorer 10 system (GE 
Healthcare) connected to a tri-angle light 
scattering detector and a differential 
refractometer (miniDAWN Tristar and Optilab, 
respectively; Wyatt Technology). A Superdex 75 
HR 10/30 column (GE Healthcare) was used 
equilibrated in 0.1 M Na-Phosphate pH 7.5, 0.1 
M NaCl, 10 mM DTT at a flow rate of 0.5 
ml/min. A sample volume of 100 ml was injected 
at a concentration of 2 mg/ml. Data were 
processed using ASTRA software (Wyatt 
Technology) assuming a specific refractive index 
increment (dn/dc) of 0.185 ml/g. To determine 
the detector delay volumes and the normalization 
coefficients for the MALS detector, a BSA 
sample (Sigma A-8531) was used as reference. 
Neither despiking nor band broadening 
correction was applied. 
 
 
RESULTS 
The C-terminus of LAP2! is involved in the 
formation of oligomeric complexes in vivo – Our 
previous studies revealed the formation of stable, 
chromatin-associated LAP2! structures during 
early nuclear assembly stages when many other 
nucleoskeleton- and nuclear envelope proteins 
were still cytoplasmic (14,17), indicating 
oligomerization of the protein. To analyze 
whether LAP2! !is indeed capable of forming 
oligomeric structures that contain several LAP2! ! 
molecules in vivo and to determine the domain of 
LAP2! !responsible for oligomerization we 
generated constructs containing full-length 
LAP2! !!or the LAP2!- #specific C-terminal 
domain, LAP2!$188-693), fused to the C-
terminus of monomeric Red Fluorescent Protein 
1 (mRFP1) (Fig. 1A), and stably expressed these 
proteins in HeLa cells. Unlike GFP and DsRed, 
mRFP1 remains entirely monomeric, and 
therefore precludes misinterpretations of LAP2! 
oligomerization due to dimerization or 
tetramerization of the tag (20). Immunoblot 
analyses of cell extracts prepared from stable cell 
clones revealed the presence of fusion proteins of 
expected sizes, in amounts comparable to that of 
the endogenous LAP2! (Figure 1B, left panel). 
Both constructs reacted with polyclonal 
antibodies against LAP2!- !C-terminus (anti-
LAP2!! and antibodies against Red Fluorescent 
Protein (anti-RFP), whereas a monoclonal 
antibody directed against the N-terminal region 
of LAP2! !that is common to all LAP2 isoforms 
recognized only mRFP1- LAP2! plus the 
endogenous protein (anti-LAP2). Both mRFP1- 
LAP2! and mRFP1- LAP2!(188-693) were 
readily extracted in buffer containing 1% Triton 
X-100 and 130mM NaCl (Fig 1B, left panel). 
However, while a small fraction of endogenous 
LAP2! and of mRFP1-LAP2! remained in the 
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pellet fraction, mRFP1- LAP2!(188-693) was 
completely soluble, indicating that full-length 
LAP2! !is more tightly bound to nuclear 
complexes than the LAP2! C-terminus. 
 Next, we examined the cellular distribution 
of the tagged proteins at various stages of the cell 
cycle, using fluorescence microscopy. As shown 
in Fig. 1C, both mRFP1- LAP2!(188-693) and 
mRFP1- LAP2! localized to the nucleoplasm in 
interphase, to the cytoplasm in metaphase, and to 
chromatin in anaphase/telophase as reported 
previously for the endogenous protein and GFP-
LAP2! (14,16,17,21). Unlike the full-length 
protein, a fraction of mRFP1- LAP2!$(188-693) 
remained in the cytoplasm during anaphase (Fig. 
1C, arrow), again indicating a more soluble 
protein and a less efficient targeting of the C-
terminus to chromatin as compared to full-length 
protein. Nevertheless, these data show that the C-
terminus is capable of interacting with chromatin 
or nuclear lamina components during nuclear 
assembly in vivo.  
To investigate whether the C-terminus can also 
be incorporated into higher order LAP2! 
!structures we developed a co-
immunoprecipitation approach. The mRFP1-
LAP2!(188-693) fusion protein was modified by 
adding a Protein C-epitope and a myc-tag at the 
N-terminus (PC-myc-mRFP1-LAP2!(188-693), 
Fig. 1A), facilitating efficient isolation of the 
fusion protein from cell extracts. In addition, we 
generated a fusion protein containing Protein C-
epitope and myc-tag fused directly to the C-
terminus of LAP2!! (PC-myc- LAP2!(188-
693)). Upon stable transfection into HeLa cells, 
the fusion constructs were expressed at similar 
levels as endogenous LAP2!% as revealed by 
immunoblot analyses of cell extracts with anti- 
LAP2! and anti-myc antibodies (Fig. 1B, right 
panel). Both proteins behaved like mRFP1-
LAP2!(188-693) upon Triton extraction (Fig. 
1B) and in immunofluorescence microscopy 
(Fig. 1C). PC-myc-mRFP1-LAP2!(188-693) 
and PC-myc-LAP2!(188-693) were precipitated 
from Triton X-100 soluble cell fractions using 
the anti-Protein C matrix (Fig. 2A). A protein of 
about 80 kDa reacting with the anti-LAP2 
common domain antibody was consistently 
found in the immunoprecipitates from these 
clones, but not in non-transfected HeLa cells or 
clones expressing unrelated constructs (Fig. 2A 
and data not shown). As the region of LAP2! 
recognized by the monoclonal antibody is not 
present in the recombinant proteins, the 80-kDa 
protein could be unambiguously identified as the 
endogenous LAP2! protein. The other LAP2 
isoforms were not co-immunoprecipitated (data 
not shown). Similarly, when the tagged LAP2! 
C-terminus was precipitated with anti-myc 
antibody, full-length LAP2! was detected in the 
immunoprecipitates, whereas a control antibody 
did not bring down any of those proteins (Fig. 
2B). Likewise, unlike control antibodies, the 
anti-LAP2 common domain antibody co-
precipitated PC-myc-mRFP1-LAP2!(188-693) 
and PC-myc-LAP2!(188-693) with the 
endogenous protein, as detected using the anti-
myc antibody for immunoblotting (Fig. 2C).  
Overall, our data demonstrate that the 
LAP2!-C-terminus associated with full-length 
LAP2! in vivo, and indicate a role of the C-
terminal region in higher order structure 
organization of LAP2! complexes.  
 
LAP2! forms stable complexes of defined 
molecular weight - In order to obtain further 
evidence for the existence of oligomeric LAP2! 
complexes, we chemically cross-linked protein 
complexes in a total HeLa cell lysate using 
Dithiobis(succinimidylpropionate) (DSP). DSP-
mediated cross-links are stable in non-reducing 
conditions but can be removed by addition of 
reducing agents. HeLa cell extracts treated with 
different concentrations of DSP were analyzed 
by reducing and non-reducing SDS-PAGE and 
immunoblotting using a monoclonal antibody 
against the LAP2!-specific C-terminus (Fig. 
3A). Depending on the concentration of the 
cross-linking agent, LAP2! was detected in a 
complex with an apparent molecular mass larger 
than 200 kDa. When the cross-linking agent was 
cleaved by addition of dithiothreitol, complexes 
were dissociated yielding monomeric LAP2!. 
Intriguingly, semi-native, non-denaturing 
electrophoresis of HeLa cell lysates also revealed 
a LAP2!-complex bigger than 200 kDa (Fig. 3A, 
left lane). Hence, LAP2! may exist in a stable 
complex of approximately 200-250 kDa in vivo.  
To test whether LAP2! is able to form 
oligomeric complexes of similar sizes in vitro, 
we cross-linked highly enriched recombinant, 
bacterially expressed LAP2!. Immunoblot 
analyses revealed a LAP2!-complex of more 
than 200 kDa in non-reducing conditions (-DTT), 
while mostly the monomeric protein of ~80 kDa 
was detected in reducing conditions (Fig. 3B). 
Intriguingly, the C-terminus of LAP2!(188-693) 
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also formed larger complexes in non-reducing 
conditions, while the N-terminal region (1-187) 
mostly remained monomeric under these 
conditions. Since both, the N- and C-terminus 
contain lysine residues, which can be targeted by 
the cross-linker, we concluded that LAP2! 
forms higher order, oligomeric complexes 
through self-association of its C-terminal region.  
To further show the homo-oligomerization of 
LAP2! we generated LAP2! by in vitro 
translation in a reticulocyte lysate and analysed 
the complex by semi-native PAGE (Fig. 3C). 
Interestingly, a major band between 200 and 
250kDa was detected, in addition to the 80-kDa 
monomer. Since the reticulocyte lysate does not 
contain any nuclear proteins, which may be 
specific interaction partners for LAP2!, it is very 
likely that the >200kDa complex represented 
homo-oligomeric LAP2! complexes.  
 
The LAP2! self-interaction is mediated by the C-
terminal region - Our data suggest a direct 
interaction of the LAP2! C-terminal region with 
itself mediating homo-oligomerization of 
LAP2!. To further show that direct self-
interaction of LAP2! polypeptides can occur via 
the C-terminus, we performed additional in vitro 
binding assays. Bacterially expressed full length 
LAP2!(1-693), LAP2! C-terminus (188-693) 
and LAP2 N-terminus (1-187) were separated by 
SDS-PAGE, blotted onto a membrane and 
overlayed with radioactively labelled in vitro 
translated full-length LAP2! or LAP2! C-
terminus. Autoradiography revealed binding of 
both labelled proteins to full-length LAP2! and 
to the C-terminus, while the N-terminus did not 
interact (Fig. 4A). Thus, only the C-terminus of 
LAP2! can mediate self-interaction of the 
protein. To narrow down the self-interaction 
domain within the LAP2! C-terminus, we 
expressed different fragments of LAP2! in 
bacteria and performed solid phase overlay 
assays with radioactively labeled, in vitro 
translated, full-length LAP2! or LAP2! C-
terminus. Results presented in Figure 4B and 
summarized in Figure 4C show that removal of 
78 residues from the C-terminus of LAP2! only 
moderately affected binding of the truncated 
protein to LAP2! and LAP2! C-terminus, 
removal of the C-terminal 279 residues 
significantly reduced binding, and deletion of the 
last 439 residues abolished binding completely. 
Concomitantly, the C-terminal 284 residues of 
LAP2! (410-693) showed a binding, although 
interaction was slightly weaker than that of the 
entire C-terminus (188-693). Vimentin as a 
negative control did not interact with LAP2!.  
In order to establish the level of assembly of 
the LAP2! C-terminus and to confirm its 
interaction in solution, we performed size 
exclusion chromatography combined with multi-
angle static light scattering (SEC-MALS) and 
refractive index measurements, which yields an 
accurate determination of the molecular mass 
independent of molecular shape or 
hydrodynamic parameters. Size exclusion 
chromatograms revealed the presence of one 
single oligomeric species in solution, indicating a 
high monodispersity of LAP2!(410-693) 
populations. Further analysis by SEC-MALS 
yielded a molecular mass of 66.3 kDa, which is 
in excellent agreement with the calculated 
theoretical mass of 65.0 kDa for a dimer of this 
construct (Fig 5).  
In summary, these in vitro data demonstrate 
that the LAP2! C-terminus can specifically and 
directly bind to itself, primarily forming homo-
dimers. The self-interaction domain is located 
between residues 410 to 693, but domains 
upstream of amino acid 410 may also contribute 
to stable interactions. In contrast, the interaction 
of LAP2!’s C-terminus with lamin C is 
restricted to the last C-terminal 78 amino acids in 
LAP2! ((11), and Fig. 4B). 
 
The self association of LAP2! is not affected by 
a disease linked mutation - A mutation in the 
extreme C-terminus of LAP2! has recently been 
linked to dilated cardiomyopathy in humans (18). 
The molecular mechanism of this disease is 
currently unknown, but we have shown that the 
disease-linked mutation in LAP2! decreased its 
binding affinity for lamins A and C. Therefore, 
we wondered whether the mutation could also 
interfere with the self-association of LAP2! 
molecules and whether this could contribute to 
the cellular defect in patient cells. To test this 
hypothesis, GFP-LAP2! and untagged wild type 
or disease-linked LAP2! variants were in vitro 
translated simultaneously using a reticulocyte 
extract, and LAP2! complexes were 
immunoprecipitated with anti-GFP antibody. 
Immunoblot analyses using LAP2! antibodies 
detected untagged LAP2! in the 
immunoprecipitates only when GFP-LAP2! was 
present in the samples, whereas untagged protein 
alone was not precipitated by anti GFP 
antibodies (Fig. 6). These data clearly support 
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the direct self-interaction of LAP2! molecules. 
Both, wild type and mutated LAP2! co-
precipitated with GFP-LAP2! with similar 
efficiencies, indicating that the disease-linked 
mutation in LAP2! does not interfere with its 
self-association.  
 
 
DISCUSSION 
The studies presented here revealed a so far 
unappreciated biochemical property of LAP2!, 
the formation of homo-oligomeric structures. 
Co-immunoprecipitation of endogenous LAP2! 
with exogenously expressed full-length LAP2! 
or different fusion proteins containing the !-
specific C-terminal domain demonstrated that 
higher order LAP2! structures occur in living 
cells, are stable and require the protein’s unique 
C-terminus. In vitro overlay studies and size 
exclusion chromatography of purified proteins 
combined with multi-angle light scattering 
showed that LAP2! can form homo-dimers by 
direct interaction of its C-terminus.  
 
LAP2! C-terminus is involved in several 
interactions - In vitro overlay experiments and 
light scattering of purified protein complexes in 
solution clearly showed that LAP2! can form 
homo-oligomers through direct interaction of the 
C-terminus. While the last 284 amino acids were 
sufficient for dimerization, other more upstream 
regions may also contribute to the stabilization of 
this interaction.  The C-terminus has been shown 
to contain several additional binding domains: 
The last 78 amino acids of LAP2! are involved 
in the interaction with lamin C (11), while 
further upstream regions mediate the interaction 
with pRb (12). Although we cannot rule out that 
the binding regions of LAP2! for pRb and for 
self-association overlap and influence each other, 
we argue that self-assembly of LAP2! may 
occur at the same time as interactions with 
laminA/C and pRb. By this LAP2! structures 
can act as a platform supporting higher order 
chromatin structure and transcriptional 
regulation.  
Intriguingly, mutated LAP2! (R690C) 
expressed in the human disease DCM showed 
reduced binding to lamin A tail in vitro (18), 
while LAP2! self-association was not impaired 
by the R690C substitution. This observation is 
consistent with the results of overlay blots 
indicating a relatively broad interface of self-
interaction between LAP2! monomers 
potentially involving several regions within its 
unique C-terminus. 
 
Size of stable homo-oligomeric LAP2! 
structures - Analysis of HeLa cell extracts after 
chemical cross-linking or in semi-native non-
denaturing gels showed the presence of stable 
LAP2!-containing complexes of molecular 
masses between 200-250 kDa. Complexes of the 
same size were detected after cross-linking of 
bacterially expressed LAP2! and by semi-native 
PAGE of LAP2! expressed in reticulocyte 
lysate, indicating that LAP2! is the only protein 
in the 200-250 kDa complex. According to their 
size, these complexes might accommodate three 
LAP2! molecules of 75-80 kDa. However, light 
scattering analyses of highly purified bacterially 
expressed LAP2! !C-terminal fragment revealed 
a high monodispersity of the sample strongly 
arguing for a stable dimeric organization. 
Therefore we consider it very unlikely that 
LAP2! forms trimers and favour the idea that 
the > 200kDa complex of LAP2! either 
represents a homodimer, which shows unusual 
mobility in gel electrophoresis due to 
anisometric features, or a compact homo-
tetramer with slightly increased mobility.  
 
Functional implication of the LAP2! self 
interaction - By fluorescent microscopy, LAP2! 
C-terminal domain stably expressed in HeLa 
cells showed a cellular distribution identical to 
endogenous LAP2!, except for anaphase-
telophase, where it showed a slightly less 
efficient association with chromosomes. This 
observation supports previous findings, showing 
that the C-terminus is required and sufficient for 
chromosome association of LAP2! during 
nuclear assembly (17). The less efficient 
chromatin binding of LAP2! C-terminus to 
chromatin also indicates that, although the C-
terminus is sufficient for targeting LAP2! to 
chromosomes, its stable association requires also 
the N-terminal common domain. However, based 
on the data presented here, we cannot rule out 
completely that the C-terminal fragment 
associated with chromosomes mainly through its 
interaction with full length endogeneous LAP2! 
during nuclear assembly in vivo. 
In any case, the engagement of LAP2! in a 
self-interaction has important implications for its 
reported functions. The formation of LAP2! 
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homo- or hetero-oligomeric complexes has 
several consequences for its chromatin binding 
properties. First, by bringing various LEM- and 
LEM-like domains together in a LAP2! 
oligomer and thus potentially generating multiple 
binding sites for BAF and DNA in the 
oligomeric complex, its affinity for chromatin 
could be significantly increased. Secondly, the 
N-termini of the oligomeric complex could 
interact simultaneously with several DNA fibers 
and thus perform efficient cross-linking of 
chromatin regions. In line with this model it was 
shown that full length LAP2! and BAF are 
essential components of the preintegration 
complex (PIC) of retroviruses (22). LAP2!’s 
proposed role in stabilizing the interaction of 
BAF with PICs required both the N-terminal 
common domain and the  -specific C-terminal 
domain of LAP2!. Our results, showing that the 
C-terminus is the determinant for 
oligomerization of LAP2!% provide a possible 
explanation for this observation. 
In conclusion, our data suggest a model 
where a homo-dimeric core complex of LAP2!, 
formed via self-association of the C-terminal 
domain, serves as the building block for higher-
order homo and hetero-oligomeric structures of 
LAP2!.  
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FIGURE LEGENDS 
 
FIGURE 1. Stable expression of LAP2!  and the ! -specific C-terminus in HeLa cells. A, 
schematic presentation of fusion proteins of full-length LAP2! and LAP2!(188-693) with mRFP1, 
Protein C epitope and myc-tag, and for comparison, the domain organizations of LAP2! and LAP2! 
are shown. The light gray region represents the LAP2!-specific C-terminus; gray and black boxes 
show positions of LEM-, LEM-like-, and transmembrane domains, respectively. Arrow indicates the 
epitope recognized by the monoclonal anti-LAP2 common domain antibody. B, untransfected HeLa 
cells (Hela) or HeLa cells stably expressing the indicated constructs described in A were lysed in 1% 
Triton X-100 and total cell lysates (T), or pellet (P) and supernatant (S) fractions following 
centrifugation were analyzed by immunoblotting using polyclonal anti- LAP2! (anti- LAP2!), 
monoclonal anti-LAP2 common domain (anti-LAP2) and polyclonal anti-DsRed (anti-RFP) or 
polyclonal anti-myc antibodies, as indicated. Numbers show molecular masses in kDa. C, cells 
expressing mRFP1- LAP2! or mRFP1- LAP2!(188-693), or PC-myc- LAP2!(188-693) as indicated, 
were analyzed at various cell cycle stages by fluorescence microscopy. Left images show mRFP1 or 
anti-myc staining, right images DAPI-stained DNA. Arrow indicates anaphase cells with remaining 
cytoplasmic staining. Bar, 10 µm.    
 
FIGURE 2. Co-immunoprecipitation of endogenous LAP2!  with expressed LAP2!  C-terminus 
from HeLa cell extracts. A, soluble cell extracts of non-transfected HeLa cells, two HeLa clones 
expressing PC-myc-mRFP1- LAP2!(188-693), and one clone expressing PC-myc- LAP2!(188-693) 
were incubated with anti-Protein C matrix and immunoprecipitates were analyzed by immunoblotting 
using anti-LAP2 common domain antibody. B, cell extracts were incubated with monoclonal anti-myc 
(+) or a control monoclonal antibody (-) and immunoprecipitates  probed with anti-LAP2 antibody. C, 
extracts were incubated with monoclonal anti-LAP2 (+) or with control (-) antibody and 
immunoprecipitates probed with anti-myc antibody. 
 
FIGURE 3. Analysis of LAP2!  complexes by chemical crosslinking and seminative gel 
electrophoresis. A, HeLa cell lysates were analyzed on semi-native polyacrylamide gels (Endogenous 
complex, left panel) or incubated with the indicated amounts of DSP for 2h, dissolved in sample buffer 
containing (+) or lacking (-) DTT and analyzed by SDS-polyacrylamide gel electrophoresis and 
immunoblotting using monoclonal anti- LAP2! !antibody 15/2. B, bacterially expressed full-length 
LAP2! and LAP2! fragments, as indicated, were incubated with 1mM DSP, mixed with sample 
buffer with (+) or without (-) DTT and analyzed by immunoblotting using monoclonal anti- LAP2! 
antibody 15/2 (left and central panels) or anti-LAP2 antibody 12 (right panel). C, in vitro translated, 
[35S]methionine-labeled LAP2! was analyzed by seminative PAGE and autoradiography. Numbers 
denote molecular masses in kDa, arrows indicate position of monomeric proteins and arrowheads 
position of complexes.  
 
FIGURE 4. LAP2!  self-associates via its !-specific C-terminus in vitro. A, in vitro translated 
[35S]methionine-labeled LAP2! or the !-specific domain LAP2!(188-693) were overlayed onto 
immobilized bacterially expressed full-length LAP2!, LAP2!(188-693) and LAP2(1-187). An 
autoradiogram of an SDS-polyacrylamide gel of in vitro translated proteins (Autoradiogram), a 
Coomassie blue-stained gel of bacterially expressed proteins (Coomassie), and autoradiograms of 
overlays (Overlay) are shown. B, transblotted vimentin and recombinant LAP2! fragments, as 
indicated, were overlayed with in vitro translated [35S]methionine-labeled recombinant full-length 
LAP2! or the !-specific domain LAP2!(188-693). Ponceau S-stain of blotted LAP2! fragments and 
autoradiograms of overlays are shown. Numbers show molecular masses in kDa. C, schematic 
diagrams of immobilized LAP2! and LAP2! fragments used in B are shown. Numbers denote amino 
acid position. The right panel indicates binding of the in vitro translated proteins to immobilized 
proteins, based on signal intensities on autoradiograms of the overlays (++++, strongest interaction; 
+, weakest interaction; -, no interaction). The calculated molecular masses (Mr) of LAP2! and 
LAP2! fragments are shown in kDa. 
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FIGURE 5:  Analysis of purified LAP2!  C-terminal fragment 410-693 by size exclusion 
chromatography combined with multi-angle light scattering (SEC-MALS).
 
The refractive index of the corresponding peak region of a size exclusion chromatogram (Superdex 75 
HR 13/30) performed in 0.1 M Na-Phosphate, pH 7.5, 0.1 M NaCl, 10 mM DTT is shown as solid 
line. The weight-averaged molecular mass measured inside the peak area at volume intervals is 
displayed as filled squares. The theoretical molecular mass is indicated by the continuous horizontal 
line.  
 
FIGURE 6: A disease (DCM)-causing mutation in LAP2!  does not affect its self-interaction. 
Wild type LAP2! !or DCM mutant LAP2! were in vitro translated and labeled with [35S]methionine in 
a reticulocyte extract either alone or with GFP-LAP2!, and complexes were immunoprecipitated 
using anti-GFP antibody. Input samples and supernatants (S) and pellet (P) fractions were analyzed by 
SDS PAGE and autoradiography. Numbers indicate molecular masses in kDa. 
 




  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5, Snyers et al.  
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